Document:

Form of Subordinated Debt Indenture between the Registrant and The Bank of New

 EXHIBIT 4.4 

 
  
 UIL HOLDINGS CORPORATION 
 as the Company 

and 

THE BANK OF NEW YORK MELLON 
 as Trustee 
 Subordinated Indenture 

Dated as of                  ,
20     
  
  

 TABLE OF CONTENTS 

 

							
	 	  	 	  	PAGE	 
	
	 ARTICLE 1
 DEFINITIONS AND INCORPORATION BY REFERENCE
	   

  

			
	 Section 1.01.
	  	 Definitions
	  	 	1	  
	 Section 1.02.
	  	 Other Definitions
	  	 	4	  
	 Section 1.03.
	  	 Incorporation of Trust Indenture Act by Reference
	  	 	4	  
	 Section 1.04.
	  	 Rules of Construction
	  	 	4	  
	
	 ARTICLE 2
 THE SECURITIES
	   

  

			
	 Section 2.01.
	  	 Form and Dating
	  	 	5	  
	 Section 2.02.
	  	 Execution And Authentication
	  	 	5	  
	 Section 2.03.
	  	 Amount Unlimited; Issuable in Series
	  	 	6	  
	 Section 2.04.
	  	 Denomination and Date of Securities; Payments of Interest
	  	 	7	  
	 Section 2.05.
	  	 Registrar and Paying Agent; Agents Generally
	  	 	7	  
	 Section 2.06.
	  	 Paying Agent to Hold Money in Trust
	  	 	8	  
	 Section 2.07.
	  	 Transfer and Exchange
	  	 	8	  
	 Section 2.08.
	  	 Replacement Securities
	  	 	9	  
	 Section 2.09.
	  	 Outstanding Securities
	  	 	10	  
	 Section 2.10.
	  	 Temporary Securities
	  	 	10	  
	 Section 2.11.
	  	 Cancellation
	  	 	10	  
	 Section 2.12.
	  	 CUSIP Numbers
	  	 	11	  
	 Section 2.13.
	  	 Defaulted Interest
	  	 	11	  
	 Section 2.14.
	  	 Series May Include Tranches
	  	 	11	  
	
	 ARTICLE 3
 REDEMPTION
	   

  

			
	 Section 3.01.
	  	 Applicability of Article
	  	 	11	  
	 Section 3.02.
	  	 Notice of Redemption; Partial Redemptions
	  	 	11	  
	 Section 3.03.
	  	 Payment Of Securities Called For Redemption
	  	 	12	  
	 Section 3.04.
	  	 Exclusion of Certain Securities from Eligibility for Selection for Redemption
	  	 	12	  
	 Section 3.05.
	  	 Mandatory and Optional Sinking Funds
	  	 	12	  
	
	 ARTICLE 4
 COVENANTS
	   

  

			
	 Section 4.01.
	  	 Payment of Securities
	  	 	14	  
	 Section 4.02.
	  	 Maintenance of Office or Agency
	  	 	14	  
	 Section 4.03.
	  	 Securityholders’ Lists
	  	 	14	  
	 Section 4.04.
	  	 Certificate to Trustee
	  	 	14	  

  
 i 

							
	 	  	 	  	PAGE	 
			
	 Section 4.05.
	  	 Reports by the Company
	  	 	14	  
	 Section 4.06.
	  	 Additional Amounts
	  	 	15	  
	
	 ARTICLE 5
 SUCCESSOR CORPORATION
	   

  

			
	 Section 5.01.
	  	 When Company May Merge, Etc.
	  	 	15	  
	 Section 5.02.
	  	 Successor Substituted
	  	 	15	  
	
	 ARTICLE 6
 DEFAULT AND REMEDIES
	   

  

			
	 Section 6.01.
	  	 Events of Default
	  	 	15	  
	 Section 6.02.
	  	 Acceleration
	  	 	16	  
	 Section 6.03.
	  	 Other Remedies
	  	 	17	  
	 Section 6.04.
	  	 Waiver of Past Defaults
	  	 	17	  
	 Section 6.05.
	  	 Control by Majority
	  	 	17	  
	 Section 6.06.
	  	 Limitation on Suits
	  	 	17	  
	 Section 6.07.
	  	 Rights of Holders to Receive Payment
	  	 	17	  
	 Section 6.08.
	  	 Collection Suit by Trustee
	  	 	17	  
	 Section 6.09.
	  	 Trustee May File Proofs of Claim
	  	 	18	  
	 Section 6.10.
	  	 Application of Proceeds
	  	 	18	  
	 Section 6.11.
	  	 Restoration of Rights and Remedies
	  	 	18	  
	 Section 6.12.
	  	 Undertaking for Costs
	  	 	18	  
	 Section 6.13.
	  	 Rights and Remedies Cumulative
	  	 	19	  
	 Section 6.14.
	  	 Delay or Omission not Waiver
	  	 	19	  
	
	 ARTICLE 7
 TRUSTEE
	   

  

			
	 Section 7.01.
	  	 General
	  	 	19	  
	 Section 7.02.
	  	 Certain Rights of Trustee
	  	 	19	  
	 Section 7.03.
	  	 Individual Rights of Trustee
	  	 	20	  
	 Section 7.04.
	  	 Trustee’s Disclaimer
	  	 	20	  
	 Section 7.05.
	  	 Notice of Default
	  	 	20	  
	 Section 7.06.
	  	 Reports by Trustee to Holders
	  	 	21	  
	 Section 7.07.
	  	 Compensation and Indemnity
	  	 	21	  
	 Section 7.08.
	  	 Replacement of Trustee
	  	 	21	  
	 Section 7.09.
	  	 Acceptance of Appointment by Successor
	  	 	22	  
	 Section 7.10.
	  	 Successor Trustee By Merger, Etc.
	  	 	22	  
	 Section 7.11.
	  	 Eligibility
	  	 	22	  
	 Section 7.12.
	  	 Money Held in Trust
	  	 	23	  
	
	 ARTICLE 8
 SATISFACTION AND DISCHARGE OF INDENTURE; UNCLAIMED MONEYS
	   

  

			
	 Section 8.01.
	  	 Satisfaction and Discharge of Indenture
	  	 	23	  

  
 ii 

							
	 	  	 	  	PAGE	 
			
	 Section 8.02.
	  	 Application by Trustee of Funds Deposited for Payment of Securities
	  	 	23	  
	 Section 8.03.
	  	 Repayment of Moneys Held by Paying Agent
	  	 	23	  
	 Section 8.04.
	  	 Return of Moneys Held by Trustee and Paying Agent Unclaimed for Two Years
	  	 	23	  
	 Section 8.05.
	  	 Defeasance and Discharge of Indenture
	  	 	24	  
	 Section 8.06.
	  	 Defeasance of Certain Obligations
	  	 	24	  
	 Section 8.07.
	  	 Reinstatement
	  	 	25	  
	 Section 8.08.
	  	 Indemnity
	  	 	25	  
	 Section 8.09.
	  	 Excess Funds
	  	 	25	  
	 Section 8.10.
	  	 Qualifying Trustee
	  	 	25	  
	
	 ARTICLE 9
 AMENDMENTS, SUPPLEMENTS AND WAIVERS
	   

  

			
	 Section 9.01.
	  	 Without Consent of Holders
	  	 	26	  
	 Section 9.02.
	  	 With Consent of Holders
	  	 	26	  
	 Section 9.03.
	  	 Revocation and Effect of Consent
	  	 	26	  
	 Section 9.04.
	  	 Notation on or Exchange of Securities
	  	 	27	  
	 Section 9.05.
	  	 Trustee to Sign Amendments, Etc.
	  	 	27	  
	 Section 9.06.
	  	 Conformity with Trust Indenture Act
	  	 	27	  
	
	 ARTICLE 10
 MISCELLANEOUS
	   

  

			
	 Section 10.01.
	  	 Trust Indenture Act of 1939
	  	 	27	  
	 Section 10.02.
	  	 Notices
	  	 	27	  
	 Section 10.03.
	  	 Certificate and Opinion as to Conditions Precedent
	  	 	28	  
	 Section 10.04.
	  	 Statements Required in Certificate or Opinion
	  	 	28	  
	 Section 10.05.
	  	 Evidence of Ownership
	  	 	28	  
	 Section 10.06.
	  	 Rules by Trustee, Paying Agent or Registrar
	  	 	29	  
	 Section 10.07.
	  	 Payment Date Other Than a Business Day
	  	 	29	  
	 Section 10.08.
	  	 Governing Law
	  	 	29	  
	 Section 10.09.
	  	 No Adverse Interpretation of Other Agreements
	  	 	29	  
	 Section 10.10.
	  	 Successors
	  	 	29	  
	 Section 10.11.
	  	 Duplicate Originals
	  	 	29	  
	 Section 10.12.
	  	 Separability
	  	 	29	  
	 Section 10.13.
	  	 Table of Contents, Headings, Etc.
	  	 	29	  
	 Section 10.14.
	  	 Incorporators, Stockholders, Officers and Directors of Company Exempt from Individual Liability
	  	 	29	  
	 Section 10.15.
	  	 Judgment Currency
	  	 	29	  
	 Section 10.16.
	  	 Submission to Jurisdiction; Waiver of Jury Trial
	  	 	29	  
	
	 ARTICLE 11
 SUBORDINATION OF SECURITIES
	   

  

			
	 Section 11.01.
	  	 Agreement to Subordinate
	  	 	30	  

  
 iii

							
	 	  	 	  	PAGE	 
			
	 Section 11.02.
	  	 Payments to Securityholders
	  	 	30	  
	 Section 11.03.
	  	 Subrogation of Securities
	  	 	31	  
	 Section 11.04.
	  	 Authorization by Securityholders
	  	 	31	  
	 Section 11.05.
	  	 Notice to Trustee
	  	 	31	  
	 Section 11.06.
	  	 Trustee’s Relation to Senior Indebtedness
	  	 	32	  
	 Section 11.07.
	  	 No Impairment of Subordination
	  	 	32	  
		
	 SIGNATURES
	  			

  
 iv 

 SUBORDINATED INDENTURE, dated as of             
    , 20    , between UIL Holdings Corporation, a Connecticut corporation, as the Company, and The Bank of New York Mellon, a corporation organized under the laws of the State of New York authorized to conduct
a banking business, as Trustee. 
 RECITALS OF THE COMPANY 

WHEREAS, the Company has duly authorized the issue from time to time of its subordinated debentures, notes or other evidences of
indebtedness to be issued in one or more series (the “Securities”) up to such principal amount or amounts as may from time to time be authorized in accordance with the terms of this Indenture and to provide, among other things, for
the authentication, delivery and administration thereof, the Company has duly authorized the execution and delivery of this Indenture; and 
 WHEREAS, all things necessary to make this Indenture a valid indenture and agreement according to its terms have been done; 
 NOW, THEREFORE: 
 In consideration of the premises and the purchases of the
Securities by the Holders thereof, the Company and the Trustee mutually covenant and agree for the equal and proportionate benefit of the respective Holders from time to time of the Securities as follows: 

ARTICLE 1 

DEFINITIONS AND INCORPORATION BY REFERENCE 
 Section 1.01. Definitions. 
 “Affiliate” of any
Person means any other Person directly or indirectly controlling or controlled by or under direct or indirect common control with such Person. For the purposes of this definition, “control” (including, with correlative meanings, the terms
“controlling”, “controlled by” and “under common control with”) when used with respect to any Person means the possession, directly or indirectly, of the power to direct or cause the direction of the management and
policies of such Person, whether through the ownership of voting securities, by contract or otherwise. 

“Agent” means any Registrar, Paying Agent, transfer agent, Authenticating Agent or any other agent appointed hereunder.

 “Board Resolution” means one or more resolutions of the board of directors of the Company or any authorized
committee thereof, certified by the secretary or an assistant secretary to have been duly adopted and to be in full force and effect on the date of certification, and delivered to the Trustee. 

“Business Day” means any day, other than a Saturday or Sunday, that is neither a legal holiday nor a day on which
banking institutions are authorized or required by law or regulation to close in The City of New York, with respect to any Security the interest on which is based on the offered quotations in the interbank Eurodollar market for dollar deposits, in
London, or with respect to Securities denominated in a specified currency other than United States dollars, in the place of payment established in accordance with Section 2.03(e). 

“Capital Lease” means, with respect to any Person, any lease of any property which, in conformity with GAAP, is required
to be capitalized on the balance sheet of such Person. 
 “Commission” means the Securities and Exchange
Commission, as from time to time constituted, created under the Exchange Act or, if at any time after the execution of this instrument such Commission is not existing and performing the duties now assigned to it under the Trust Indenture Act, then
the body performing such duties at such time. 
 “Company” means the party named as such in the first paragraph
of this Indenture until a successor replaces it pursuant to Article 5 of this Indenture and thereafter means the successor. 
 “Corporate Trust Office” means the office of the Trustee at which the corporate trust business of the Trustee shall, at any particular time, be principally administered, which office is,
at the date of this Indenture, located at 101 Barclay Street, 4E New York, New York 10286. 
 “Currency
Agreement” means, with respect to any Person, any foreign exchange contract, currency swap agreement or other similar agreement or arrangement designed to protect such Person or any of its Subsidiaries against fluctuations in currency
values to or under which such Person or any of its Subsidiaries is a party or a beneficiary on the date hereof or becomes a party or a beneficiary thereafter. 

 “Debt” means, with respect to any Person at any date of determination
(without duplication), (i) all indebtedness of such Person for borrowed money, (ii) all obligations of such Person evidenced by bonds, debentures, notes or other similar instruments, (iii) all obligations of such Person in respect of
letters of credit or bankers’ acceptance or other similar instruments (or reimbursement obligations with respect thereto), (iv) all obligations of such Person to pay the deferred purchase price of property or services, except Trade
Payables, (v) all obligations of such Person as lessee under Capital Leases, (vi) all Debt of others secured by a Lien on any asset of such Person, whether or not such Debt is assumed by such Person; provided that, for purposes of
determining the amount of any Debt of the type described in this clause, if recourse with respect to such Debt is limited to such asset, the amount of such Debt shall be limited to the lesser of the fair market value of such asset or the amount of
such Debt, (vii) all Debt of others Guaranteed by such Person to the extent such Debt is Guaranteed by such Person, (viii) all redeemable stock valued at the greater of its voluntary or involuntary liquidation preference plus accrued and
unpaid dividends and (ix) to the extent not otherwise included in this definition, all obligations of such Person under Currency Agreements and Interest Rate Agreements. 
 “Default” means any event that is, or after notice or passage of time or both would be, an Event of Default. 
 “Depositary” means, with respect to the Securities of any series issuable or issued in the form of one or more Global Securities, the Person designated as Depositary by the Company
pursuant to Section 2.03 until a successor Depositary shall have become such pursuant to the applicable provisions of this Indenture, and thereafter “Depositary” shall mean or include each Person who is then a Depositary
hereunder, and if at any time there is more than one such Person, “Depositary” as used with respect to the Securities of any such series shall mean the Depositary with respect to the Global Securities of that series.

 “Exchange Act” means the Securities Exchange Act of 1934, as amended. 

“GAAP” means generally accepted accounting principles in the U.S. as in effect as of the date hereof applied on a basis
consistent with the principles, methods, procedures and practices employed in the preparation of the Company’s audited financial statements, including, without limitation, those set forth in the opinions and pronouncements of the Accounting
Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such other entity as is approved by a significant segment of the
accounting profession. 
 “Global Security” means a Security evidencing all or a part of a series of
Securities, issued to the Depositary or its nominee for such series in accordance with Section 2.02, and bearing the legend prescribed in Section 2.02. 
 “Guarantee” means any obligation, contingent or otherwise, of any Person directly or indirectly guaranteeing any Debt or other obligation of any other Person and, without limiting the
generality of the foregoing, any obligation, direct or indirect, contingent or otherwise, of such Person (i) to purchase or pay (or advance or supply funds for the purchase or payment of) such Debt or other obligation of such other Person
(whether arising by virtue of partnership arrangements, or by agreement to keepwell, to purchase assets, goods, securities or services, to take-or-pay, or to maintain financial statement conditions or otherwise) or (ii) entered into for
purposes of assuring in any other manner the obligee of such Debt or other obligation of the payment thereof or to protect such obligee against loss in respect thereof (in whole or in part); provided that the term “Guarantee”
shall not include endorsements for collection or deposit in the ordinary course of business. The term “Guarantee” used as a verb has a corresponding meaning. 
 “Holder” or “Securityholder” means the Person shown in the Security Register kept by the Registrar as the registered holder of any Security. 

“Indenture” means this Indenture as originally executed and delivered or as it may be amended or supplemented from time
to time by one or more indentures supplemental to this Indenture entered into pursuant to the applicable provisions of this Indenture and shall include the forms and terms of the Securities of each series established as contemplated pursuant to
Sections 2.01 and 2.03. 
 “Interest Rate Agreement” means, with respect to any Person, any interest rate
protection agreement, interest rate future agreement, interest rate option agreement, interest rate swap agreement, interest rate cap agreement, interest rate collar agreement, interest rate hedge agreement or other similar agreement or arrangement
designed to protect such Person or any of its Subsidiaries against fluctuations in interest rates to or under which such Person or any of its Subsidiaries is a party or a beneficiary on the date hereof or becomes a party or a beneficiary thereafter.

 “Lien” means, with respect to any property, any mortgage, lien, pledge, charge, security interest or
encumbrance of any kind in respect of such property. For purposes of this Indenture, the Company shall be deemed to own subject to a Lien any property which it has acquired or holds subject to the interest of a vendor or lessor under any conditional
sale agreement, Capital Lease or other title retention agreement relating to such property. 
 “Officer” means,
with respect to the Company, the chairman of the board of directors, the president or chief executive officer, any vice president, the chief financial officer, the treasurer or any assistant treasurer, or the secretary or any assistant secretary.

  
 2 

 “Officers’ Certificate” means a certificate signed in the name
of the Company (i) by the chairman of the board of directors, the president or chief executive officer or a vice president and (ii) by the chief financial officer, the treasurer or any assistant treasurer, or the secretary or any assistant
secretary, and delivered to the Trustee. Each such certificate shall comply with Section 314 of the Trust Indenture Act, if applicable, and include (except as otherwise expressly provided in this Indenture) the statements provided in
Section 10.04, if applicable. 
 “Opinion of Counsel” means a written opinion signed by legal counsel, who
may be an employee of or counsel to the Company, satisfactory to the Trustee. Each such opinion shall comply with Section 314 of the Trust Indenture Act, if applicable, and include the statements provided in Section 10.04, if and to the
extent required thereby. 
 “original issue date” of any Security (or portion thereof) means the earlier of
(a) the date of authentication of such Security or (b) the date of any Security (or portion thereof) for which such Security was issued (directly or indirectly) on registration of transfer, exchange or substitution. 

“Original Issue Discount Security” means any Security that provides for an amount less than the principal amount thereof
to be due and payable upon a declaration of acceleration of the maturity thereof pursuant to Section 6.02. 

“Periodic Offering” means an offering of Securities of a series from time to time, the specific terms of which
Securities, including, without limitation, the rate or rates of interest, if any, thereon, the stated maturity or maturities thereof and the redemption provisions, if any, with respect thereto, are to be determined by the Company or its agents upon
the issuance of such Securities. 
 “Person” means an individual, a corporation, a partnership, a limited
liability company, an association, a trust or any other entity or organization, including a government or political subdivision or an agency or instrumentality thereof. 
 “Principal” of a Security means the principal amount of, and, unless the context indicates otherwise, includes any premium payable on, the Security. 

“Responsible Officer” when used with respect to the Trustee, shall mean an officer of the Trustee in the Corporate Trust
Office, having direct responsibility for the administration of this Indenture, and also, with respect to a particular matter, any other officer to whom such matter is referred because of such officer’s knowledge of and familiarity with the
particular subject. 
 “Securities” means any of the securities, as defined in the first paragraph of the
recitals hereof, that are authenticated and delivered under this Indenture. 
 “Securities Act” means the
Securities Act of 1933, as amended. 
 “Senior Indebtedness” means the principal of (and premium, if any) and
interest on all Debt of the Company whether created, incurred or assumed before, on or after the date of this Indenture; provided that such Senior Indebtedness shall not include (i) Debt of the Company that, when incurred and without respect to
any election under Section 1111(b) of Title 11, U.S. Code, was without recourse, (ii) any other Debt of the Company which by the terms of the instrument creating or evidencing the same are specifically designated as not being senior in
right of payment to the Securities, and in particular the Securities shall rank pari passu with all other debt securities and guarantees issued to any trust, partnership or other entity affiliated with the Company which is a financing vehicle of the
Company in connection with an issuance of preferred securities by such financing entity and (iii) redeemable stock of the Company.  
 “Subsidiary” means, with respect to any Person, any corporation, association or other business entity of which a majority of the capital stock or other ownership interests having ordinary
voting power to elect a majority of the board of directors or other persons performing similar functions are at the time directly or indirectly owned by such Person. 
 “Trade Payables” means, with respect to any Person, any accounts payable or any other indebtedness or monetary obligation to trade creditors created, assumed or Guaranteed by such Person
or any of its Subsidiaries arising in the ordinary course of business in connection with the acquisition of goods or services. 

“Trustee” means the party named as such in the first paragraph of this Indenture until a successor replaces it in
accordance with the provisions of Article 7 and thereafter shall mean or include each Person who is then a Trustee hereunder, and if at any time there is more than one such Person, “Trustee” as used with respect to the Securities of
any series shall mean the Trustee with respect to Securities of that series. 
 “Trust Indenture Act” means the
Trust Indenture Act of 1939, as amended (15 U.S. Code §§ 77aaa-77bbbb), as it may be amended from time to time. 

  
 3 

 “U.S. Government Obligations” means securities that are (i) direct
obligations of the United States of America for the payment of which its full faith and credit is pledged or (ii) obligations of an agency or instrumentality of the United States of America the payment of which is unconditionally guaranteed as
a full faith and credit obligation by the United States of America, and shall also include a depository receipt issued by a bank or trust company as custodian with respect to any such U.S. Government Obligation or a specific payment of interest on
or principal of any such U.S. Government Obligation held by such custodian for the account of the holder of a depository receipt; provided that (except as required by law) such custodian is not authorized to make any deduction from the amount
payable to the holder of such depository receipt from any amount received by the custodian in respect of the U.S. Government Obligation or the specific payment of interest on or principal of the U.S. Government Obligation evidenced by such
depository receipt. 
 “Yield to Maturity” means, as the context may require, the yield to maturity (i) on
a series of Securities or (ii) if the Securities of a series are issuable from time to time, on a Security of such series, calculated at the time of issuance of such series in the case of clause (i) or at the time of issuance of such
Security of such series in the case of clause (ii), or, if applicable, at the most recent redetermination of interest on such series or on such Security, and calculated in accordance with the constant interest method or such other accepted financial
practice as is specified in the terms of such Security. 
 Section 1.02. Other Definitions. Each of
the following terms is defined in the section set forth opposite such term: 
  

					
	 Term
	  	Section	 
		
	 Authenticating Agent
	  	 	2.02    	  
	 Cash Transaction
	  	 	7.03    	  
	 Dollars
	  	 	4.02    	  
	 Event of Default
	  	 	6.01    	  
	 Judgment Currency
	  	 	10.15(a	) 
	 mandatory sinking fund payment
	  	 	3.05    	  
	 optional sinking fund payment
	  	 	3.05    	  
	 Paying Agent
	  	 	2.05    	  
	 record date
	  	 	2.04    	  
	 Registrar
	  	 	2.05    	  
	 Required Currency
	  	 	10.15(a	) 
	 Security Register
	  	 	2.05    	  
	 self-liquidating paper
	  	 	7.03    	  
	 sinking fund payment date
	  	 	3.05    	  
	 tranche
	  	 	2.14    	  

 Section 1.03. Incorporation of Trust Indenture Act by Reference. Whenever this
Indenture refers to a provision of the Trust Indenture Act, the provision is incorporated by reference in and made a part of this Indenture. The following terms used in this Indenture that are defined by the Trust Indenture Act have the following
meanings: 
 “indenture securities” means the Securities; 

“indenture security holder” means a Holder or a Securityholder; 

“indenture to be qualified” means this Indenture; 

“indenture trustee” or “institutional trustee” means the Trustee; and 

“obligor” on the indenture securities means the Company or any other obligor on the Securities. 

All other terms used in this Indenture that are defined by the Trust Indenture Act, defined by reference in the Trust Indenture Act to
another statute or defined by a rule of the Commission and not otherwise defined herein have the meanings assigned to them therein. 
 Section 1.04. Rules of Construction. Unless the context otherwise requires: 
 (a) an accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP; 
 (b) words in the singular include the plural, and words in the plural include the singular; 
 (c) “herein,” “hereof” and other words of similar import refer to this Indenture as a whole and not to any particular Article, Section or other subdivision; 

  
 4 

 (d) all references to Sections or Articles refer to Sections or Articles of this
Indenture unless otherwise indicated; and 
 (e) use of masculine, feminine or neuter pronouns should not be deemed a
limitation, and the use of any such pronouns should be construed to include, where appropriate, the other pronouns. 
 ARTICLE
2 
 THE SECURITIES 
 Section 2.01. Form and Dating. The Securities of each series shall be substantially in such form or forms (not inconsistent with this Indenture) as shall be established by or
pursuant to one or more Board Resolutions or in one or more indentures supplemental hereto, in each case with such appropriate insertions, omissions, substitutions and other variations as are required or permitted by this Indenture and may have
imprinted or otherwise reproduced thereon such legend or legends or endorsements, not inconsistent with the provisions of this Indenture, as may be required to comply with any law, or with any rules of any securities exchange or usage, all as may be
determined by the Officers executing such Securities as evidenced by their execution of the Securities. 

Section 2.02. Execution And Authentication. Two Officers shall execute the Securities for the Company by
facsimile or manual signature in the name and on behalf of the Company. If an Officer whose signature is on a Security no longer holds that office at the time the Security is authenticated, the Security shall nevertheless be valid. 

The Trustee, at the expense of the Company, may appoint an authenticating agent (the “Authenticating Agent”) to
authenticate Securities. The Authenticating Agent may authenticate Securities whenever the Trustee may do so. Each reference in this Indenture to authentication by the Trustee includes authentication by such Authenticating Agent. 

A Security shall not be valid until the Trustee or Authenticating Agent manually signs the certificate of authentication on the Security
by an authorized signatory. The signature shall be conclusive evidence that the Security has been authenticated under this Indenture. 
 At any time and from time to time after the execution and delivery of this Indenture, the Company may deliver Securities of any series executed by the Company to the Trustee for authentication together
with the applicable documents referred to below in this Section, and the Trustee shall thereupon authenticate and deliver such Securities to or upon the written order of the Company. In authenticating any Securities of a series, the Trustee shall be
entitled to receive prior to the authentication of any Securities of such series, and (subject to Article 7) shall be fully protected in relying upon, unless and until such documents have been superseded or revoked: 

(a) any Board Resolution and/or executed supplemental indenture referred to in Sections 2.01 and 2.03 by or pursuant to which
the forms and terms of the Securities of that series were established; 
 (b) an Officers’ Certificate setting forth
the form or forms and terms of the Securities, stating that the form or forms and terms of the Securities of such series have been, or, in the case of a Periodic Offering, will be when established in accordance with such procedures as shall be
referred to therein, established in compliance with this Indenture; and 
 (c) an Opinion of Counsel substantially to the
effect that the form or forms and terms of the Securities of such series have been, or, in the case of a Periodic Offering, will be when established in accordance with such procedures as shall be referred to therein, established in compliance with
this Indenture and that the supplemental indenture, to the extent applicable, and Securities have been duly authorized and, if authenticated in accordance with the provisions of the Indenture and delivered to and duly paid for by the purchasers
thereof on the date of such opinion, would be entitled to the benefits of the Indenture and would be valid and binding obligations of the Company, enforceable against the Company in accordance with their respective terms, subject to bankruptcy,
insolvency, reorganization, receivership, moratorium and other similar laws affecting creditors’ rights generally, general principles of equity, and covering such other matters as shall be specified therein and as shall be reasonably requested
by the Trustee. 
 The Trustee shall not be required to authenticate such Securities if the issue of such Securities pursuant to
this Indenture will affect the Trustee’s own rights, duties or immunities under the Securities and this Indenture or otherwise in a manner which is not reasonably acceptable to the Trustee. 

Notwithstanding the provisions of Sections 2.01 and 2.02, if, in connection with a Periodic Offering, all Securities of a series are
not to be originally issued at one time, it shall not be necessary to deliver the Board Resolution otherwise required pursuant to Section 2.01 or the written order, Officers’ Certificate and Opinion of Counsel otherwise required pursuant
to Section 2.02 at or prior to the authentication of each Security of such series if such documents are delivered at or prior to the authentication upon original issuance of the first Security of such series to be issued. 

  
 5 

 With respect to Securities of a series offered in a Periodic Offering, the Trustee may rely,
as to the authorization by the Company of any of such Securities, the forms and terms thereof and the legality, validity, binding effect and enforceability thereof, upon the Opinion of Counsel and the other documents delivered pursuant to
Sections 2.01 and 2.02, as applicable, in connection with the first authentication of Securities of such series. 
 If the
Company shall establish pursuant to Section 2.03 that the Securities of a series or a portion thereof are to be issued in the form of one or more Global Securities, then the Company shall execute and the Trustee shall authenticate and deliver
one or more Global Securities that (i) shall represent and shall be denominated in an amount equal to the aggregate Principal amount of all of the Securities of such series issued in such form and not yet cancelled, (ii) shall be
registered in the name of the Depositary for such Global Security or Securities or the nominee of such Depositary, (iii) shall be delivered by the Trustee to such Depositary or its custodian or pursuant to such Depositary’s instructions
and (iv) shall bear a legend substantially to the following effect: “Unless and until it is exchanged in whole or in part for Securities in definitive registered form, this Security may not be transferred except as a whole by the
Depositary to the nominee of the Depositary or by a nominee of the Depositary to the Depositary or another nominee of the Depositary or by the Depositary or any such nominee to a successor Depositary or a nominee of such successor Depositary.”

 Section 2.03. Amount Unlimited; Issuable in Series. The aggregate Principal amount of Securities
which may be authenticated and delivered under this Indenture is unlimited. 
 The Securities may be issued in one or more
series and shall be subordinated to the Senior Indebtedness pursuant to the provisions of Article 11 hereof. There shall be established in or pursuant to Board Resolution or one or more indentures supplemental hereto, prior to the initial
issuance of Securities of any series, subject to the last sentence of this Section 2.03, 
 (a) the designation of
the Securities of the series, which shall distinguish the Securities of the series from the Securities of all other series; 

(b) any limit upon the aggregate Principal amount of the Securities of the series that may be authenticated and delivered under
this Indenture and any limitation on the ability of the Company to increase such aggregate Principal amount after the initial issuance of the Securities of that series (except for Securities authenticated and delivered upon registration of transfer
of, or in exchange for, or in lieu of, or upon redemption of, other Securities of the series pursuant hereto); 
 (c) the
date or dates on which the Principal of the Securities of the series is payable (which date or dates may be fixed or extendible); 
 (d) the rate or rates (which may be fixed or variable) per annum at which the Securities of the series shall bear interest, if any, the date or dates from which such interest shall accrue, on which
such interest shall be payable and on which a record shall be taken for the determination of Holders to whom interest is payable and/or the method by which such rate or rates or date or dates shall be determined; 

(e) if other than as provided in Section 4.02, the place or places where the Principal of and any interest on Securities of
the series shall be payable, any Securities of the series may be surrendered for exchange, and notices, demands to or upon the Company in respect of the Securities of the series and this Indenture may be served; 

(f) the right, if any, of the Company to redeem Securities of the series, in whole or in part, at its option and the period or
periods within which, the price or prices at which and any terms and conditions upon which Securities of the series may be so redeemed, pursuant to any sinking fund or otherwise; 

(g) the obligation, if any, of the Company to redeem, purchase or repay Securities of the series pursuant to any mandatory
redemption, sinking fund or analogous provisions or at the option of a Holder thereof and the price or prices at which and the period or periods within which and any of the terms and conditions upon which Securities of the series shall be redeemed,
purchased or repaid, in whole or in part, pursuant to such obligation; 
 (h) if other than denominations of $1,000 and
any integral multiple thereof, the denominations in which Securities of the series shall be issuable; 
 (i) if other
than the Principal amount thereof, the portion of the Principal amount of Securities of the series which shall be payable upon declaration of acceleration of the maturity thereof; 

(j) if other than the coin or currency in which the Securities of the series are denominated, the coin or currency in which
payment of the Principal of or interest on the Securities of the series shall be payable or if the amount of payments of Principal of and/or interest on the Securities of the series may be determined with reference to an index based on a coin or
currency other than that in which the Securities of the series are denominated, the manner in which such amounts shall be determined; 

  
 6 

 (k) if other than the currency of the United States of America, the currency or
currencies, including composite currencies, in which payment of the Principal of and interest on the Securities of the series shall be payable, and the manner in which any such currencies shall be valued against other currencies in which any other
Securities shall be payable; 
 (l) whether the Securities of the series or any portion thereof will be issuable as
Global Securities; 
 (m) whether and under what circumstances the Company will pay additional amounts on the Securities
of the series held by a Person who is not a U.S. person in respect of any tax, assessment or governmental charge withheld or deducted and, if so, whether the Company will have the option to redeem such Securities rather than pay such additional
amounts; 
 (n) if the Securities of the series are to be issuable in definitive, non-global form (whether upon original
issue or upon exchange of a temporary Security of such series) only upon receipt of certain certificates or other documents or satisfaction of other conditions, the form and terms of such certificates, documents or conditions; 

(o) any trustees, depositaries, authenticating or paying agents, transfer agents or the registrar or any other agents with respect
to the Securities of the series; 
 (p) provisions, if any, for the defeasance of the Securities of the series (including
provisions permitting defeasance of less than all Securities of the series), which provisions may be in addition to, in substitution for, or in modification of (or any combination of the foregoing) the provisions of Article 8; 

(q) if the Securities of the series are issuable in whole or in part as one or more Global Securities, the identity of the
Depositary or common Depositary for such Global Securities; 
 (r) any other Events of Default or covenants with respect
to the Securities of the series; and 
 (s) any other terms of the Securities of the series (which terms shall not be
inconsistent with the provisions of this Indenture). 
 All Securities of any one series shall be substantially identical,
except as to date and denomination, except in the case of any Periodic Offering and except as may otherwise be provided by or pursuant to the Board Resolution referred to above or as set forth in any such indenture supplemental hereto. All
Securities of any one series need not be issued at the same time and may be issued from time to time, consistent with the terms of this Indenture, if so provided by or pursuant to such Board Resolution or in any such indenture supplemental hereto
and any forms and terms of Securities to be issued from time to time may be completed and established from time to time prior to the issuance thereof by procedures described in such Board Resolution or supplemental indenture. 

Unless otherwise expressly provided with respect to a series of Securities, the aggregate Principal amount of a series of Securities may
be increased and additional Securities of such series may be issued up to the maximum aggregate Principal amount authorized with respect to such series as increased. 
 Section 2.04. Denomination and Date of Securities; Payments of Interest. The Securities of each series shall be issuable in denominations established as contemplated by
Section 2.03 or, if not so established with respect to Securities of any series, in denominations of $1,000 and any integral multiple thereof. The Securities of each series shall be numbered, lettered or otherwise distinguished in such manner
or in accordance with such plan as the Officers of the Company executing the same may determine, as evidenced by their execution thereof. 
 Unless otherwise specified with respect to a series of Securities, each Security shall be dated the date of its authentication. The Securities of each series shall bear interest, if any, from the date,
and such interest shall be payable on the dates, established as contemplated by Section 2.03. 
 The Person in whose name
any Security of any series is registered at the close of business on any record date applicable to a particular series with respect to any interest payment date for such series shall be entitled to receive the interest, if any, payable on such
interest payment date notwithstanding any transfer or exchange of such Security subsequent to the record date and prior to such interest payment date, except if and to the extent the Company shall default in the payment of the interest due on such
interest payment date for such series, in which case the provisions of Section 2.13 shall apply. The term “record date” as used with respect to any interest payment date (except a date for payment of defaulted interest) for the
Securities of any series shall mean the date specified as such in the terms of the Securities of such series established as contemplated by Section 2.03, or, if no such date is so established, the fifteenth day next preceding such interest
payment date, whether or not such record date is a Business Day. 
 Section 2.05. Registrar and Paying
Agent; Agents Generally. The Company shall maintain an office or agency where Securities may be presented for registration, registration of transfer or for exchange (the “Registrar”) and an office or agency where Securities

  
 7 

 
may be presented for payment (the “Paying Agent”), which shall be in the Borough of Manhattan, The City of New York. The Company shall cause the Registrar to keep a register of
the Securities and of their registration, transfer and exchange (the “Security Register”). The Company may have one or more additional Paying Agents or transfer agents with respect to any series. 

The Company shall enter into an appropriate agency agreement with any Agent not a party to this Indenture. The agreement shall implement
the provisions of this Indenture and the Trust Indenture Act that relate to such Agent. The Company shall give prompt written notice to the Trustee of the name and address of any Agent and any change in the name or address of an Agent. If the
Company fails to maintain at least one Registrar or Paying Agent in the State of New York, the Trustee shall act as such. The Company may remove any Agent upon written notice to such Agent and the Trustee and any Agent may resign upon written notice
to the Company and the Trustee. The Company or any Affiliate of the Company may act as Paying Agent or Registrar; provided that neither the Company nor an Affiliate of the Company shall act as Paying Agent in connection with the defeasance of
the Securities or the discharge of this Indenture under Article 8. 
 The Company initially appoints the Trustee as
Registrar, Paying Agent and Authenticating Agent. If, at any time, the Trustee is not the Registrar, the Registrar shall make available to the Trustee ten days prior to each interest payment date and at such other times as the Trustee may reasonably
request the names and addresses of the Holders as they appeared in the Security Register on the record date for such interest payment date. 
 Section 2.06. Paying Agent to Hold Money in Trust. Not later than 10:00 a.m. New York City time on the Business Day prior to the due date of any Principal or interest on any
Securities, the Company shall deposit with the Paying Agent money in immediately available funds sufficient to pay such Principal or interest. The Company shall require each Paying Agent other than the Trustee to agree in writing that such Paying
Agent shall hold in trust for the benefit of the Holders of such Securities or the Trustee all money held by the Paying Agent for the payment of Principal of and interest on such Securities and shall promptly notify the Trustee of any default by the
Company in timely making any such payment. The Company at any time may require a Paying Agent to pay all money held by it to the Trustee and account for any funds disbursed, and the Trustee may at any time during the continuance of any payment
default, upon written request to a Paying Agent, require such Paying Agent to pay all money held by it to the Trustee and to account for any funds disbursed. Upon doing so, the Paying Agent shall have no further liability for the money so paid over
to the Trustee. If the Company or any Affiliate of the Company acts as Paying Agent, it will, in accordance with the times set forth above, segregate and hold in a separate trust fund for the benefit of the Holders thereof a sum of money sufficient
to pay such Principal or interest so becoming due until such sum of money shall be paid to such Holders or otherwise disposed of as provided in this Indenture, and will promptly notify the Trustee in writing of its action or failure to act as
required by this Section. 
 Section 2.07. Transfer and Exchange. At the option of the Holder thereof,
Securities of any series (other than a Global Security, except as set forth below) may be exchanged for a Security or Securities of such series and tenor having authorized denominations and an equal aggregate Principal amount, upon surrender of such
Securities to be exchanged at the agency of the Company that shall be maintained for such purpose in accordance with Section 2.05 and upon payment, if the Company shall so require, of the charges hereinafter provided. Whenever any Securities
are so surrendered for exchange, the Company shall execute, and the Trustee shall authenticate and deliver, the Securities which the Holder making the exchange is entitled to receive. 

Upon surrender for registration of transfer of any Security of a series at the agency of the Company that shall be maintained for that
purpose in accordance with Section 2.05 and upon payment, if the Company shall so require, of the charges hereinafter provided, the Company shall execute, and the Trustee shall authenticate and deliver, in the name of the designated transferee
or transferees, one or more new Securities of the same series, of any authorized denominations and of like tenor and aggregate Principal amount. 
 All Securities presented for registration of transfer, exchange, redemption or payment shall be duly endorsed by, or be accompanied by a written instrument or instruments of transfer in form satisfactory
to the Company and the Trustee duly executed by, the holder or his attorney duly authorized in writing. 
 The Company may
require payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in connection with any exchange or registration of transfer of Securities. No service charge shall be made for any such transaction. 

Notwithstanding any other provision of this Section 2.07, unless and until it is exchanged in whole or in part for Securities in
definitive registered form, a Global Security representing all or a portion of the Securities of a series may not be transferred except as a whole by the Depositary for such series to a nominee of such Depositary or by a nominee of such Depositary
to such Depositary or another nominee of such Depositary or by such Depositary or any such nominee to a successor Depositary for such series or a nominee of such successor Depositary. 

None of the Trustee or any Agent shall: (i) have any duty to monitor compliance with or with respect to any securities or tax laws
(including but not limited to any U.S. federal or state or other securities or tax laws) or (ii) except as specifically provided herein, have any duty to obtain documentation on any transfers or exchanges of the Securities. 

  
 8 

 If at any time the Depositary for any Global Securities of any series notifies the Company
that it is unwilling or unable to continue as Depositary for such Global Securities or if at any time the Depositary for such Global Securities shall no longer be eligible under applicable law, the Company shall appoint a successor Depositary
eligible under applicable law with respect to such Global Securities. If a successor Depositary eligible under applicable law for such Global Securities is not appointed by the Company within 90 days after the Company receives such notice or
becomes aware of such ineligibility, the Company will execute, and the Trustee, upon receipt of the Company’s order for the authentication and delivery of definitive non-global Securities of such series and tenor, will authenticate and deliver
definitive non-global Securities of such series and tenor, in any authorized denominations, in an aggregate Principal amount equal to the Principal amount of such Global Securities, in exchange for such Global Securities. 

The Company may at any time and in its sole discretion and subject to the procedures of the Depositary determine that any Global
Securities of any series shall no longer be maintained in global form. In such event the Company will execute, and the Trustee, upon receipt of the Company’s order for the authentication and delivery of definitive non-global Securities of such
series and tenor, will authenticate and deliver, definitive non-global Securities of such series and tenor in any authorized denominations, in an aggregate Principal amount equal to the Principal amount of such Global Securities, in exchange for
such Global Securities. 
 Any time the Securities of any series are not in the form of Global Securities pursuant to the
preceding two paragraphs, the Company agrees to supply the Trustee with a reasonable supply of definitive non-global Securities without the legend required by Section 2.02 and the Trustee agrees to hold such Securities in safekeeping until
authenticated and delivered pursuant to the terms of this Indenture. 
 If established by the Company pursuant to
Section 2.03 with respect to any Global Security, the Depositary for such Global Security may surrender such Global Security in exchange in whole or in part for Securities of the same series and tenor in definitive registered form on such terms
as are acceptable to the Company and such Depositary. Thereupon, the Company shall execute, and the Trustee shall authenticate and deliver, without service charge, 
 (a) to the Person specified by such Depositary new definitive non-global Securities of the same series and tenor, of any authorized denominations as requested by such Person, in an aggregate
Principal amount equal to and in exchange for such Person’s beneficial interest in the Global Security; and 
 (b)
to such Depositary a new Global Security in a denomination equal to the difference, if any, between the Principal amount of the surrendered Global Security and the aggregate Principal amount of definitive non-global Securities authenticated and
delivered pursuant to clause (a) above. 
 Definitive non-global Securities issued in exchange for a Global Security
pursuant to this Section 2.07 shall be registered in such names and in such authorized denominations as the Depositary for such Global Security shall instruct pursuant to written instructions from its direct or indirect participants to the
Trustee. The Trustee shall deliver such Securities to or as directed in writing by the Persons in whose names such Securities are so registered. 
 All Securities issued upon any transfer or exchange of Securities shall be valid obligations of the Company, evidencing the same debt, and entitled to the same benefits under this Indenture, as the
Securities surrendered upon such transfer or exchange. 
 The Registrar shall not be required (i) to issue, authenticate,
register the transfer of or exchange Securities of any series for a period of 15 days before a selection of such Securities to be redeemed or (ii) to register the transfer of or exchange any Security selected for redemption in whole or in
part. 
 None of the Company, the Trustee nor any Agent will have any responsibility or liability for any aspect of the records
relating to or payments made on account of beneficial interests in any Global Securities or for maintaining, supervising or reviewing any records relating to such beneficial interests. 

Section 2.08. Replacement Securities. If any mutilated Security is surrendered to the Trustee, the Company
shall execute and the Trustee shall authenticate and deliver, in exchange for such mutilated Security, a new Security of the same series and of like tenor and Principal amount and bearing a number not contemporaneously outstanding. 

If there shall be delivered to the Company and the Trustee (i) evidence to their satisfaction of the destruction, loss or theft of
any Security and (ii) such security or indemnity as may be required by them to save each of them and any agent of any of them harmless, then, in the absence of notice to the Company or the Trustee that such Security has been acquired by a
protected purchaser, the Company shall execute and the Trustee shall authenticate and deliver, in lieu of any such destroyed, lost or stolen Security, a new Security of the same series and of like tenor and Principal amount and bearing a number not
contemporaneously outstanding. 
 In case any such mutilated, destroyed, lost or stolen Security has become or is about to
become due and payable, the Company in its discretion may, instead of issuing a new Security, pay such Security (without surrender thereof except in the case of a mutilated 

  
 9 

 
Security) if the applicant for such payment shall furnish to the Company and the Trustee such security or indemnity as may be required by them to save each of them and any agent of any of them
harmless, and in the case of destruction, loss or theft, evidence satisfactory to the Company and the Trustee and any agent of them of the destruction, loss or theft of such Security and the ownership thereof. 

Upon the issuance of any new Security under this Section, the Company may require payment of a sum sufficient to cover any tax or other
governmental charge that may be imposed in relation thereto and any other expenses (including the fees and expenses of the Trustee) connected therewith. 
 Every new Security of any series issued pursuant to this Section in lieu of any destroyed, lost or stolen Security or in exchange for any mutilated Security, shall constitute an original additional
contractual obligation of the Company, whether or not the mutilated, destroyed, lost or stolen Security shall be at any time enforceable by anyone, and any such new Security shall be entitled to all the benefits of this Indenture equally and
proportionately with any and all other Securities of that series duly issued hereunder. 
 The provisions of this Section are
exclusive and shall preclude (to the extent lawful) any other rights and remedies with respect to the replacement or payment of mutilated, destroyed, lost or stolen Securities. 

Section 2.09. Outstanding Securities. Securities outstanding at any time are all Securities that have been
authenticated by the Trustee except for those cancelled by it, those delivered to it for cancellation, those described in this Section as not outstanding and those that have been defeased pursuant to Section 8.05. 

If a Security is replaced pursuant to Section 2.08, it ceases to be outstanding unless and until the Trustee and the Company receive
proof satisfactory to them that the replaced Security is held by a protected purchaser. 
 If the Paying Agent (other than the
Company or an Affiliate of the Company) holds on the maturity date or any redemption date or date for repurchase of the Securities money sufficient to pay Securities payable or to be redeemed or repurchased on that date, then on and after that date
such Securities cease to be outstanding and interest on them shall cease to accrue. 
 A Security does not cease to be
outstanding because the Company or one of its Affiliates holds such Security, provided, however , that, in determining whether the Holders of the requisite Principal amount of the outstanding Securities have given any request, demand,
authorization, direction, notice, consent or waiver hereunder, Securities owned by the Company or any Affiliate of the Company shall be disregarded and deemed not to be outstanding, except that, in determining whether the Trustee shall be protected
in relying upon any such request, demand, authorization, direction, notice, consent or waiver, only Securities as to which a Responsible Officer of the Trustee has received written notice to be so owned shall be so disregarded. Any Securities so
owned which are pledged by the Company, or by any Affiliate of the Company, as security for loans or other obligations, otherwise than to another such Affiliate of the Company, shall be deemed to be outstanding, if the pledgee is entitled pursuant
to the terms of its pledge agreement and is free to exercise in its or his discretion the right to vote such securities, uncontrolled by the Company or by any such Affiliate. 
 Section 2.10. Temporary Securities. Until definitive Securities of any series are ready for delivery, the Company may prepare and the Trustee shall authenticate temporary
Securities of such series. Temporary Securities of any series shall be substantially in the form of definitive Securities of such series but may have insertions, substitutions, omissions and other variations determined to be appropriate by the
Officers executing the temporary Securities, as evidenced by their execution of such temporary Securities. If temporary Securities of any series are issued, the Company will cause definitive Securities of such series to be prepared without
unreasonable delay. After the preparation of definitive Securities of any series, the temporary Securities of such series shall be exchangeable for definitive Securities of such series and tenor upon surrender of such temporary Securities at the
office or agency of the Company designated for such purpose pursuant to Section 4.02, without charge to the Holder. Upon surrender for cancellation of any one or more temporary Securities of any series the Company shall execute and the Trustee
shall authenticate and deliver in exchange therefor a like Principal amount of definitive Securities of such series and tenor and authorized denominations. Until so exchanged, the temporary Securities of any series shall be entitled to the same
benefits under this Indenture as definitive Securities of such series. 
 Section 2.11. Cancellation.
The Company at any time may deliver to the Trustee for cancellation any Securities previously authenticated and delivered hereunder which the Company may have acquired in any manner whatsoever, and may deliver to the Trustee for cancellation any
Securities previously authenticated hereunder which the Company has not issued and sold. The Registrar, any transfer agent and the Paying Agent shall forward to the Trustee any Securities surrendered to them for transfer, exchange or payment. The
Trustee shall cancel and dispose of in accordance with its customary procedures all Securities surrendered for transfer, exchange, payment or cancellation and shall deliver a certificate of disposition to the Company. The Company may not issue new
Securities to replace Securities it has paid in full or delivered to the Trustee for cancellation. 

  
 10 

 Section 2.12. CUSIP Numbers. The Company in issuing the Securities
may use “CUSIP,” “ISIN” and/or “CINS” numbers (if then generally in use), and the Trustee shall use CUSIP numbers, ISIN numbers or CINS numbers, as the case may be, in notices of redemption or exchange as a convenience
to Holders and no representation shall be made as to the correctness of such numbers either as printed on the Securities or as contained in any notice of redemption or exchange. 

Section 2.13. Defaulted Interest. If the Company defaults in a payment of interest on the Securities, it shall
pay, or shall deposit with the Paying Agent money in immediately available funds sufficient to pay, the defaulted interest plus (to the extent lawful) any interest payable on the defaulted interest (as may be specified in the terms thereof,
established pursuant to Section 2.03) to the Persons who are Holders on a subsequent special record date, which shall mean the 15th day next preceding the date fixed by the Company for the payment of defaulted interest, whether or not such day
is a Business Day. At least 15 days before such special record date, the Company shall mail to each Holder of such Securities and to the Trustee a notice that states the special record date, the payment date and the amount of defaulted interest
to be paid. 
 Section 2.14. Series May Include Tranches. A series of Securities may include one
or more tranches (each a “tranche”) of Securities, including Securities issued in a Periodic Offering. The Securities of different tranches may have one or more different terms, including authentication dates and public offering
prices, but all the Securities within each such tranche shall have identical terms, including authentication date and public offering price. Notwithstanding any other provision of this Indenture, with respect to Sections 2.02 (other than the
fourth, sixth and seventh paragraphs thereof), 2.03, 2.04, 2.07, 2.08, 2.10, 3.01 through 3.05, 4.02, 6.01 through 6.14, 8.01 through 8.07, 9.02 and Section 10.07, if any series of Securities includes more than one tranche, all provisions of
such sections applicable to any series of Securities shall be deemed equally applicable to each tranche of any series of Securities in the same manner as though originally designated a series unless otherwise provided with respect to such series or
tranche pursuant to Section 2.03. In particular, and without limiting the scope of the next preceding sentence, any of the provisions of such sections which provide for or permit action to be taken with respect to a series of Securities shall
also be deemed to provide for and permit such action to be taken instead only with respect to Securities of one or more tranches within that series (and such provisions shall be deemed satisfied thereby), even if no comparable action is taken with
respect to Securities in the remaining tranches of that series. 
 ARTICLE 3 

REDEMPTION 

Section 3.01. Applicability of Article. The provisions of this Article shall be applicable to the Securities of
any series which are redeemable before their maturity or to any sinking fund for the retirement of Securities of a series except as otherwise specified as contemplated by Section 2.03 for Securities of such series. 

Section 3.02. Notice of Redemption; Partial Redemptions. Notice of redemption to the Holders of Securities of
any series to be redeemed as a whole or in part at the option of the Company shall be given by mailing notice of such redemption by first class mail, postage prepaid, at least 30 days and not more than 60 days prior to the date fixed for
redemption to such Holders of Securities of such series at their last addresses as they shall appear upon the Security Register.

Any notice which is mailed in the manner herein provided shall be conclusively presumed to have been duly given, whether or not the
Holder receives the notice. Failure to give notice by mail, or any defect in the notice to the Holder of any Security of a series designated for redemption as a whole or in part shall not affect the validity of the proceedings for the redemption of
any other Security of such series. 
 The notice of redemption to each such Holder shall specify the Principal amount of each
Security of such series held by such Holder to be redeemed, the CUSIP numbers of the Securities to be redeemed, the date fixed for redemption, the redemption price, or if not then ascertainable, the manner of calculation thereof, the place or places
of payment, that payment will be made upon presentation and surrender of such Securities, that such redemption is pursuant to the mandatory or optional sinking fund, or both, if such be the case, that interest accrued to the date fixed for
redemption will be paid as specified in such notice and that on and after said date interest thereon or on the portions thereof to be redeemed will cease to accrue. In case any Security of a series is to be redeemed in part only, the notice of
redemption shall state the portion of the Principal amount thereof to be redeemed and shall state that on and after the date fixed for redemption, upon surrender of such Security, a new Security or Securities of such series and tenor in Principal
amount equal to the unredeemed portion thereof will be issued. 
 The notice of redemption of Securities of any series to be
redeemed at the option of the Company shall be given by the Company or, at the Company’s written request which shall include the information to be included in the notice to the Holders required by the preceding paragraph, by the Trustee in the
name and at the expense of the Company. 
 On or before 10:00 a.m. New York City time on the Business Day prior to the
redemption date specified in the notice of redemption given as provided in this Section, the Company will deposit with the Trustee or with one or more Paying Agents (or, if the Company is acting as its own Paying Agent, set aside, segregate and hold
in trust as provided in Section 2.06) an amount of money 

  
 11 

 
sufficient to redeem on the redemption date all the Securities of such series so called for redemption at the appropriate redemption price, together with accrued interest to the date fixed for
redemption. If all of the outstanding Securities of a series are to be redeemed, the Company will deliver to the Trustee at least 10 days prior to the last date on which notice of redemption may be given to Holders pursuant to the first
paragraph of this Section 3.02 (or such shorter period as shall be acceptable to the Trustee) an Officers’ Certificate stating that all such Securities are to be redeemed. If less than all the outstanding Securities of a series are to be
redeemed, the Company will deliver to the Trustee at least 15 days prior to the last date on which notice of redemption may be given to Holders pursuant to the first paragraph of this Section 3.02 (or such shorter period as shall be
acceptable to the Trustee) an Officers’ Certificate stating the aggregate Principal amount of such Securities to be redeemed. In the case of any redemption of Securities (a) prior to the expiration of any restriction on such redemption
provided in the terms of such Securities or elsewhere in this Indenture, or (b) pursuant to an election of the Company which is subject to a condition specified in the terms of such Securities or elsewhere in this Indenture, the Company shall
deliver to the Trustee, prior to the giving of any notice of redemption to Holders pursuant to this Section, an Officers’ Certificate evidencing compliance with such restriction or condition. 

If less than all the Securities of a series are to be redeemed, the Trustee shall select, pro rata, by lot or in such manner as it shall
deem appropriate and fair, Securities of such series to be redeemed in whole or in part. Securities may be redeemed in part in Principal amounts equal to authorized denominations for Securities of such series. The Trustee shall promptly notify the
Company in writing of the Securities of such series selected for redemption and, in the case of any Securities of such series selected for partial redemption, the Principal amount thereof to be redeemed. For all purposes of this Indenture, unless
the context otherwise requires, all provisions relating to the redemption of Securities shall relate, in the case of any Security redeemed or to be redeemed only in part, to the portion of the Principal amount of such Security which has been or is
to be redeemed. 
 Section 3.03. Payment Of Securities Called For Redemption. If notice of redemption
has been given as above provided, the Securities or portions of Securities specified in such notice shall become due and payable on the date and at the place stated in such notice at the applicable redemption price, together with interest accrued to
the date fixed for redemption, and on and after such date (unless the Company shall default in the payment of such Securities at the redemption price, together with interest accrued to such date) interest on the Securities or portions of Securities
so called for redemption shall cease to accrue, and, except as provided in Sections 7.12 and 8.02, such Securities shall cease from and after the date fixed for redemption to be entitled to any benefit under this Indenture, and the Holders
thereof shall have no right in respect of such Securities except the right to receive the redemption price thereof and unpaid interest to the date fixed for redemption. On presentation and surrender of such Securities at a place of payment specified
in said notice, said Securities or the specified portions thereof shall be paid and redeemed by the Company at the applicable redemption price, together with interest accrued thereon to the date fixed for redemption; provided that payment of
interest becoming due on or prior to the date fixed for redemption shall be payable to the Holders of such Securities registered as such on the relevant record date subject to the terms and provisions of Sections 2.04 and 2.13 hereof.

 If any Security called for redemption shall not be so paid upon surrender thereof for redemption, the Principal shall, until
paid or duly provided for, bear interest from the date fixed for redemption at the rate of interest or Yield to Maturity (in the case of an Original Issue Discount Security) borne by such Security. 

Upon presentation of any Security of any series redeemed in part only, the Company shall execute and the Trustee shall authenticate and
deliver to or on the order of the Holder thereof, at the expense of the Company, a new Security or Securities of such series and tenor, of authorized denominations, in Principal amount equal to the unredeemed portion of the Security so presented.

 Section 3.04. Exclusion of Certain Securities from Eligibility for Selection for Redemption.
Securities shall be excluded from eligibility for selection for redemption if they are identified by registration and certificate number in a written statement signed by an authorized Officer of the Company and delivered to the Trustee at least
40 days prior to the last date on which notice of redemption may be given as being owned of record or beneficially by, and not pledged or hypothecated by, either (a) the Company or (b) an Affiliate of the Company. 

Section 3.05. Mandatory and Optional Sinking Funds. The minimum amount of any sinking fund payment provided for
by the terms of Securities of any series is herein referred to as a “mandatory sinking fund payment,” and any payment in excess of such minimum amount provided for by the terms of the Securities of any series is herein referred to
as an “optional sinking fund payment.” The date on which a sinking fund payment is to be made is herein referred to as the “sinking fund payment date.” 

In lieu of making all or any part of any mandatory sinking fund payment with respect to any series of Securities in cash, the Company may
at its option (a) deliver to the Trustee Securities of such series theretofore purchased or otherwise acquired (except through a mandatory sinking fund payment) by the Company or receive credit for Securities of such series (not previously so
credited) theretofore purchased or otherwise acquired (except as aforesaid) by the Company and delivered to the Trustee for cancellation pursuant to Section 2.11, (b) receive credit for optional sinking fund payments (not previously so
credited) made pursuant to this Section, or (c) receive credit for Securities of such series (not previously so credited) redeemed by the Company at the option of the Company pursuant to the terms of such Securities or through any optional
sinking fund payment. Securities so delivered or credited shall be received or credited by the Trustee at the sinking fund redemption price specified in such Securities. 

  
 12 

 On or before the sixtieth day next preceding each sinking fund payment date for any series,
or such shorter period as shall be acceptable to the Trustee, the Company will deliver to the Trustee an Officers’ Certificate (a) specifying the portion of the mandatory sinking fund payment to be satisfied by payment of cash and the
portion to be satisfied by credit of specified Securities of such series and the basis for such credit, (b) stating that none of the specified Securities of such series has theretofore been so credited, (c) stating that no defaults in the
payment of interest or Events of Default with respect to such series have occurred (which have not been waived or cured) and are continuing and (d) stating whether or not the Company intends to exercise its right to make an optional sinking
fund payment with respect to such series and, if so, specifying the amount of such optional sinking fund payment which the Company intends to pay on or before the next succeeding sinking fund payment date. Any Securities of such series to be
credited and required to be delivered to the Trustee in order for the Company to be entitled to credit therefor as aforesaid which have not theretofore been delivered to the Trustee shall be delivered for cancellation pursuant to Section 2.11
to the Trustee with such Officers’ Certificate (or reasonably promptly thereafter if acceptable to the Trustee). Such Officers’ Certificate shall be irrevocable and upon its receipt by the Trustee the Company shall become unconditionally
obligated to make all the cash payments or delivery of Securities therein referred to, if any, on or before the next succeeding sinking fund payment date. Failure of the Company, on or before any such sixtieth day, to deliver such Officer’s
Certificate and Securities specified in this paragraph, if any, shall not constitute a default but shall constitute, on and as of such date, the irrevocable election of the Company (i) that the mandatory sinking fund payment for such series due
on the next succeeding sinking fund payment date shall be paid entirely in cash without the option to deliver or credit Securities of such series in respect thereof and (ii) that the Company will make no optional sinking fund payment with
respect to such series as provided in this Section. 
 If the sinking fund payment or payments (mandatory or optional or both)
to be made in cash on the next succeeding sinking fund payment date plus any unused balance of any preceding sinking fund payments made in cash shall exceed $50,000 (or a lesser sum if the Company shall so request with respect to the Securities of
any series), such cash shall be applied on the next succeeding sinking fund payment date to the redemption of Securities of such series at the sinking fund redemption price thereof together with accrued interest thereon to the date fixed for
redemption. If such amount shall be $50,000 (or such lesser sum) or less and the Company makes no such request then it shall be carried over until a sum in excess of $50,000 (or such lesser sum) is available. The Trustee shall select, in the manner
provided in Section 3.02, for redemption on such sinking fund payment date a sufficient Principal amount of Securities of such series to absorb said cash, as nearly as may be, and shall (if requested in writing by the Company) inform the
Company of the serial numbers of the Securities of such series (or portions thereof) so selected. Securities shall be excluded from eligibility for redemption under this Section if they are identified by registration and certificate number in an
Officers’ Certificate delivered to the Trustee at least 60 days prior to the sinking fund payment date as being owned of record or beneficially by, and not pledged or hypothecated by either (a) the Company or (b) an Affiliate of
the Company. The Trustee, in the name and at the expense of the Company (or the Company, if it shall so request the Trustee in writing) shall cause notice of redemption of the Securities of such series to be given in substantially the manner
provided in Section 3.02 (and with the effect provided in Section 3.03) for the redemption of Securities of such series in part at the option of the Company. The amount of any sinking fund payments not so applied or allocated to the
redemption of Securities of such series shall be added to the next cash sinking fund payment for such series and, together with such payment, shall be applied in accordance with the provisions of this Section. Any and all sinking fund moneys held on
the stated maturity date of the Securities of any particular series (or earlier, if such maturity is accelerated), which are not held for the payment or redemption of particular Securities of such series shall be applied, together with other moneys,
if necessary, sufficient for the purpose, to the payment of the Principal of, and interest on, the Securities of such series at maturity. 
 On or before 10:00 a.m. New York City time on the Business Day prior to the sinking fund payment date, the Company shall pay to the Trustee in cash or by credit of Securities or shall otherwise
provide for the payment of all Principal and interest accrued to the date fixed for redemption on Securities to be redeemed on the next following sinking fund payment date. 
 The Trustee shall not redeem or cause to be redeemed any Securities of a series with sinking fund moneys or mail any notice of redemption of Securities of such series by operation of the sinking fund
during the continuance of a Default in payment of interest on such Securities or of any Event of Default except that, where the mailing of notice of redemption of any Securities shall theretofore have been made, the Trustee shall redeem or cause to
be redeemed such Securities, provided that it shall have received from the Company a sum sufficient for such redemption. Except as aforesaid, any moneys in the sinking fund for such series at the time when any such Default or Event of Default shall
occur, and any moneys thereafter paid into the sinking fund, shall, during the continuance of such Default or Event of Default, be deemed to have been collected under Article 6 and held for the payment of all such Securities. In case such Event of
Default shall have been waived as provided in Section 6.04 or the Default cured on or before the sixtieth day preceding the sinking fund payment date in any year, such moneys shall thereafter be applied on the next succeeding sinking fund
payment date in accordance with this Section to the redemption of such Securities. 

  
 13 

 ARTICLE 4 
 COVENANTS 
 Section 4.01. Payment of Securities. The
Company shall pay the Principal of and interest on the Securities on the dates and in the manner provided in the Securities and this Indenture. The interest on Securities (together with any additional amounts payable pursuant to the terms of such
Securities) shall be payable only to the Holders thereof (subject to Section 2.04) and at the option of the Company may be paid by mailing checks for such interest payable to or upon the written order of such Holders at their last addresses as
they appear on the Security Register of the Company. 
 Notwithstanding any provisions of this Indenture and the Securities of
any series to the contrary, if the Company and a Holder of any Security so agree, payments of interest on, and any portion of the Principal of, such Holder’s Security (other than interest payable at maturity or on any redemption or repayment
date or the final payment of Principal on such Security) shall be made by the Paying Agent, upon receipt from the Company of immediately available funds by 10:00 A.M., New York City time on the Business Day prior to the payment date (or such
other time as may be agreed to between the Company and the Paying Agent), directly to the Holder of at least $500,000 in aggregate Principal amount of Securities (by Federal funds wire transfer or otherwise) if such Holder has delivered written
instructions to the Trustee 15 days prior to such payment date requesting that such payment be so made and designating the bank account to which such payments shall be so made and in the case of payments of Principal, surrenders the same to the
Trustee in exchange for a Security or Securities aggregating the same Principal amount as the unredeemed Principal amount of the Securities surrendered. The Trustee shall be entitled to rely on the last instruction delivered by the Holder pursuant
to this Section 4.01 unless a new instruction is delivered 15 days prior to a payment date. 
 The Company shall pay
interest on overdue Principal, and interest on overdue installments of interest, to the extent lawful, at the rate per annum specified in the Securities. 
 Section 4.02. Maintenance of Office or Agency. The Company will maintain in the Borough of Manhattan, The City of New York an office or agency where Securities may be surrendered
for registration of transfer or exchange or for presentation for payment and where notices and demands to or upon the Company in respect of the Securities and this Indenture may be served. The Company hereby initially designates the Corporate Trust
Office of the Trustee, located in New York, New York, as such office or agency of the Company. The Company will give prompt written notice to the Trustee of the location, and any change in the location, of such office or agency. If at any time the
Company shall fail to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such presentations, surrenders, notices and demands may be made or served at the address of the Trustee set forth in
Section 10.02. 
 The Company may also from time to time designate one or more other offices or agencies where the
Securities of any series may be presented or surrendered for any or all such purposes and may from time to time rescind such designations; provided that no such designation or rescission shall in any manner relieve the Company of its obligation to
maintain an office or agency in the Borough of Manhattan, The City of New York for such purposes. The Company will give prompt written notice to the Trustee of any such designation or rescission and of any change in the location of any such other
office or agency. 
 Section 4.03. Securityholders’ Lists. The Company will furnish or cause to
be furnished to the Trustee a list in such form as the Trustee may reasonably require of the names and addresses of the holders of the Securities pursuant to Section 312 of the Trust Indenture Act of 1939 (a) semi-annually not more than
5 days after each record date for the payment of semi-annual interest on the Securities, as hereinabove specified, as of such record date, and (b) at such other times as the Trustee may request in writing, within thirty days after receipt
by the Company of any such request as of a date not more than 15 days prior to the time such information is furnished. 

Section 4.04. Certificate to Trustee. The Company will furnish to the Trustee annually, on or before a date not
more than four months after the end of its fiscal year (which, on the date hereof, is a calendar year), a brief certificate (which need not contain the statements required by Section 10.04) from its principal executive, financial or accounting
officer as to his or her knowledge of the compliance of the Company with all conditions and covenants under this Indenture (such compliance to be determined without regard to any period of grace or requirement of notice provided under this
Indenture) which certificate shall comply with the requirements of the Trust Indenture Act. 
 Section 4.05.
Reports by the Company. The Company covenants to file with the Trustee, within 15 days after the Company is required to file the same with the Commission, copies of the annual reports and of the information, documents, and other reports
which the Company may be required to file with the Commission pursuant to Section 13 or Section 15(d) of the Exchange Act. 
 Delivery of the above reports to the Trustee is for informational purposes only and the Trustee’s receipt of such reports shall not constitute constructive notice of any information contained therein
or determinable from information contained therein, including the Company’s compliance with any of its covenants in this Indenture (as to which the Trustee is entitled to rely exclusively on an Officers’ Certificate) or any other agreement
or document. 

  
 14 

 Section 4.06. Additional Amounts. If the Securities of a series provide
for the payment of additional amounts, at least 10 days prior to the first interest payment date with respect to that series of Securities and at least 10 days prior to each date of payment of Principal of or interest on the Securities of
that series if there has been a change with respect to the matters set forth in the below-mentioned Officers’ Certificate, the Company shall furnish to the Trustee and the Paying Agents, if other than the Trustee, an Officers’ Certificate
instructing the Trustee and such Paying Agents whether such payment of Principal of or interest on the Securities of that series shall be made to Holders of the Securities of that series without withholding or deduction for or on account of any tax,
assessment or other governmental charge described in the Securities of that series. If any such withholding or deduction shall be required, then such Officers’ Certificate shall specify by country the amount, if any, required to be withheld or
deducted on such payments to such Holders and shall certify (i) that the Company shall make such withholding or deduction and shall remit the relevant tax, assessment or other governmental charge to the relevant taxing authority and
(ii) the fact that additional amounts will be payable and the amounts so payable to each Holder, and the Company shall pay to the Trustee or such Paying Agents the additional amounts required to be paid by this Section. The Company covenants to
indemnify each of the Trustee and any Paying Agents for, and to hold each of them harmless against, any loss, liability or expense reasonably incurred without bad faith on its part arising out of or in connection with actions taken or omitted by it
in reliance on any Officers’ Certificate furnished pursuant to this Section. The provisions of this Section shall survive the satisfaction and discharge of the Securities, the resignation or removal of the Trustee or any Paying Agent and the
payment of the Securities. 
 Whenever in this Indenture there is mentioned, in any context, the payment of the Principal of or
interest or any other amounts on, or in respect of, any Security of any series, such mention shall be deemed to include mention of the payment of additional amounts provided by the terms of such series established hereby or pursuant hereto to the
extent that, in such context, additional amounts are, were or would be payable in respect thereof pursuant to such terms, and express mention of the payment of additional amounts (if applicable) in any provision hereof shall not be construed as
excluding the payment of additional amounts in those provisions hereof where such express mention is not made. 
 ARTICLE 5

 SUCCESSOR CORPORATION 
 Section 5.01. When Company May Merge, Etc. The Company shall not consolidate with, merge with or into, or sell, convey, transfer, lease or otherwise dispose of all or
substantially all of its property and assets (in one transaction or a series of related transactions) to, any Person unless either (x) the Company shall be the continuing Person or (y) the Person (if other than the Company) formed by such
consolidation or into which the Company is merged or to which properties and assets of the Company shall be sold, conveyed, transferred or leased shall be a corporation organized and validly existing under the laws of the United States of America or
any jurisdiction thereof and shall expressly assume, by a supplemental indenture, executed and delivered to the Trustee, all of the obligations of the Company on all of the Securities and under this Indenture and the Company in the case of clauses
(x) and (y) shall have delivered to the Trustee (A) an Opinion of Counsel stating that such consolidation, merger or sale, conveyance, transfer or lease and such supplemental indenture (if any) complies with this provision and that
all conditions precedent provided for herein relating to such transaction have been complied with and that such supplemental indenture (if any) constitutes the legal, valid and binding obligation of the Company and such successor enforceable against
such entity in accordance with its terms, subject to customary exceptions and (B) an Officers’ Certificate to the effect that immediately after giving effect to such transaction, no Default shall have occurred and be continuing.

 Section 5.02. Successor Substituted. Upon any consolidation or merger, or any sale, conveyance,
transfer, lease or other disposition of all or substantially all of the property and assets of the Company in accordance with Section 5.01 of this Indenture, the successor Person formed by such consolidation or into which the Company is merged
or to which such sale, conveyance, transfer, lease or other disposition is made shall succeed to, and be substituted for, and may exercise every right and power of, the Company under this Indenture with the same effect as if such successor Person
had been named as the Company herein and thereafter the predecessor Person, except in the case of a lease, shall be relieved of all obligations and covenants under this Indenture and the Securities. 

ARTICLE 6 

DEFAULT AND REMEDIES 
 Section 6.01. Events of Default. An “Event of Default” shall occur with respect to the Securities of any series if: 

(a) the Company defaults in the payment of the Principal of any Security of such series when the same becomes due and payable at
maturity, upon acceleration, redemption or mandatory repurchase, including as a sinking fund installment, or otherwise; 

  
 15 

 (b) the Company defaults in the payment of interest on any Security of such series
when the same becomes due and payable, and such default continues for a period of 30 days; 
 (c) the Company
defaults in the performance of or breaches any other covenant or agreement of the Company in this Indenture with respect to any Security of such series and such default or breach continues for a period of 30 consecutive days after written notice to
the Company by the Trustee or to the Company and the Trustee by the Holders of 25% or more in aggregate Principal amount of the Securities of all series affected thereby specifying such default or breach and requiring it to be remedied and stating
that such notice is a “Notice of Default” hereunder; 
 (d) a court having jurisdiction in the premises shall
enter a decree or order for relief in respect of the Company in an involuntary case under any applicable bankruptcy, insolvency or other similar law now or hereafter in effect, or appointing a receiver, liquidator, assignee, custodian, trustee,
sequestrator (or similar official) of the Company or for any substantial part of its property or ordering the winding up or liquidation of its affairs, and such decree or order shall remain unstayed and in effect for a period of 60 consecutive days;

 (e) the Company (i) commences a voluntary case under any applicable bankruptcy, insolvency or other similar law
now or hereafter in effect, or consents to the entry of an order for relief in an involuntary case under any such law, (ii) consents to the appointment of or taking possession by a receiver, liquidator, assignee, custodian, trustee,
sequestrator or similar official of the Company or for all or substantially all of the property and assets of the Company or (iii) effects any general assignment for the benefit of creditors; or 

(f) any other Event of Default established pursuant to Section 2.03 with respect to the Securities of such series occurs.

 Section 6.02. Acceleration. (a) If an Event of Default other than as described in clauses
(d) or (e) of Section 6.01 with respect to the Securities of any series then outstanding occurs and is continuing, then, and in each and every such case, except for any series of Securities the Principal of which shall have already
become due and payable, either the Trustee or the Holders of not less than 25% in aggregate Principal amount of the Securities of any such series then outstanding hereunder (each such series treated as a separate class) by notice in writing to the
Company (and to the Trustee if given by Securityholders), may declare the entire Principal (or, if the Securities of any such series are Original Issue Discount Securities, such portion of the Principal amount as may be specified in the terms of
such series established pursuant to Section 2.03) of all Securities of such series, and the interest accrued thereon, if any, to be due and payable immediately, and upon any such declaration the same shall become immediately due and payable.

 (b) If an Event of Default described in clause (d) or (e) of Section 6.01 occurs and is continuing,
then the Principal amount (or, if any Securities are Original Issue Discount Securities, such portion of the Principal as may be specified in the terms thereof established pursuant to Section 2.03) of all the Securities then outstanding and
interest accrued thereon, if any, shall be and become immediately due and payable, without any notice or other action by any Holder or the Trustee, to the full extent permitted by applicable law. 

The foregoing provisions, however, are subject to the condition that if, at any time after the Principal (or, if the Securities are
Original Issue Discount Securities, such portion of the Principal as may be specified in the terms thereof established pursuant to Section 2.03) of the Securities of any series (or of all the Securities, as the case may be) shall have been so
declared or become due and payable, and before any judgment or decree for the payment of the moneys due shall have been obtained or entered as hereinafter provided, the Company shall pay or shall deposit with the Trustee a sum sufficient to pay all
matured installments of interest upon all the Securities of each such series (or of all the Securities, as the case may be) and the Principal of any and all Securities of each such series (or of all the Securities, as the case may be) which shall
have become due otherwise than by acceleration (with interest upon such Principal and, to the extent that payment of such interest is enforceable under applicable law, on overdue installments of interest, at the same rate as the rate of interest or
Yield to Maturity (in the case of Original Issue Discount Securities) specified in the Securities of each such series to the date of such payment or deposit) and such amount as shall be sufficient to cover all amounts owing the Trustee under
Section 7.07, and if any and all Events of Default under the Indenture, other than the non-payment of the Principal of Securities which shall have become due by acceleration, shall have been cured, waived or otherwise remedied as provided
herein, then and in every such case the Holders of a majority in aggregate Principal amount of all the then outstanding Securities of all such series that have been accelerated (voting as a single class), by written notice to the Company and to the
Trustee, may waive all defaults with respect to all such series (or with respect to all the Securities, as the case may be) and rescind and annul such declaration and its consequences, but no such waiver or rescission and annulment shall extend to
or shall affect any subsequent default or shall impair any right consequent thereon. 
 For all purposes under this Indenture,
if a portion of the Principal of any Original Issue Discount Securities shall have been accelerated and declared or become due and payable pursuant to the provisions hereof, then, from and after such declaration, unless such declaration has been
rescinded and annulled, the Principal amount of such Original Issue Discount Securities shall be deemed, for all purposes hereunder, to be such portion of the Principal thereof as shall be due and payable as a result of such acceleration, and
payment of such portion of the Principal thereof as shall be due and payable as a result of such acceleration, together with interest, if any, thereon and all other amounts owing thereunder, shall constitute payment in full of such Original Issue
Discount Securities. 

  
 16 

 Section 6.03. Other Remedies. If a payment default or an Event of
Default with respect to the Securities of any series occurs and is continuing, the Trustee may pursue, in its own name or as trustee of an express trust, any available remedy by proceeding at law or in equity to collect the payment of Principal of
and interest on the Securities of such series or to enforce the performance of any provision of the Securities of such series or this Indenture. 
 The Trustee may maintain a proceeding even if it does not possess any of the Securities or does not produce any of them in the proceeding. 

Section 6.04. Waiver of Past Defaults. Subject to Sections 6.02, 6.07 and 9.02, the Holders of at least a
majority in Principal amount (or, if the Securities are Original Issue Discount Securities, such portion of the Principal as is then accelerable under Section 6.02) of the outstanding Securities of all series affected (voting as a single
class), by notice to the Trustee, may waive an existing Default or Event of Default with respect to the Securities of such series and its consequences, except a Default in the payment of Principal of or interest on any Security as specified in
clauses (a) or (b) of Section 6.01 or in respect of a covenant or provision of this Indenture which cannot be modified or amended without the consent of the Holder of each outstanding Security affected. Upon any such waiver, such
Default shall cease to exist, and any Event of Default with respect to the Securities of such series arising therefrom shall be deemed to have been cured, for every purpose of this Indenture; but no such waiver shall extend to any subsequent or
other Default or Event of Default or impair any right consequent thereto. 
 Section 6.05. Control by
Majority. Subject to Sections 7.01 and 7.02(e), the Holders of at least a majority in aggregate Principal amount (or, if any Securities are Original Issue Discount Securities, such portion of the Principal as is then accelerable under
Section 6.02) of the outstanding Securities of all series affected (voting as a single class) may direct the time, method and place of conducting any proceeding for any remedy available to the Trustee or exercising any trust or power conferred
on the Trustee with respect to the Securities of such series by this Indenture; provided, that the Trustee may refuse to follow any direction that conflicts with law or this Indenture, that may involve the Trustee in personal liability or that the
Trustee determines in good faith may be unduly prejudicial to the rights of Holders not joining in the giving of such direction; and provided further, that the Trustee may take any other action it deems proper that is not inconsistent with any
directions received from Holders of Securities pursuant to this Section 6.05. 
 Section 6.06.
Limitation on Suits. No Holder of any Security of any series may institute any proceeding, judicial or otherwise, with respect to this Indenture or the Securities of such series, or for the appointment of a receiver or trustee, or for any
other remedy hereunder, unless: 
 (a) such Holder has previously given to the Trustee written notice of a continuing
Event of Default with respect to the Securities of such series; 
 (b) the Holders of at least 25% in aggregate Principal
amount of outstanding Securities of all such series affected shall have made written request to the Trustee to institute proceedings in respect of such Event of Default in its own name as Trustee hereunder; 

(c) such Holder or Holders have offered to the Trustee indemnity satisfactory to the Trustee against any costs, liabilities or
expenses to be incurred in compliance with such request; 
 (d) the Trustee for 60 days after its receipt of such
notice, request and offer of indemnity has failed to institute any such proceeding; and 
 (e) during such 60-day period,
the Holders of a majority in aggregate Principal amount of the outstanding Securities of all such affected series have not given the Trustee a direction that is inconsistent with such written request. 

A Holder may not use this Indenture to prejudice the rights of another Holder or to obtain a preference or priority over such other
Holder. 
 Section 6.07. Rights of Holders to Receive Payment. Notwithstanding any other provision of
this Indenture, the right of any Holder of a Security to receive payment of Principal of or interest, if any, on such Holder’s Security on or after the respective due dates expressed on such Security, or to bring suit for the enforcement of any
such payment on or after such respective dates, shall not be impaired or affected without the consent of such Holder. 

Section 6.08. Collection Suit by Trustee. If an Event of Default with respect to the Securities of any series
in payment of Principal or interest specified in clause (a) or (b) of Section 6.01 occurs and is continuing, the Trustee may recover judgment in its own name and as trustee of an express trust against the Company for the whole amount
(or such portion thereof as specified in the terms 

  
 17 

 
established pursuant to Section 2.03 of Original Issue Discount Securities) of Principal of, and accrued interest remaining unpaid on, together with interest on overdue Principal of, and, to
the extent that payment of such interest is lawful, interest on overdue installments of interest on, the Securities of such series, in each case at the rate or Yield to Maturity (in the case of Original Issue Discount Securities) specified in such
Securities, and such further amount as shall be sufficient to cover all amounts owing the Trustee under Section 7.07. 

Section 6.09. Trustee May File Proofs of Claim. The Trustee may file such proofs of claim and other papers or
documents as may be necessary or advisable in order to have the claims of the Trustee (including any claim for amounts due the Trustee under Section 7.07) and the Holders allowed in any judicial proceedings relative to the Company (or any other
obligor on the Securities), its creditors or its property and shall be entitled and empowered to collect and receive any moneys, securities or other property payable or deliverable upon conversion or exchange of the Securities or upon any such
claims and to distribute the same, and any custodian, receiver, assignee, trustee, liquidator, sequestrator or other similar official in any such judicial proceeding is hereby authorized by each Holder to make such payments to the Trustee and, in
the event that the Trustee shall consent to the making of such payments directly to the Holders, to pay to the Trustee any amount due to it under Section 7.07. Nothing herein contained shall be deemed to empower the Trustee to authorize or
consent to, or accept or adopt on behalf of any Holder, any plan of reorganization, arrangement, adjustment or composition affecting the Securities or the rights of any Holder thereof, or to authorize the Trustee to vote in respect of the claim of
any Holder in any such proceeding. 
 Section 6.10. Application of Proceeds. Any moneys collected by
the Trustee pursuant to this Article in respect of the Securities of any series shall be applied in the following order at the date or dates fixed by the Trustee and, in case of the distribution of such moneys on account of Principal or interest,
upon presentation of the several Securities in respect of which moneys have been collected and noting thereon the payment, or issuing Securities of such series and tenor in reduced Principal amounts in exchange for the presented Securities of such
series and tenor if only partially paid, or upon surrender thereof if fully paid: 
 FIRST: To the payment of all amounts due
the Trustee under Section 7.07 applicable to the Securities of such series in respect of which moneys have been collected; 

SECOND: Subject to Article 11, in case the Principal of the Securities of such series in respect of which moneys have been collected
shall not have become and be then due and payable, to the payment of interest on the Securities of such series in default in the order of the maturity of the installments of such interest, with interest (to the extent that such interest has been
collected by the Trustee) upon the overdue installments of interest at the same rate as the rate of interest or Yield to Maturity (in the case of Original Issue Discount Securities) specified in such Securities, such payments to be made ratably to
the persons entitled thereto, without discrimination or preference; 
 THIRD: Subject to Article 11, in case any Principal
of the Securities of such series in respect of which moneys have been collected shall have become and shall be then due and payable, to the payment of the whole amount then owing and unpaid upon all the Securities of such series for Principal and
interest, with interest upon the overdue Principal, and (to the extent that such interest has been collected by the Trustee) upon overdue installments of interest at the same rate as the rate of interest or Yield to Maturity (in the case of Original
Issue Discount Securities) specified in the Securities of such series; and in case such moneys shall be insufficient to pay in full the whole amount so due and unpaid upon the Securities of such series, then to the payment of such Principal and
interest or Yield to Maturity, without preference or priority of Principal over interest or Yield to Maturity, or of interest or Yield to Maturity over Principal, or of any installment of interest over any other installment of interest, or of any
Security of such series over any other Security of such series, ratably to the aggregate of such Principal and accrued and unpaid interest or Yield to Maturity; and 
 FOURTH: To the payment of the remainder, if any, to the Company or any other Person lawfully entitled thereto. 
 Section 6.11. Restoration of Rights and Remedies. If the Trustee or any Holder has instituted any proceeding to enforce any right or remedy under this Indenture and such
proceeding has been discontinued or abandoned for any reason, or has been determined adversely to the Trustee or to such Holder, then, and in every such case, subject to any determination in such proceeding, the Company, the Trustee and the Holders
shall be restored to their former positions hereunder and thereafter all rights and remedies of the Company, Trustee and the Holders shall continue as though no such proceeding had been instituted. 

Section 6.12. Undertaking for Costs. In any suit for the enforcement of any right or remedy under this Indenture or in
any suit against the Trustee for any action taken or omitted by it as Trustee, in either case in respect to the Securities of any series, a court may require any party litigant in such suit (other than the Trustee) to file an undertaking to pay the
costs of the suit, and the court may assess reasonable costs, including reasonable attorneys’ fees, against any party litigant (other than the Trustee) in the suit having due regard to the merits and good faith of the claims or defenses made by
the party litigant. This Section 6.12 does not apply to a suit by a Holder pursuant to Section 6.07, a suit instituted by the Trustee or a suit by Holders of more than 10% in Principal amount of the outstanding Securities of such series.

  
 18 

 Section 6.13. Rights and Remedies Cumulative. Except as otherwise
provided with respect to the replacement or payment of mutilated, destroyed, lost or wrongfully taken Securities in Section 2.08, no right or remedy herein conferred upon or reserved to the Trustee or to the Holders is intended to be exclusive
of any other right or remedy, and every right and remedy shall, to the extent permitted by law, be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The
assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other appropriate right or remedy. 
 Section 6.14. Delay or Omission not Waiver. No delay or omission of the Trustee or of any Holder to exercise any right or remedy accruing upon any Event of Default shall impair
any such right or remedy or constitute a waiver of any such Event of Default or an acquiescence therein. Every right and remedy given by this Article 6 or by law to the Trustee or to the Holders may be exercised from time to time, and as often
as may be deemed expedient, by the Trustee or by the Holders, as the case may be. 
 ARTICLE 7 

TRUSTEE 

Section 7.01. General. The duties and responsibilities of the Trustee shall be as provided by the Trust
Indenture Act and as set forth herein. Notwithstanding the foregoing, no provision of this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur any financial liability in the performance of any of its duties
hereunder, or in the exercise of any of its rights or powers, unless it receives indemnity satisfactory to it against any loss, liability or expense. Whether or not therein expressly so provided, every provision of this Indenture relating to the
conduct or affecting the liability of or affording protection to the Trustee shall be subject to the provisions of this Article 7. 
 Section 7.02. Certain Rights of Trustee. Subject to Trust Indenture Act Sections 315(a) through (d): 
 (a) the Trustee may conclusively rely and shall be protected in acting or refraining from acting upon any resolution, certificate, Officers’ Certificate, Opinion of Counsel, statement,
instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, other evidence of indebtedness or other paper or document believed by it to be genuine and to have been signed or presented by the proper person or
persons. The Trustee need not investigate any fact or matter stated in the document, but the Trustee, in its discretion, may make such further inquiry or investigation into such facts or matters as it may see fit; 

(b) before the Trustee acts or refrains from acting, it may require an Officers’ Certificate and/or an Opinion of Counsel,
which shall conform to Section 10.04 and shall cover such other matters as the Trustee may reasonably request. The Trustee shall not be liable for any action it takes or omits to take in good faith in reliance on such certificate or opinion.
Subject to Sections 7.01 and 7.02, whenever in the administration of the trusts of this Indenture the Trustee shall deem it necessary or desirable that a matter be proved or established prior to taking or suffering or omitting any action
hereunder, such matter (unless other evidence in respect thereof be herein specifically prescribed) may, in the absence of bad faith on the part of the Trustee, be deemed to be conclusively proved and established by an Officers’ Certificate
delivered to the Trustee, and such certificate, in the absence of bad faith on the part of the Trustee, shall be full warrant to the Trustee for any action taken, suffered or omitted by it under the provisions of this Indenture upon the faith
thereof; 
 (c) the Trustee may act through its attorneys and agents not regularly in its employ and shall not be
responsible for the misconduct or negligence of any agent or attorney appointed with due care; 
 (d) any request,
direction, order or demand of the Company mentioned herein shall be sufficiently evidenced by an Officers’ Certificate (unless other evidence in respect thereof be herein specifically prescribed); and any Board Resolution may be evidenced to
the Trustee by a copy thereof certified by the secretary or an assistant secretary of the Company; 
 (e) the Trustee
shall be under no obligation to exercise any of the rights or powers vested in it by this Indenture at the request, order or direction of any of the Holders, unless such Holders shall have offered to the Trustee security or indemnity against the
costs, expenses and liabilities that might be incurred by it in compliance with such request or direction; 
 (f) the
Trustee shall not be liable for any action it takes or omits to take in good faith that it believes to be authorized or within its rights or powers or for any action it takes or omits to take in accordance with the direction of the Holders in
accordance with Section 6.05 relating to the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred upon the Trustee, under this Indenture; 

(g) the Trustee may consult with counsel and the written advice of such counsel or any Opinion of Counsel shall be full and
complete authorization and protection in respect of any action taken, suffered or omitted by it hereunder in good faith and in reliance thereon; and 

  
 19 

 (h) prior to the occurrence of an Event of Default hereunder and after the curing or
waiving of all Events of Default, the Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, Officers’ Certificate, Opinion of Counsel, Board Resolution, statement, instrument,
opinion, report, notice, request, consent, order, approval, appraisal, bond, debenture, note, coupon, security, or other paper or document unless requested in writing so to do by the Holders of not less than a majority in aggregate Principal amount
of the Securities of all series affected then outstanding; provided that, if the payment within a reasonable time to the Trustee of the costs, expenses or liabilities likely to be incurred by it in the making of such investigation is, in the opinion
of the Trustee, not reasonably assured to the Trustee by the security afforded to it by the terms of this Indenture, the Trustee may require reasonable indemnity satisfactory to it against such expenses or liabilities as a condition to proceeding.

 (i) Except as otherwise provided by the Trust Indenture Act, the duties and obligations of the Trustee with
respect to the Securities shall be determined solely by the express provisions of this Indenture and the Securities, and the Trustee shall not be liable except for the performance of such duties and obligations as are specifically set forth in this
Indenture and the Securities, and no implied covenants or obligations shall be read into this Indenture or the Securities against it. 
 (j) Notwithstanding any provision herein to the contrary, in no event shall the Trustee be liable for any failure or delay in the performance of its obligations under this Indenture because of
circumstances beyond its control, including, but not limited to, acts of God, flood, war (whether declared or undeclared), terrorism, fire, riot, strikes or work stoppages for any reason, embargo, government action, including any laws, ordinances,
regulations or the like which restrict or prohibit the providing of the services contemplated by this Indenture, inability to obtain material, equipment, or communications or computer facilities, or the failure of equipment or interruption of
communications or computer facilities, and other causes beyond its control whether or not of the same class or kind as specifically named above. 
 (k) The Trustee may at any time request that the Company deliver an Officers’ Certificate setting forth the specimen signatures and the names of individuals and/or titles of Officers
authorized at such time to take specified actions pursuant to this Indenture, which Officers’ Certificate may be signed by any Person authorized to sign an Officers’ Certificate, including any Person specified as so authorized in any such
certificate previously delivered and not superseded. 
 (l) In no event shall the Trustee be responsible or liable
for special, indirect, consequential or punitive loss or damage of any kind whatsoever (including, but not limited to, loss of profit), irrespective of whether the Trustee has been advised of the likelihood of such loss or damage and regardless of
the form of action. 
 (m) Every provision of this Indenture relating to the conduct or affecting the liability or
offering protection, immunity or indemnity to the Trustee shall be deemed to apply with the same force and effect to the Trustee in its capacities as Registrar, Paying Agent, Authenticating Agent and transfer agent and to each other Agent appointed
hereunder. 
 Section 7.03. Individual Rights of Trustee. The Trustee, in its individual or any other
capacity, may become the owner or pledgee of Securities and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not the Trustee. Any Agent may do the same with like rights. However, the Trustee is
subject to Trust Indenture Act Sections 310(b) and 311. For purposes of Trust Indenture Act Section 311(b)(4) and (6), the following terms shall mean: 
 (a) “cash transaction” means any transaction in which full payment for goods or securities sold is made within seven days after delivery of the goods or securities in currency or
in checks or other orders drawn upon banks or bankers and payable upon demand; and 
 (b) “self-liquidating
paper” means any draft, bill of exchange, acceptance or obligation which is made, drawn, negotiated or incurred by the Company for the purpose of financing the purchase, processing, manufacturing, shipment, storage or sale of goods, wares
or merchandise and which is secured by documents evidencing title to, possession of, or a lien upon, the goods, wares or merchandise or the receivables or proceeds arising from the sale of the goods, wares or merchandise previously constituting the
security, provided the security is received by the Trustee simultaneously with the creation of the creditor relationship with the Company arising from the making, drawing, negotiating or incurring of the draft, bill of exchange, acceptance or
obligation. 
 Section 7.04. Trustee’s Disclaimer. The recitals contained herein and in the
Securities (except the Trustee’s certificate of authentication) shall be taken as statements of the Company and not of the Trustee and the Trustee assumes no responsibility for the correctness of the same. Neither the Trustee nor any of its
agents (a) makes any representation as to the validity or adequacy of this Indenture, the Securities or any offering materials and (b) shall be accountable for the Company’s use or application of the proceeds from the Securities.

  
 20 

 Section 7.05. Notice of Default. If any Default with respect to
the Securities of any series occurs and is continuing and if such Default is known to the actual knowledge of a Responsible Officer with the Corporate Trust Office of the Trustee, the Trustee shall give to each Holder of Securities of such series
notice of such Default within 90 days after it occurs to all Holders of Securities of such series in the manner and to the extent provided in Section 313(c) of the Trust Indenture Act, unless such Default shall have been cured or waived
before the mailing of such notice; provided, however, that, except in the case of a Default in the payment of the Principal of or interest on any Security, the Trustee shall be protected in withholding such notice if the Trustee in good faith
determines that the withholding of such notice is in the interests of the Holders. 
 The Trustee shall not be charged with
knowledge of any Default or Event of Default with respect to the Securities, unless either (i) a Responsible Officer shall have actual knowledge of such Default or Event of Default or (ii) written notice of such Default or Event of Default
shall have been given to the Trustee by the Company or by any Holder. 
 Section 7.06. Reports by Trustee
to Holders. The Trustee shall transmit to Holders such reports concerning the Trustee and its actions under this Indenture as may be required pursuant to the Trust Indenture Act at the times and in the manner provided pursuant thereto. If
required by Section 313(a) of the Trust Indenture Act, the Trustee shall, within 60 days after each May 15 following the date of this Indenture, deliver to Holders a brief report, dated as of such May 15, which complies with the
provisions of such Section 313(a). 
 A copy of each such report shall, at the time of such transmission to Holders, be
filed by the Trustee with each stock exchange upon which any Securities are listed, with the Commission and with the Company. The Company will promptly notify the Trustee in writing when any Securities are listed on any stock exchange. 

Section 7.07. Compensation and Indemnity. The Company shall pay to the Trustee such compensation as shall be
agreed upon in writing from time to time for its services. The compensation of the Trustee shall not be limited by any law on compensation of a Trustee of an express trust. The Company shall reimburse the Trustee and any predecessor Trustee upon
request for all reasonable out-of-pocket expenses, disbursements and advances incurred or made by the Trustee or such predecessor Trustee. Such expenses shall include, without limitation, the reasonable compensation and expenses of the
Trustee’s or such predecessor Trustee’s agents, legal counsel and other persons not regularly in their employ. 
 The
Company shall indemnify each of the Trustee and any predecessor Trustee for, and hold it harmless against, any loss, liability, damage, claim or expense (including, without limitation, the fees and expenses of its counsel) incurred by it without
negligence or bad faith on its part arising out of or in connection with the acceptance or administration of this Indenture and the Securities or the issuance of the Securities or any series or tranches thereof or the trusts hereunder and the
performance of duties or the exercise of its rights under this Indenture and the Securities, including the costs and expenses of defending itself against or investigating any claim or liability and of complying with any process served upon it or any
of its officers in connection with the exercise or performance of any of its rights, powers or duties under this Indenture and the Securities. 
 To secure the Company’s payment obligations in this Section 7.07, the Trustee shall have a lien prior to the Securities on all money or property held or collected by the Trustee, in its capacity
as Trustee, except money or property held in trust to pay Principal of, and interest on particular Securities. 
 The
obligations of the Company under this Section to compensate and indemnify the Trustee and each predecessor Trustee and to pay or reimburse the Trustee and each predecessor Trustee for expenses, disbursements and advances shall constitute additional
indebtedness hereunder and shall survive the satisfaction and discharge of this Indenture or the rejection or termination of this Indenture under bankruptcy law and/or the resignation or removal of the Trustee and/or the payment of Securities. Such
additional indebtedness shall be a senior claim to that of the Securities upon all property and funds held or collected by the Trustee as such, except funds held in trust for the benefit of the Holders of particular Securities, and the Securities
are hereby subordinated to such senior claim. Without prejudice to any other rights available to the Trustee under applicable law, if the Trustee renders services and incurs expenses following an Event of Default under Section 6.01(d) or
Section 6.01(e) hereof, the parties hereto and the holders by their acceptance of the Securities hereby agree that such expenses are intended to constitute expenses of administration under any bankruptcy law. 

Section 7.08. Replacement of Trustee. A resignation or removal of the Trustee as Trustee with respect to the
Securities of any series and appointment of a successor Trustee as Trustee with respect to the Securities of any series shall become effective only upon the successor Trustee’s acceptance of appointment as provided in this Section 7.08.

 The Trustee may resign as Trustee with respect to the Securities of any series at any time by so notifying the Company in
writing. The Holders of a majority in Principal amount of the outstanding Securities of any series may remove the Trustee as Trustee with respect to the Securities of such series by so notifying the Trustee in writing and may appoint a successor
Trustee with respect thereto with the consent of the Company. The Company may remove the Trustee as Trustee with respect to the Securities of any series if: (i) the Trustee is no longer eligible under Section 7.11 of this Indenture;
(ii) the Trustee is adjudged a bankrupt or insolvent; (iii) a receiver or other public officer takes charge of the Trustee or its property; or (iv) the Trustee becomes incapable of acting. 

  
 21 

 If the Trustee resigns or is removed as Trustee with respect to the Securities of any
series, or if a vacancy exists in the office of Trustee with respect to the Securities of any series for any reason, the Company shall promptly appoint a successor Trustee with respect thereto. Within one year after the successor Trustee takes
office, the Holders of a majority in Principal amount of the outstanding Securities of such series may appoint a successor Trustee in respect of such Securities to replace the successor Trustee appointed by the Company. If the successor Trustee with
respect to the Securities of any series does not deliver its written acceptance required by Section 7.09 within 30 days after the retiring Trustee resigns or is removed, the retiring Trustee, the Company or the Holders of a majority in
Principal amount of the outstanding Securities of such series may petition any court of competent jurisdiction for the appointment of a successor Trustee with respect thereto. 
 The Company shall give notice of any resignation and any removal of the Trustee with respect to the Securities of any series and each appointment of a successor Trustee in respect of the Securities of
such series to all Holders of Securities of such series. Each notice shall include the name of the successor Trustee and the address of its Corporate Trust Office. 
 Notwithstanding replacement of the Trustee with respect to the Securities of any series pursuant to this Section 7.08 and Section 7.09, the Company’s obligations under Section 7.07
shall survive and continue for the benefit of the retiring Trustee. 
 Section 7.09. Acceptance of Appointment by
Successor. In case of the appointment hereunder of a successor Trustee with respect to all Securities, every such successor Trustee so appointed shall execute, acknowledge and deliver to the Company and to the retiring Trustee an instrument
accepting such appointment, and thereupon the resignation or removal of the retiring Trustee shall become effective and such successor Trustee, without any further act, deed or conveyance, shall become vested with all the rights, powers, trusts and
duties of the retiring Trustee; but, on the request of the Company or the successor Trustee, such retiring Trustee shall, upon payment of its charges and subject to the lien provided for in Section 7.07, execute and deliver an instrument
transferring to such successor Trustee all the rights, powers and trusts of the retiring Trustee and shall duly assign, transfer and deliver to such successor Trustee all property and money held by such retiring Trustee hereunder. 

In case of the appointment hereunder of a successor Trustee with respect to the Securities of one or more (but not all) series, the
Company, the retiring Trustee and each successor Trustee with respect to the Securities of one or more series shall execute and deliver an indenture supplemental hereto wherein each successor Trustee shall accept such appointment and which
(1) shall contain such provisions as shall be necessary or desirable to transfer and confirm to, and to vest in, each successor Trustee all the rights, powers, trusts and duties of the retiring Trustee with respect to the Securities of that or
those series to which the appointment of such successor Trustee relates, (2) if the retiring Trustee is not retiring with respect to all Securities, shall contain such provisions as shall be deemed necessary or desirable to confirm that all the
rights, powers, trusts and duties of the retiring Trustee with respect to the Securities of that or those series as to which the retiring Trustee is not retiring shall continue to be vested in the retiring Trustee, and (3) shall add to or
change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration of the trusts hereunder by more than one Trustee, it being understood that nothing herein or in such supplemental indenture shall
constitute such Trustees co-trustees of the same trust and that each such Trustee shall be trustee of a trust or trusts hereunder separate and apart from any trust or trusts hereunder administered by any other such Trustee; and upon the execution
and delivery of such supplemental indenture the resignation or removal of the retiring Trustee shall become effective to the extent provided therein and each such successor Trustee, without any further act, deed or conveyance, shall become vested
with all the rights, powers, trusts and duties of the retiring Trustee with respect to the Securities of that or those series to which the appointment of such successor Trustee relates; but, on request of the Company or any successor Trustee, such
retiring Trustee shall duly assign, transfer and deliver to such successor Trustee all property and money held by such retiring Trustee hereunder with respect to the Securities of that or those series to which the appointment of such successor
Trustee relates. 
 Upon request of any such successor Trustee, the Company shall execute any and all instruments for more fully
and certainly vesting in and confirming to such successor Trustee all such rights, powers and trusts referred to in the first or second preceding paragraph, as the case may be. 

No successor Trustee shall accept its appointment unless at the time of such acceptance such successor Trustee shall be eligible under
this Article and qualified under Section 310(b) of the Trust Indenture Act. 
 Section 7.10. Successor
Trustee By Merger, Etc. If the Trustee consolidates with, merges or converts into, or transfers all or substantially all of its corporate trust business (including this transaction) to, another corporation or national banking association, the
resulting, surviving or transferee corporation or national banking association without any further act shall be the successor Trustee with the same effect as if the successor Trustee had been named as the Trustee herein. 

Section 7.11. Eligibility. This Indenture shall always have a Trustee who satisfies the requirements of Trust
Indenture Act Section 310(a). The Trustee shall have a combined capital and surplus of at least $25,000,000 as set forth in its most recent published annual report of condition. 

  
 22 

 Section 7.12. Money Held in Trust. The Trustee shall not be liable
for the investment of or the payment of any interest on any money received by it except as the Trustee may agree in writing with the Company. Money held in trust by the Trustee need not be segregated from other funds except to the extent required by
law and except for money held in trust under Article 8 of this Indenture. 
 ARTICLE 8 

SATISFACTION AND DISCHARGE OF INDENTURE; UNCLAIMED MONEYS 
 Section 8.01. Satisfaction and Discharge of Indenture. If at any time (a) the Company shall have paid or caused to be paid the Principal of and interest on all the
Securities of any series outstanding hereunder (other than Securities of such series which have been destroyed, lost or stolen and which have been replaced or paid as provided in Section 2.08) as and when the same shall have become due and
payable, or (b) the Company shall have delivered to the Trustee for cancellation all Securities of any series theretofore authenticated (other than any Securities of such series which shall have been destroyed, lost or stolen and which shall
have been replaced or paid as provided in Section 2.08) or (c) (i) all the Securities of such series not theretofore delivered to the Trustee for cancellation shall have become due and payable, or are by their terms to become due and
payable within one year or are to be called for redemption within one year under arrangements satisfactory to the Trustee for the giving of notice of redemption, and (ii) the Company shall have irrevocably deposited or caused to be deposited
with the Trustee as trust funds the entire amount in cash (other than moneys repaid by the Trustee or any Paying Agent to the Company in accordance with Section 8.04) or U.S. Government Obligations, maturing as to Principal and interest in such
amounts and at such times as will insure (without consideration of the reinvestment of such interest) the availability of cash, or a combination thereof, sufficient to pay at maturity or upon redemption all Securities of such series (other than any
Securities of such series which shall have been destroyed, lost or stolen and which shall have been replaced or paid as provided in Section 2.08) not theretofore delivered to the Trustee for cancellation, including Principal and interest due or
to become due on or prior to such date of maturity or redemption as the case may be, and if, in any such case, the Company is not prohibited from making payments in respect of the Securities by Article 11 hereof and shall also pay or cause to
be paid all other sums payable hereunder by the Company with respect to Securities of such series, then this Indenture shall cease to be of further effect with respect to Securities of such series (except as to (i) rights of registration of
transfer and exchange of securities of such series, and the Company’s right of optional redemption, if any, (ii) substitution of mutilated, defaced, destroyed, lost or stolen Securities, (iii) rights of Holders to receive payments of
Principal thereof and interest thereon, upon the original stated due dates therefor (but not upon acceleration) and remaining rights of the Holders to receive mandatory sinking fund payments, if any, (iv) the rights, obligations, protections,
indemnities and immunities of the Trustee and each Agent hereunder and (v) the rights of the Securityholders of such series as beneficiaries hereof with respect to the property so deposited with the Trustee payable to all or any of them), and
the Trustee, on written demand of the Company accompanied by an Officers’ Certificate and an Opinion of Counsel and at the cost and expense of the Company, shall execute proper instruments acknowledging such satisfaction of and discharging this
Indenture with respect to such series; provided, that the rights of Holders of the Securities to receive amounts in respect of Principal of and interest on the Securities held by them shall not be delayed longer than required by then-applicable
mandatory rules or policies of any securities exchange upon which the Securities are listed. The Company agrees to reimburse the Trustee for any costs or expenses thereafter reasonably and properly incurred and to compensate the Trustee for any
services thereafter reasonably and properly rendered by the Trustee in connection with this Indenture or the Securities of such series. 
 Section 8.02. Application by Trustee of Funds Deposited for Payment of Securities. Subject to Section 8.04, all moneys (including U.S. Government Obligations and the
proceeds thereof) deposited with the Trustee pursuant to Section 8.01, Section 8.05 or Section 8.06 shall be held in trust and applied by it to the payment, either directly or through any Paying Agent to the Holders of the particular
Securities of such series for the payment or redemption of which such moneys have been deposited with the Trustee, of all sums due and to become due thereon for Principal and interest; but such money need not be segregated from other funds except to
the extent required by law. Funds and U.S. Government Obligations held in trust under Section 8.01, 8.05 or 8.06 shall not be subject to the claims of the holders of Senior Indebtedness under Article 11. 

Section 8.03. Repayment of Moneys Held by Paying Agent. In connection with the satisfaction and discharge of
this Indenture with respect to Securities of any series, all moneys then held by any Paying Agent under the provisions of this Indenture with respect to such series of Securities shall, upon written demand of the Company, be repaid to it or paid to
the Trustee and thereupon such Paying Agent shall be released from all further liability with respect to such moneys. 

Section 8.04. Return of Moneys Held by Trustee and Paying Agent Unclaimed for Two Years. Any moneys deposited
with or paid to the Trustee or any Paying Agent for the payment of the Principal of or interest on any Security of any series and not applied but remaining unclaimed for two years after the date upon which such Principal or interest shall have
become due and payable, shall, upon the written request of the Company and unless otherwise required by mandatory provisions of applicable escheat or abandoned or 

  
 23 

 
unclaimed property law, be repaid to the Company by the Trustee for such series or such Paying Agent, and the Holder of the Security of such series shall, unless otherwise required by mandatory
provisions of applicable escheat or abandoned or unclaimed property laws, thereafter look only to the Company for any payment which such Holder may be entitled to collect, and all liability of the Trustee or any Paying Agent with respect to such
moneys shall thereupon cease. 
 Section 8.05. Defeasance and Discharge of Indenture. The Company
shall be deemed to have paid and shall be discharged from any and all obligations in respect of the Securities of any series, on the 123rd day after the deposit referred to in clause (i) hereof has been made, and the provisions of this
Indenture shall no longer be in effect with respect to the Securities of such series (and the Trustee, at the expense of the Company, shall execute proper instruments acknowledging the same), except as to: (a) rights of registration of transfer
and exchange, and the Company’s right of optional redemption, (b) substitution of apparently mutilated, defaced, destroyed, lost or stolen Securities, (c) rights of Holders to receive payments of Principal thereof and interest
thereon, upon the original stated due dates therefor (but not upon acceleration), (d) the rights, obligations and immunities of the Trustee hereunder and (e) the rights of the Securityholders of such series as beneficiaries hereof with
respect to the property so deposited with the Trustee payable to all or any of them; provided that the following conditions shall have been satisfied: 
 (i) with reference to this provision the Company has deposited or caused to be irrevocably deposited with the Trustee (or another qualifying trustee satisfying the requirements of
Section 7.11) as trust funds in trust, specifically pledged as security for, and dedicated solely to, the benefit of the Holders of the Securities of such series, (A) money in an amount, or (B) U.S. Government Obligations which
through the payment of interest and principal in respect thereof in accordance with their terms will provide not later than one day before the due date of any payment referred to in subclause (x) or (y) of this clause (i) money in an
amount, or (C) a combination thereof, sufficient, in the opinion of a nationally recognized firm of independent public accountants expressed in a written certification thereof delivered to the Trustee, to pay and discharge without consideration
of the reinvestment of such interest and after payment of all federal, state and local taxes or other charges and assessments in respect thereof payable by the Trustee (x) the Principal of, premium, if any, and each installment of interest on
the outstanding Securities of such series on the due dates thereof and (y) any mandatory sinking fund payments or analogous payments applicable to the Securities of such series on the day on which such payments are due and payable in accordance
with the terms of Securities of such series and the Indenture with respect to the Securities of such series; 
 (ii) the
Company has delivered to the Trustee (A) either (x) an Opinion of Counsel to the effect that Holders of Securities of such series will not recognize income, gain or loss for federal income tax purposes as a result of the Company’s
exercise of its option under this Section 8.05 and will be subject to federal income tax on the same amount and in the same manner and at the same times as would have been the case if such deposit, defeasance and discharge had not occurred,
which Opinion of Counsel must be based upon a ruling of the Internal Revenue Service to the same effect or a change in applicable federal income tax law or related treasury regulations after the date of this Indenture or (y) a ruling directed
to the Trustee received from the Internal Revenue Service to the same effect as the aforementioned Opinion of Counsel and (B) an Opinion of Counsel to the effect that the creation of the defeasance trust does not violate the Investment Company
Act of 1940 and after the passage of 123 days following the deposit, the trust fund will not be subject to the effect of Section 547 of the U.S. Bankruptcy Code or Section 15 of the New York Debtor and Creditor Law; 

(iii) immediately after giving effect to such deposit on a pro forma basis, no Event of Default, or event that after the giving of
notice or lapse of time or both would become an Event of Default, shall have occurred and be continuing on the date of such deposit or during the period ending on the 123rd day after the date of such deposit, and such deposit shall not result in a
breach or violation of, or constitute a default under, any other agreement or instrument to which the Company is a party or by which the Company is bound; 
 (iv) if at such time the Securities of such series are listed on a national securities exchange, the Company has delivered to the Trustee an Opinion of Counsel to the effect that the Securities of
such series will not be delisted as a result of such deposit, defeasance and discharge; 
 (v) the Company shall have
delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that all conditions precedent to the defeasance and discharge under this Section have been complied with; and 

(vi) if the Securities of such series are to be redeemed prior to the final maturity thereof (other than from mandatory sinking
fund payments or analogous payments), notice of such redemption shall have been duly given pursuant to this Indenture or provision therefor satisfactory to the Trustee shall have been made. 

Section 8.06. Defeasance of Certain Obligations. The Company may omit to comply with any term, provision or
condition set forth in, and this Indenture will no longer be in effect with respect to, any covenant established pursuant to Section 2.03(r) and clause (c) (with respect to any covenants established pursuant to Section 2.03(r)) and
clause (f) of Section 6.01 shall be deemed not to be an Event of Default, if 

  
 24 

 (a) with reference to this Section 8.06, the Company has deposited or caused to
be irrevocably deposited with the Trustee (or another qualifying trustee satisfying the requirements of Section 7.11) as trust funds in trust, specifically pledged as security for, and dedicated solely to, the benefit of the Holders of the
Securities of such series and the Indenture with respect to the Securities of such series, (i) money in an amount or (ii) U.S. Government Obligations which through the payment of interest and principal in respect thereof in accordance with
their terms will provide not later than one day before the due dates thereof or earlier redemption (irrevocably provided for under agreements satisfactory to the Trustee), as the case may be, of any payment referred to in subclause (x) or
(y) of this clause (a) money in an amount, or (iii) a combination thereof, sufficient, in the opinion of a nationally recognized firm of independent public accountants expressed in a written certification thereof delivered to the
Trustee, to pay and discharge without consideration of the reinvestment of such interest and after payment of all federal, state and local taxes or other charges and assessments in respect thereof payable by the Trustee (x) the Principal of,
premium, if any, and each installment of interest on the outstanding Securities on the due date thereof or earlier redemption (irrevocably provided for under arrangements satisfactory to the Trustee), as the case may be, and (y) any mandatory
sinking fund payments or analogous payments applicable to the Securities of such series and the Indenture with respect to the Securities of such series on the day on which such payments are due and payable in accordance with the terms of the
Indenture and of Securities of such series and the Indenture with respect to the Securities of such series; 
 (b) the
Company has delivered to the Trustee (i) an Opinion of Counsel to the effect that Holders of Securities of such series will not recognize income, gain or loss for federal income tax purposes as a result of the Company’s exercise of its
option under this Section 8.06 and will be subject to federal income tax on the same amount and in the same manner and at the same times as would have been the case if such deposit and defeasance had not occurred and (ii) an Opinion of
Counsel to the effect that the creation of the defeasance trust does not violate the Investment Company Act of 1940 and after the passage of 123 days following the deposit, the trust fund will not be subject to the effect of Section 547 of
the U.S. Bankruptcy Code or Section 15 of the New York Debtor and Creditor Law; 
 (c) immediately after giving
effect to such deposit on a pro forma basis, no Event of Default, or event that after the giving of notice or lapse of time or both would become an Event of Default, shall have occurred and be continuing on the date of such deposit or during the
period ending on the 123rd day after the date of such deposit, and such deposit shall not result in a breach or violation of, or constitute a default under, any other agreement or instrument to which the Company is a party or by which the Company is
bound; 
 (d) if at such time the Securities of such series are listed on a national securities exchange, the Company has
delivered to the Trustee an Opinion of Counsel to the effect that the Securities of such series will not be delisted as a result of such deposit, defeasance and discharge; and 
 (e) the Company shall have delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that all conditions precedent to the defeasance under this Section
have been complied with. 
 Section 8.07. Reinstatement. If the Trustee or Paying Agent is unable to
apply any monies or U.S. Government Obligations in accordance with Article 8 by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such
application, the Company’s obligations under this Indenture and the Securities shall be revived and reinstated as though no deposit had occurred pursuant to this Article until such time as the Trustee or Paying Agent is permitted to apply all
such monies or U.S. Government Obligations in accordance with Article 8; provided, however , that if the Company has made any payment of Principal of or interest on any Securities because of the reinstatement of its obligations, the
Company shall be subrogated to the rights of the Holders of such Securities to receive such payment from the monies or U.S. Government Obligations held by the Trustee or Paying Agent. 

Section 8.08. Indemnity. The Company shall pay and indemnify the Trustee (or other qualifying trustee, collectively
for purposes of this Section 8.08 and Section 8.02, the “Trustee”) against any tax, fee or other charge, imposed on or assessed against the U.S. Government Obligations deposited pursuant to Section 8.01, 8.05 or 8.06 or the
principal or interest received in respect thereof other than any such tax, fee or other charge which by law is for the account of the Holders of the Securities. 
 Section 8.09. Excess Funds. Anything in this Article 8 to the contrary notwithstanding, the Trustee shall deliver or pay to the Company from time to time upon written
request of the Company, any money or U.S. Government Obligations (or other property and any proceeds therefrom) held by it as provided in Section 8.01, 8.05 or 8.06 which, in the opinion of a nationally recognized firm of Independent Public
Accountants expressed in a written certification thereof delivered to the Trustee, are in excess of the amount thereof which would then be required to be deposited to effect a discharge or defeasance, as applicable, in accordance with this Article
8. 
 Section 8.10. Qualifying Trustee. Any trustee appointed pursuant to Section 8.05 or 8.06 (other
than the Trustee) for the purpose of holding money or U.S. Government Obligations deposited pursuant to such Sections shall be appointed under an agreement in form 

  
 25 

 
acceptable to the Trustee and shall provide to the Trustee a certificate, upon which certificate the Trustee shall be entitled to conclusively rely, that all conditions precedent provided for
herein to the related defeasance have been complied with. In no event shall the Trustee be liable for any acts or omissions of said trustee. 
 ARTICLE 9 
 AMENDMENTS, SUPPLEMENTS AND WAIVERS 

Section 9.01. Without Consent of Holders. The Company and the Trustee may amend or supplement this Indenture or
the Securities of any series without notice to or the consent of any Holder: 
 (a) to cure any ambiguity, defect or
inconsistency in this Indenture; provided that such amendments or supplements shall not materially adversely affect the interests of the Holders; 
 (b) to comply with Article 5; 
 (c) to comply with any
requirements of the Commission in connection with the qualification of this Indenture under the Trust Indenture Act; 

(d) to evidence and provide for the acceptance of appointment hereunder with respect to the Securities of any or all series by a
successor Trustee and to add to or change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration of the trusts hereunder by more than one Trustee, pursuant to the requirements of
Section 7.09; 
 (e) to establish the form or forms or terms of Securities of any series as permitted by
Section 2.03; and 
 (f) to make any change that does not materially adversely affect the rights of any Holder.

 Section 9.02. With Consent of Holders. Subject to Sections 6.04 and 6.07, without prior notice
to any Holders, the Company and the Trustee may amend this Indenture and the Securities of any series with the written consent of the Holders of a majority in Principal amount of the outstanding Securities of all series affected by such amendment
(all such series voting as a separate class), and the Holders of a majority in principal amount of the outstanding Securities of all series affected thereby (all such series voting as a separate class) by written notice to the Trustee may waive
future compliance by the Company with any provision of this Indenture or the Securities of such series. 
 Notwithstanding the
provisions of this Section 9.02, without the consent of each Holder affected thereby, an amendment or waiver, including a waiver pursuant to Section 6.04, may not: 
 (a) change the stated maturity of the Principal of, or any sinking fund obligation or any installment of interest on, such Holder’s Security, 

(b) reduce the Principal amount thereof or the rate of interest thereon (including any amount in respect of original issue
discount); 
 (c) reduce the above stated percentage of outstanding Securities the consent of whose Holders is necessary
to modify or amend the Indenture with respect to the Securities of the relevant series; and 
 (d) reduce the percentage
in Principal amount of outstanding Securities of the relevant series the consent of whose Holders is required for any supplemental indenture or for any waiver of compliance with certain provisions of this Indenture or certain Defaults and their
consequences provided for in this Indenture. 
 A supplemental indenture which changes or eliminates any covenant or other
provision of this Indenture which has expressly been included solely for the benefit of one or more particular series of Securities, or which modifies the rights of Holders of Securities of such series with respect to such covenant or provision,
shall be deemed not to affect the rights under this Indenture of the Holders of Securities of any other series. 
 It shall not
be necessary for the consent of any Holder under this Section 9.02 to approve the particular form of any proposed amendment, supplement or waiver, but it shall be sufficient if such consent approves the substance thereof. 

After an amendment, supplement or waiver under this Section 9.02 becomes effective, the Company shall give to the Holders affected
thereby a notice briefly describing the amendment, supplement or waiver. The Company will mail supplemental indentures to Holders upon request. Any failure of the Company to mail such notice, or any defect therein, shall not, however, in any way
impair or affect the validity of any such supplemental indenture or waiver. 
 Section 9.03. Revocation
and Effect of Consent. Until an amendment or waiver becomes effective, a consent to it by a Holder is a continuing consent by the Holder and every subsequent Holder of a Security or portion of a Security that evidences the same debt as

  
 26 

 
the Security of the consenting Holder, even if notation of the consent is not made on any Security. However, any such Holder or subsequent Holder may revoke the consent as to its Security or
portion of its Security. Such revocation shall be effective only if the Trustee receives the notice of revocation before the date the amendment, supplement or waiver becomes effective. An amendment, supplement or waiver shall become effective with
respect to any Securities affected thereby on receipt by the Trustee of written consents from the requisite Holders of outstanding Securities affected thereby. 
 The Company may, but shall not be obligated to, fix a record date (which may be not less than five nor more than 60 days prior to the solicitation of consents) for the purpose of determining the
Holders of the Securities of any series affected entitled to consent to any amendment, supplement or waiver. If a record date is fixed, then, notwithstanding the immediately preceding paragraph, those Persons who were such Holders at such record
date (or their duly designated proxies) and only those Persons shall be entitled to consent to such amendment, supplement or waiver or to revoke any consent previously given, whether or not such Persons continue to be such Holders after such record
date. No such consent shall be valid or effective for more than 90 days after such record date. 
 After an amendment,
supplement or waiver becomes effective with respect to the Securities of any series affected thereby, it shall bind every Holder of such Securities unless it is of the type described in any of clauses (a) through (d) of Section 9.02.
In case of an amendment or waiver of the type described in clauses (a) through (d) of Section 9.02, the amendment or waiver shall bind each such Holder who has consented to it and every subsequent Holder of a Security that evidences
the same indebtedness as the Security of the consenting Holder. 
 Section 9.04. Notation on or Exchange
of Securities. If an amendment, supplement or waiver changes the terms of any Security, the Trustee may require the Holder thereof to deliver it to the Trustee. The Trustee may place an appropriate notation on the Security about the changed
terms and return it to the Holder and the Trustee may place an appropriate notation on any Security of such series thereafter authenticated. Alternatively, if the Company or the Trustee so determines, the Company in exchange for the Security shall
issue and the Trustee shall authenticate a new Security of the same series and tenor that reflects the changed terms. 

Section 9.05. Trustee to Sign Amendments, Etc. The Trustee shall be entitled to receive, and shall be fully
protected in relying upon, an Opinion of Counsel stating that the execution of any amendment, supplement or waiver authorized pursuant to this Article 9 is authorized or permitted by this Indenture, stating that all requisite consents have been
obtained or that no consents are required and stating that such supplemental indenture constitutes the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to customary exceptions.
The Trustee may, but shall not be obligated to, execute any such amendment, supplement or waiver that affects the Trustee’s own rights, duties or immunities under this Indenture or otherwise. 

Section 9.06. Conformity with Trust Indenture Act. Every supplemental indenture executed pursuant to this
Article 9 shall conform to the requirements of the Trust Indenture Act as then in effect. 
 ARTICLE 10 

MISCELLANEOUS 

Section 10.01. Trust Indenture Act of 1939. This Indenture shall incorporate and be governed by the provisions
of the Trust Indenture Act that are required to be part of and to govern indentures qualified under the Trust Indenture Act. 

Section 10.02. Notices. Any notice or communication shall be given in writing and delivered (a) in person,
(b) by first class mail, (c) by facsimile transmission or (d) by overnight courier, in each case addressed as follows: 
 if to the Company: 
 UIL Holdings Corporation 

157 Church Street 
 New Haven, CT 06506

 Facsimile: 203-499-3664 
 Attention:
General Counsel 
 if to the Trustee: 
 The Bank of New York Mellon 
 101 Barclay Street, 4 East 

New York, New York 10286 
 Facsimile:
(212) 815 — 5802/03 
 Attention: Corporate Trust Department 

  
 27 

 The Company or the Trustee by written notice to the other may designate additional or
different addresses for subsequent notices or communications. Notice and communications to the Trustee and the Company shall be deemed sufficiently given upon actual receipt thereof; provided that notices and communications delivered by facsimile
transmission shall be deemed sufficiently given only upon receipt by the delivering party of written confirmation of such actual receipt. 
 Any notice or communication shall be sufficiently given to Holders of Securities by mailing to such Holders at their addresses as they shall appear on the Security Register. Notice mailed shall be
sufficiently given if so mailed within the time prescribed. Copies of any such communication or notice to a Holder shall also be mailed to the Trustee and each Agent at the same time. 

Failure to mail a notice or communication to a Holder or any defect in it shall not affect its sufficiency with respect to other Holders.
Except as otherwise provided in this Indenture, if a notice or communication to a Holder is given in the manner provided in this Section 10.02, it is duly given, whether or not the Holder receives it. 

Where this Indenture provides for notice in any manner, such notice may be waived in writing by the Person entitled to receive such
notice, either before or after the event, and such waiver shall be the equivalent of such notice. Waivers of notice by Holders shall be filed with the Trustee, but such filing shall not be a condition precedent to the validity of any action taken in
reliance upon such waiver. 
 In case it shall be impracticable to give notice as herein contemplated, then such notification as
shall be made with the approval of the Trustee shall constitute a sufficient notification for every purpose hereunder. 
 In
respect of this Indenture, the Trustee shall not have any duty or obligation to verify or confirm that the Person sending instructions, directions, reports, notices or other communications or information by electronic transmission is, in fact, a
person authorized to give such instructions, directions, reports, notices or other communications or information on behalf of the party purporting to send such e-mail; and the Trustee shall not have any liability for any losses, liabilities, costs
or expenses incurred or sustained by any party as a result of such reliance upon or compliance with such instructions, directions, reports, notices or other communications or information. Each other party agrees to assume all risks arising out of
the use of electronic methods to submit instructions, directions, reports, notices or other communications or information to the Trustee, including without limitation the risk of the Trustee acting on unauthorized instructions, notices, reports or
other communications or information, and the risk of interception and misuse by third parties. 

Section 10.03. Certificate and Opinion as to Conditions Precedent. Upon any request or application by the
Company to the Trustee to take any action under this Indenture, the Company shall furnish to the Trustee: 
 (a) an
Officers’ Certificate stating that, in the opinion of the signers, all conditions precedent, if any, provided for in this Indenture relating to the proposed action have been complied with; and 

(b) an Opinion of Counsel stating that, in the opinion of such counsel, all such conditions precedent have been complied with.

 Section 10.04. Statements Required in Certificate or Opinion. Each certificate or opinion with
respect to compliance with a condition or covenant provided for in this Indenture (other than the certificate required by Section 4.04) shall include: 
 (a) a statement that each Person signing such certificate or opinion has read such covenant or condition and the definitions herein relating thereto; 

(b) a brief statement as to the nature and scope of the examination or investigation upon which the statement or opinion contained
in such certificate or opinion is based; 
 (c) a statement that, in the opinion of each such person, he has made such
examination or investigation as is necessary to enable him to express an informed opinion as to whether or not such covenant or condition has been complied with; and 
 (d) a statement as to whether or not, in the opinion of each such Person, such condition or covenant has been complied with; provided, however , that, with respect to matters of fact, an
Opinion of Counsel may rely on an Officers’ Certificate or certificates of public officials. 

Section 10.05. Evidence of Ownership. The Company, the Trustee and any agent of the Company or the Trustee may
deem and treat the person in whose name any Security shall be registered upon the Security Register for such series as the absolute owner of such Security (whether or not such Security shall be overdue and notwithstanding any notation of ownership
or other writing thereon) for the purpose of receiving payment of or on account of the Principal of and, subject to the provisions of this Indenture, interest on such Security and for all other purposes; and neither the Company nor the Trustee nor
any agent of the Company or the Trustee shall be affected by any notice to the contrary. 

  
 28 

 Section 10.06. Rules by Trustee, Paying Agent or Registrar. The
Trustee may make reasonable rules for action by or at a meeting of Holders. The Paying Agent or Registrar may make reasonable rules for its functions. 
 Section 10.07. Payment Date Other Than a Business Day. Except as otherwise provided with respect to a series of Securities, if any date for payment of Principal or interest on
any Security shall not be a Business Day at any place of payment, then payment of Principal of or interest on such Security, as the case may be, need not be made on such date, but may be made on the next succeeding Business Day at any place of
payment with the same force and effect as if made on such date and no interest shall accrue in respect of such payment for the period from and after such date. 
 Section 10.08. Governing Law. The laws of the State of New York shall govern this Indenture and the Securities. 

Section 10.09. No Adverse Interpretation of Other Agreements. This Indenture may not be used to interpret
another indenture or loan or debt agreement of the Company or any Subsidiary of the Company. Any such indenture or agreement may not be used to interpret this Indenture. 
 Section 10.10. Successors. All agreements of the Company in this Indenture and the Securities shall bind its successors. All agreements of the Trustee in this Indenture shall
bind its successors. 
 Section 10.11. Duplicate Originals. The parties may sign any number of copies
of this Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. 

Section 10.12. Separability. In case any provision in this Indenture or in the Securities shall be invalid,
illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 
 Section 10.13. Table of Contents, Headings, Etc. The Table of Contents and headings of the Articles and Sections of this Indenture have been inserted for convenience of reference
only, are not to be considered a part hereof and shall in no way modify or restrict any of the terms and provisions hereof. 

Section 10.14. Incorporators, Stockholders, Officers and Directors of Company Exempt from Individual Liability.
No recourse under or upon any obligation, covenant or agreement contained in this Indenture or any indenture supplemental hereto, or in any Security, or because of any indebtedness evidenced thereby, shall be had against any incorporator, as such or
against any past, present or future stockholder, officer, director or employee, as such, of the Company or of any successor, either directly or through the Company or any successor, under any rule of law, statute or constitutional provision or by
the enforcement of any assessment or by any legal or equitable proceeding or otherwise, all such liability being expressly waived and released by the acceptance of the Securities by the Holders thereof and as part of the consideration for the issue
of the Securities. 
 Section 10.15. Judgment Currency. The Company agrees, to the fullest extent that
it may effectively do so under applicable law, that (a) if for the purpose of obtaining judgment in any court it is necessary to convert the sum due in respect of the Principal of or interest on the Securities of any series (the
“Required Currency”) into a currency in which a judgment will be rendered (the “Judgment Currency”), the rate of exchange used shall be the rate at which in accordance with normal banking procedures the Trustee
could purchase in The City of New York the Required Currency with the Judgment Currency on the day on which final unappealable judgment is entered, unless such day is not a Business Day, then, to the extent permitted by applicable law, the rate of
exchange used shall be the rate at which in accordance with normal banking procedures the Trustee could purchase in The City of New York the Required Currency with the Judgment Currency on the Business Day preceding the day on which final
unappealable judgment is entered and (b) its obligations under this Indenture to make payments in the Required Currency (i) shall not be discharged or satisfied by any tender, or any recovery pursuant to any judgment (whether or not
entered in accordance with subsection (a)), in any currency other than the Required Currency, except to the extent that such tender or recovery shall result in the actual receipt, by the payee, of the full amount of the Required Currency expressed
to be payable in respect of such payments, (ii) shall be enforceable as an alternative or additional cause of action for the purpose of recovering in the Required Currency the amount, if any, by which such actual receipt shall fall short of the
full amount of the Required Currency so expressed to be payable and (iii) shall not be affected by judgment being obtained for any other sum due under this Indenture. 
 Section 10.16. Submission to Jurisdiction; Waiver of Jury Trial. Any suit, action or proceeding against the Company or its properties, assets or revenues with respect to this Indenture
or the Securities (a “Related Proceeding”) may be brought in the Supreme Court of the State of New York, County of New York, or in the United States District Court for the Southern District of New York, as the Person bringing such
Related Proceeding may elect in its sole discretion. The Company hereby consents to the non-exclusive jurisdiction of each such court for the purpose of any Related Proceeding and has irrevocably waived any objection to the laying of venue of any
Related Proceeding brought in any such court and to the fullest extent it may effectively do so and the defense of an inconvenient forum to the maintenance of any Related Proceeding or any such suit, action or proceeding in any such court. The
Company has agreed that service of all writs, claims, process and summonses in any Related Proceeding brought against it in the State 

  
 29 

 
of New York may be made upon Wiggin and Dana LLP, 450 Lexington Avenue, Suite 3800, New York, NY 10017-3913 (the “Process Agent”), and the Company irrevocably appointed the
Process Agent as its agent and true and lawful attorney in fact in its name, place and stead to accept such service of any and all such writs, claims, process and summonses, and has agreed that the failure of the Process Agent to give any notice to
it of any such service of process shall not impair or affect the validity of such service or of any judgment based thereon. The Company has agreed to maintain at all times an agent with offices in New York City to act as its Process Agent. Nothing
in this Indenture shall in any way be deemed to limit the ability to serve any such writs, process or summonses in any other manner permitted by applicable law. 
 ARTICLE 11 
 SUBORDINATION OF SECURITIES 

Section 11.01. Agreement to Subordinate. The Company covenants and agrees, and each Holder of Securities issued
hereunder by his acceptance thereof likewise covenants and agrees, that all Securities shall be issued subject to the provisions of this Article; and each Person holding any Security, whether upon original issue or upon transfer, assignment or
exchange thereof accepts and agrees that the Principal of and interest on all Securities issued hereunder shall, to the extent and in the manner herein set forth, be subordinated and subject in right of payment to the prior payment in full of all
Senior Indebtedness. 
 Section 11.02. Payments to Securityholders. No payments on account of
Principal of or interest on the Securities shall be made if at the time of such payment or immediately after giving effect thereto there shall exist a default in any payment with respect to any Senior Indebtedness, and such default shall not have
been cured or waived or shall not have ceased to exist. 
 Upon any payment or distribution of assets of the Company of any kind
or character, whether in cash, property or securities, to creditors upon any liquidation, dissolution, winding up, receivership, reorganization, assignment for the benefit of creditors, marshalling of assets and liabilities or any bankruptcy,
insolvency or similar proceedings of the Company, all amounts due or to become due upon all Senior Indebtedness shall first be paid in full, in cash or cash equivalents, or payment thereof provided for in accordance with its terms, before any
payment is made on account of the Principal of, or interest on the indebtedness evidenced by the Securities, and upon any such liquidation, dissolution, winding up, receivership, reorganization, assignment, marshalling or proceeding, any payment or
distribution of assets of the Company of any kind or character, whether in cash, property or securities, to which the Holders of the Securities or the Trustee under this Indenture would be entitled, except for the provisions hereof, shall be paid by
the Company or by any receiver, trustee in bankruptcy, liquidating trustee, agent or other Person making such payment or distribution, directly to the holders of Senior Indebtedness (pro rata to such holders on the basis of the respective amounts of
Senior Indebtedness held by such holders) or their respective representatives, or to the trustee or trustees under any indenture pursuant to which any instruments evidencing any of such Senior Indebtedness may have been issued, as their respective
interests may appear, to the extent necessary to pay all Senior Indebtedness in full (including, without limitation, except to the extent, if any, prohibited by mandatory provisions of law, post-petition interest, in any such proceedings), after
giving effect to any concurrent payment or distribution to or for the holders of Senior Indebtedness, before any payment or distribution is made to the holders of the indebtedness evidenced by the Securities or to the Trustee under this Indenture.

 In the event that, notwithstanding the foregoing, any payment or distribution of assets of the Company of any kind or
character, whether in cash, property or securities, prohibited by the foregoing, shall be received by the Trustee under this Indenture or the Holders of the Securities before all Senior Indebtedness is paid in full or provision is made for such
payment in accordance with its terms, such payment or distribution shall be held in trust for the benefit of and shall be paid over or delivered to the holders of such Senior Indebtedness or their respective representatives, or to the trustee or
trustees under any indenture pursuant to which any instruments evidencing any of such Senior Indebtedness may have been issued, as their respective interests may appear, for application to the payment of all Senior Indebtedness remaining unpaid
until all such Senior Indebtedness shall have been paid in full in accordance with its terms, after giving effect to any concurrent payment or distribution to or for the holders of such Senior Indebtedness. 

For purposes of this Article, the words, “cash, property or securities” shall not be deemed to include shares of stock of the
Company as reorganized or readjusted, or securities of the Company or any other corporation provided for by a plan of arrangement, reorganization or readjustment, the payment of which is subordinated (at least to the extent provided in this Article
with respect to the Securities) to the payment of all Senior Indebtedness which may at the time be outstanding; provided , that (i) the Senior Indebtedness is assumed by the new corporation, if any, resulting from any such arrangement,
reorganization or readjustment, and (ii) the rights of the holders of the Senior Indebtedness are not, without the consent of such holders, altered by such arrangement, reorganization or readjustment. The consolidation of the Company with, or
the merger of the Company into, another corporation or the liquidation or dissolution of the Company following the sale, conveyance or transfer of all or substantially all of its property and assets to another corporation upon the terms and
conditions provided in Article 5 shall not be deemed a dissolution, winding-up, liquidation or 

  
 30 

 
reorganization for the purposes of this Section if such other corporation shall, as a part of such consolidation, merger, sale, conveyance or transfer, comply with the conditions stated in
Article 5. Nothing in this Section shall apply to claims of, or payments to, the Trustee under or pursuant to Article 7. This Section shall be subject to the further provisions of Section 11.05. 

Section 11.03. Subrogation of Securities. Subject to the payment in full of all Senior Indebtedness, the
Holders of the Securities shall be subrogated to the rights of the holders of Senior Indebtedness to receive payments or distributions of cash, property or securities of the Company applicable to the Senior Indebtedness until the Principal of and
interest on the Securities shall be paid in full; and, for the purposes of such subrogation, no payments or distributions to the holders of the Senior Indebtedness of any cash, property or securities to which the Holders of the Securities or the
Trustee on their behalf would be entitled except for the provisions of this Article, and no payment over pursuant to the provisions of this Article to the holders of Senior Indebtedness by Holders of the Securities or the Trustee on their behalf
shall, as between the Company, its creditors other than holders of Senior Indebtedness and the Holders of the Securities, be deemed to be a payment by the Company to or on account of the Senior Indebtedness; and no payments or distributions of cash,
property or securities to or for the benefit of the Securityholders pursuant to the subrogation provision of this Article, which would otherwise have been paid to the holders of Senior Indebtedness shall be deemed to be a payment by the Company to
or for the account of the Securities. It is understood that the provisions of this Article are and are intended solely for the purpose of defining the relative rights of the Holders of the Securities, on the one hand, and the holders of the Senior
Indebtedness, on the other hand. 
 Nothing contained in this Article or elsewhere in this Indenture or in the Securities is
intended to or shall impair, as between the Company, its creditors other than the holders of Senior Indebtedness, and the Holders of the Securities, the obligation of the Company, which is absolute and unconditional, to pay to the Holders of the
Securities the Principal of and interest on the Securities as and when the same shall become due and payable in accordance with their terms, or is intended to or shall affect the relative rights of the Holders of the Securities and creditors of the
Company other than the holders of the Senior Indebtedness, nor shall anything herein or therein prevent any Holder of any Security or the Trustee on his behalf from exercising all remedies otherwise permitted by applicable law upon default under
this Indenture, subject to the rights, if any, under this Article of the holders of Senior Indebtedness in respect of cash, property or securities of the Company received upon the exercise of any such remedy. 

Upon any payment or distribution of assets of the Company referred to in this Article, the Trustee, subject to the provisions of
Sections 7.01 and 7.02, and the Holders of the Securities shall be entitled to rely upon any order or decree made by any court of competent jurisdiction in which such liquidation, dissolution, winding up, receivership, reorganization,
assignment or marshalling proceedings are pending, or a certificate of the receiver, trustee in bankruptcy, liquidating trustee, agent or other Person making such payment or distribution, delivered to the Trustee or to the Holders of the Securities,
for the purpose of ascertaining the Persons entitled to participate in such distribution, the holders of the Senior Indebtedness and other indebtedness of the Company, the amount thereof or payable thereon, the amount or amounts paid or distributed
thereon and all other facts pertinent thereto or to this Article. 
 Section 11.04. Authorization by
Securityholders. Each Holder of a Security by his acceptance thereof authorizes the Trustee in his behalf to take such action as may be necessary or appropriate to effectuate the subordination provided in this Article and appoints the Trustee
his attorney-in-fact for any and all such purposes. 
 Section 11.05. Notice to Trustee. The Company
shall give prompt written notice to the Trustee and to any Paying Agent of any fact known to the Company which would prohibit the making of any payment of moneys to or by the Trustee or any Paying Agent in respect of the Securities pursuant to the
provisions of this Article or would end such prohibition. Regardless of anything to the contrary contained in this Article or elsewhere in this Indenture, the Trustee shall not be charged with knowledge of the existence of any Senior Indebtedness or
of any default or event of default with respect to any Senior Indebtedness or of any other facts which would prohibit the making of any payment of moneys to or by the Trustee or which would end such prohibition, unless and until the Trustee shall
have received notice in writing at its principal Corporate Trust Office to that effect signed by an Officer of the Company, or by a holder or agent of a holder of Senior Indebtedness or by the trustee under any indenture pursuant to which Senior
Indebtedness shall be outstanding, who shall have been certified by the Company or otherwise established to the reasonable satisfaction of the Trustee to be such holder or agent or trustee, and, prior to the receipt of any such written notice, the
Trustee shall, subject to Sections 7.01 and 7.02, be entitled to assume that no such facts exist; provided that if on a date at least three Business Days prior to the date upon which by the terms hereof any such moneys shall become payable for
any purpose (including, without limitation, the payment of the Principal of, or interest on any Security) the Trustee shall not have received with respect to such moneys the notice of prohibition provided for in this Section, then, regardless of
anything herein to the contrary, the Trustee shall have full power and authority to receive such moneys and to apply the same to the purpose for which they were received, and shall not be affected by any notice to the contrary which may be received
by it on or after such prior date. 
 Regardless of anything to the contrary herein, nothing shall prevent (a) any payment
by the Company or the Trustee to the Securityholders of amounts in connection with a redemption of Securities if (i) notice of such redemption has been given pursuant to 

  
 31 

 
Article 3 prior to the receipt by the Trustee of written notice of prohibition as aforesaid, and (ii) such notice of redemption is given not earlier than 60 days before the
redemption date, or (b) any payment by the Trustee to the Securityholders of amounts deposited with it pursuant to Sections 8.01, 8.05 or 8.06. 
 Section 11.06. Trustee’s Relation to Senior Indebtedness. The Trustee and any agent of the Company or the Trustee shall be entitled to all the rights set forth in this
Article with respect to any Senior Indebtedness which may at any time be held by it in its individual or any other capacity to the same extent as any other holder of Senior Indebtedness and nothing in this Indenture shall deprive the Trustee or any
such agent, of any of its rights as such holder. Nothing in this Article shall apply to claims of, or payments to, the Trustee under or pursuant to 7.07. 
 With respect to the holders of Senior Indebtedness, the Trustee undertakes to perform or to observe only such of its covenants and obligations as are specifically set forth in this Article, and no implied
covenants or obligations with respect to the holders of Senior Indebtedness shall be read into this Indenture against the Trustee. The Trustee shall not be deemed to owe any fiduciary duty to the holders of Senior Indebtedness and, subject to the
provisions of Sections 7.01 and 7.02, the Trustee shall not be liable to any holder of Senior Indebtedness if it shall pay over or deliver to Holders of Securities, the Company or any other Person moneys or assets to which any holder of Senior
Indebtedness shall be entitled by virtue of this Article or otherwise. 
 Section 11.07. No Impairment of
Subordination. No right of any present or future holder of any Senior Indebtedness to enforce subordination as herein provided shall at any time in any way be prejudiced or impaired by any act or failure to act on the part of the Company or by
any act or failure to act, in good faith, by any such holder, or by any noncompliance by the Company with the terms, provisions and covenants of this Indenture, regardless of any knowledge thereof which any such holder may have or otherwise be
charged with. 

  
 32 

 SIGNATURES 
 IN WITNESS WHEREOF, the parties hereto have caused this Indenture to be duly executed, all as of the date first written above. 

 

			
	 UIL HOLDINGS CORPORATION
 as the Company

		
	By:	 	  

		 	Name:
		 	Title:
	
	 THE BANK OF NEW YORK MELLON
 as the Trustee

		
	By:	 	  

		 	Name:
		 	Title:EX-10.1

 Exhibit 10.1 
 EXECUTION VERSION 
 REPLACEMENT REVOLVING CREDIT FACILITY AND
INCREMENTAL TERM LOAN ASSUMPTION AGREEMENT dated as of March 6, 2012 (this “Agreement”), among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation (the “Borrower”), COMMUNITY HEALTH
SYSTEMS, INC., a Delaware corporation (“Parent”), the Subsidiary Guarantors listed on the signature pages hereto, the Incremental Term Lenders listed on the signature pages hereto, the Replacement Revolving Credit Facility
Lenders listed on the signature pages hereto and CREDIT SUISSE AG, as Administrative Agent and Collateral Agent. 
 PRELIMINARY
STATEMENT 
 A. Reference is made to the Credit Agreement dated as of July 25, 2007, as amended and restated as of
November 5, 2010, and February 2, 2012 (the “Credit Agreement”), among the Borrower, Parent, the Lenders from time to time party thereto and Credit Suisse AG, as administrative agent (in such capacity, the
“Administrative Agent”) and collateral agent for the Lenders. 
 B. Pursuant to Section 2.24 of the
Credit Agreement, the Borrower has requested that the persons set forth on Schedule I hereto (together with their permitted successors and assigns, the “Incremental Term Lenders”) commit to make Incremental Term Loans
to the Borrower on the Effective Date in an aggregate principal amount of $750,000,000 (the “Incremental Term Loans”; the commitment of each Incremental Term Lender to provide its applicable portion of the Incremental Term
Loans, an “Incremental Term Loan Commitment”). 
 C. The Incremental Term Lenders are willing to make
the Incremental Term Loans to the Borrower on the Effective Date on the terms and subject to the conditions set forth herein and in the Credit Agreement. 
 D. Pursuant to Section 2.25(d) of the Credit Agreement, the Borrower has requested that the persons set forth on Schedule I hereto (together with their permitted successors and assigns, the
“Replacement Revolving Credit Facility Lenders”) commit to provide to the Borrower on the Effective Date a new senior secured revolving credit facility in an aggregate principal amount of $750,000,000 (the
“Replacement Revolving Credit Facility”; the commitment of each Replacement Revolving Credit Facility Lender to provide its applicable portion of the Replacement Revolving Credit Facility, a “Replacement Revolving
Credit Facility Commitment”). 
 E. The Replacement Revolving Credit Facility Lenders are willing to provide such
Replacement Revolving Credit Facility Commitments to the Borrower on the Effective Date on the terms and subject to the conditions set forth herein and in the Credit Agreement. 

 Accordingly, in consideration of the foregoing and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows: 

SECTION 1. Terms Generally. Capitalized terms used but not otherwise defined herein (including in the Preliminary Statement
hereto) shall have the meanings assigned thereto in the Credit Agreement. The provisions of Section 1.02 of the Credit Agreement are hereby incorporated by reference herein, mutatis mutandis. This Agreement shall be a “Loan
Document” for all purposes of the Credit Agreement and the other Loan Documents and, to the extent it relates to the making of Incremental Term Loans, an “Incremental Term Loan Assumption Agreement” for all purposes of the Credit
Agreement and the other Loan Documents. 
 SECTION 2. Incremental Term Loans. (a) On the terms and subject to the
conditions set forth herein and in the Credit Agreement and in reliance upon the representations and warranties set forth herein and in the other Loan Documents, each Incremental Term Lender agrees, severally and not jointly, to make, on the
Effective Date, an Incremental Term Loan to the Borrower in an aggregate principal amount equal to its Incremental Term Loan Commitment. Amounts paid or prepaid in respect of the Incremental Term Loans may not be reborrowed. 

(b) The Incremental Term Loan Commitment of each Incremental Term Lender shall automatically terminate upon the making of the Incremental
Term Loans on the Effective Date. 
 (c) The proceeds of the Incremental Term Loans are to be used by the Borrower solely to
prepay Term Loans that are outstanding on the Effective Date immediately prior to giving effect to this Agreement. 
 (d) The
Borrower hereby unconditionally promises to pay to the Administrative Agent, for the account of each Incremental Term Lender, the principal amount of each Incremental Term Loan of such Incremental Term Lender as provided in Section 2.11(a)(iv)
of the Credit Agreement and Exhibit A hereto. 
 (e) The Incremental Term Loans shall constitute Other Term Loans, Other
Term A Loans, Refinancing Incremental Term Loans and Term Loans for all purposes of the Credit Agreement and the other Loan Documents, and shall have the terms that are set forth in Exhibit A hereto. 

SECTION 3. Replacement Revolving Credit Facility; Letters of Credit. (a) Subject to the terms and conditions set forth herein
and in the Credit Agreement and in reliance upon the representations and warranties set forth herein and in the other Loan Documents, each Replacement Revolving Credit Facility Lender agrees, severally and not jointly, to assume its Replacement
Revolving Credit Facility Commitment on the Effective Date. On the Effective Date, the Revolving Credit Commitments as in effect immediately prior to the Effective Date shall terminate and be replaced by the Replacement Revolving Credit Commitments.
From and after the Effective Date, each 

  
 2 

 
Replacement Revolving Credit Facility Lender shall constitute a “Revolving Credit Lender”, each Replacement Revolving Credit Commitment shall constitute a “Revolving Credit
Commitment” and the loans made pursuant thereto shall constitute “Revolving Loans”, in each case for all purposes of the Credit Agreement and the other Loan Documents, and the Replacement Revolving Credit Facility shall have the terms
that are set forth in Exhibit B hereto. 
 (b) Each of Credit Suisse AG and Wells Fargo Bank, N.A., in their
capacities as Issuing Banks under the Credit Agreement, and each Replacement Revolving Credit Facility Lender agree that notwithstanding the termination of the existing Revolving Credit Commitments, the Letters of Credit outstanding on the Effective
Date shall remain outstanding, and each Replacement Revolving Credit Facility Lender shall be deemed to have acquired a participation therein in accordance with its applicable Pro Rata Percentage in effect on the Effective Date and in accordance
with the provisions of Section 2.23 of the Credit Agreement. 
 (c) Each of Credit Suisse AG and Wells Fargo Bank, N.A.
agrees to act as an Issuing Bank in respect of the Replacement Revolving Credit Facility and Credit Suisse AG agrees to act as Swingline Lender in respect of the Replacement Revolving Credit Facility, in each case on the terms and subject to the
conditions set forth herein and in the Credit Agreement. 
 SECTION 4. Representations and Warranties. Each of Parent,
the Borrower and each Subsidiary Guarantor hereby represents and warrants to each other party hereto that: 
 (a) This Agreement
has been duly executed and delivered by each Loan Party and constitutes a legal, valid and binding obligation of such Loan Party enforceable against such Loan Party in accordance with its terms, except as such enforceability may be limited by
applicable bankruptcy, insolvency, reorganization, moratorium, or similar laws affecting creditors’ rights generally and by general principles of equity (regardless of whether enforcement is sought in a proceeding in equity or at law).

 (b) The representations and warranties set forth in Article III of the Credit Agreement and in each other Loan Document
are true and correct in all material respects on and as of the Effective Date as though made on and as of such date, except to the extent that such representations and warranties expressly relate to an earlier date, in which case such
representations and warranties were true and correct in all material respects as of such earlier date. 
 (c) No Default or
Event of Default has occurred and is continuing. 
 (d) None of the Security Documents in effect on the Effective Date will be
rendered invalid, non-binding or unenforceable against any Loan Party as a result of this Agreement. The Guarantees created under such Security Documents will continue to guarantee the Obligations (as the Obligations are modified hereunder) to the
same extent as they guaranteed the Obligations immediately prior to the Effective Date. Upon the 

  
 3 

 
filing of the Mortgage Amendments (as defined below), the Liens created under such Security Documents will continue to secure the Obligations (as the Obligations are modified hereunder), and will
continue to be perfected, in each case, to the same extent as they secured the Obligations or were perfected immediately prior to the Effective Date. 
 SECTION 5. Effectiveness. This Agreement shall become effective on and as of the date on which each of the following conditions precedent is satisfied (such date, the “Effective
Date”): 
 (a) The Administrative Agent shall have received counterparts hereof duly executed and delivered by
Parent, the Borrower, each Subsidiary Loan Party, each Incremental Term Lender and each Replacement Revolving Credit Facility Lender. 
 (b) The Administrative Agent shall have received a favorable written opinion of (i) Kirkland & Ellis LLP, counsel for Parent and the Borrower, substantially to the effect set forth on
Exhibit C-1 and (ii) the general counsel of Parent, substantially to the effect set forth in Exhibit C-2. 

(c) The Administrative Agent shall have received (i) a certificate as to the good standing of each Loan Party as of a recent date,
from the Secretary of State of its state of organization; (ii) a certificate of the Secretary or Assistant Secretary of each Loan Party dated the Effective Date and certifying (A) that attached thereto is a true and complete copy of
(1) the by-laws (or equivalent thereof) and (2) the certificate or articles of incorporation, certified as of a recent date by the Secretary of State of the applicable state of organization, in each case of such Loan Party as in effect on
the Effective Date and at all times since a date prior to the date of the resolutions described in clause (B) below, (or, if such by-laws (or equivalent thereof) or certificate or articles of incorporation have not been amended or modified
since any delivery thereof to the Administrative Agent on the Closing Date, the First Restatement Effective Date or the Second Restatement Effective Date, as applicable, certifying that no such amendment or modification has occurred), (B) that
attached thereto is a true and complete copy of resolutions duly adopted by the Board of Directors (or equivalent thereof) of such Loan Party authorizing the execution, delivery and performance of the Loan Documents to which such person is a party,
and that such resolutions have not been modified, rescinded or amended and are in full force and effect and (C) as to the incumbency and specimen signature of each officer executing this Agreement or any other document delivered in connection
herewith on behalf of such Loan Party; (iii) a certificate of another officer as to the incumbency and specimen signature of the Secretary or Assistant Secretary executing the certificate pursuant to clause (ii) above; and (iv) such
other documents as the Administrative Agent may reasonably request. 
 (d) The Administrative Agent shall have received a
certificate, dated the Effective Date and signed by a Financial Officer of the Borrower, confirming compliance with the conditions precedent set forth in paragraphs (b) and (c) of Section 4.01 of the Credit Agreement. 

  
 4 

 (e) The Administrative Agent shall have received a notice of termination of the existing
Revolving Credit Commitments from the Borrower pursuant to Section 2.09(b) of the Credit Agreement, and all Revolving Loans and Swingline Loans that are outstanding on the Effective Date immediately prior to giving effect to this Agreement
shall have been repaid pursuant to Section 2.12(a) of the Credit Agreement, together with any accrued and unpaid interest and Commitment Fees, in each case in respect of the existing Revolving Credit Commitments. 

(f) The Administrative Agent shall have received all Fees and other amounts due and payable on or prior to the Effective Date, including
upfront fees in the amounts agreed with each Incremental Term Lender and each Replacement Revolving Credit Facility Lender and, to the extent invoiced, reimbursement or payment of all out-of-pocket expenses required to be reimbursed or paid by the
Borrower hereunder or under any other Loan Document. 
 (g) The Security Documents shall be in full force and effect on the
Effective Date, and the Collateral Agent on behalf of the Secured Parties shall have a security interest in the Collateral of the type and priority described in each Security Document. 
 The Administrative Agent shall notify the Borrower, the Replacement Revolving Credit Lenders, the Incremental Term Lenders and the other Lenders under the Credit Agreement of the Effective Date and such
notice shall be conclusive and binding. 
 SECTION 6. Reaffirmation; Further Assurances. (a) Each of Parent, the
Borrower and each of the Subsidiary Guarantors identified on the signature pages hereto (collectively, Parent, the Borrower and such Subsidiary Guarantors, the “Reaffirming Loan Parties”) hereby acknowledges that it expects
to receive substantial direct and indirect benefits as a result of this Agreement and the transactions contemplated hereby. Each Reaffirming Loan Party hereby consents to this Agreement and the transactions contemplated hereby, and hereby confirms
its respective guarantees (including in respect of the Incremental Term Loans and the Replacement Revolving Credit Facility), pledges and grants of security interests (including in respect of the Incremental Term Loans and the Replacement Revolving
Credit Facility), as applicable, under each of the Loan Documents to which it is party, and agrees that, notwithstanding the effectiveness of this Agreement and the transactions contemplated hereby, such guarantees, pledges and grants of security
interests shall continue to be in full force and effect and shall accrue to the benefit of the Secured Parties (including in respect of the Incremental Term Lenders and the Replacement Revolving Credit Facility Lenders). Each of the Reaffirming Loan
Parties further agrees to take any action that may be required or that is reasonably requested by the Administrative Agent to effect the purposes of this Agreement, the transactions contemplated hereby or the Loan Documents and hereby reaffirms its
obligations under each provision of each Loan Document to which it is party. 
 (b) Within 90 days after the Effective Date (or
such later date as the Administrative Agent in its sole discretion may permit) the Borrower shall deliver, with respect to each Mortgage encumbering a Mortgaged Property, either (x) an amendment

  
 5 

 
thereof (each, a “Mortgage Amendment”), setting forth such changes as are reasonably necessary to reflect that the lien securing the Obligations under the Credit Agreement
encumbers such Mortgaged Property and to further grant, preserve, protect, confirm and perfect the first-priority lien and security interest thereby created and perfected, and opinions by local counsel reasonably acceptable to the Administrative
Agent regarding the enforceability of each such Mortgage Amendment, or (y) opinions or other written confirmations from local counsel reasonably acceptable to the Administrative Agent stating, to the reasonably satisfaction of the
Administrative Agent, that no such Mortgage Amendment is required with respect to a Mortgaged Property, in each case in substantially the same form as those Mortgage Amendments and local counsel opinions delivered to the Administrative Agent on the
First Restatement Effective Date, except for those changes necessary to reflect the transactions contemplated hereby, and each of the foregoing being in all respects reasonably acceptable to the Administrative Agent. 

SECTION 7. Consent. Each of the Incremental Term Lenders and the Replacement Revolving Credit Facility Lenders hereby agrees that,
so long as any Non-Extended Term Loans are outstanding, if the Borrower seeks to obtain the consent of any Class of Lenders to amend Section 2.13(g) of the Credit Agreement, or to waive compliance by the Borrower with such Section, in each case
solely to permit the Borrower to apply the proceeds of Permitted Additional Debt or Pari Passu Debt first, to repay Non-Extended Term Loans before being applied as otherwise required by such Section (a “Prepayment
Amendment”), then the execution and delivery of this Agreement by such Incremental Term Lender and Replacement Revolving Credit Facility Lender shall be deemed to constitute the consent of each such Lender and its successors and assigns
to any such Prepayment Amendment, without any further action of the Incremental Term Lenders or the Replacement Revolving Credit Facility Lenders. 
 SECTION 8. Expenses. The Borrower agrees to reimburse the Administrative Agent for its reasonable out-of-pocket expenses in connection with the Loan Documents (including the preparation of this
Agreement), including the reasonable fees, charges and disbursements of counsel for the Administrative Agent. 
 SECTION 9.
Notices. All notices hereunder shall be given in accordance with the provisions of Section 9.01 of the Credit Agreement. 
 SECTION 10. Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same
instrument. Delivery by electronic transmission of an executed counterpart of a signature page to this Agreement shall be effective as delivery of an original executed counterpart of this Agreement. 

SECTION 11. Governing Law. (a) THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE
OF NEW YORK. 
 (b) EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO
A 

  
 6 

 
TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER
THEORY). EACH PARTY HERETO (I) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND
(II) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION. 

SECTION 12. Headings. Section headings used herein are for convenience of reference only, are not part of this Agreement and shall
not affect the construction of, or be taken into consideration in interpreting, this Agreement. 
 [Remainder of page
intentionally left blank] 

  
 7 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by
their respective authorized officers as of the date first above written. 
  

					
	CHS/COMMUNITY HEALTH SYSTEMS, INC.,
		 	by	 	
		 		 	 /s/ James W. Doucette

		 		 	Name: James W. Doucette
		 		 	Title: Vice President and Treasurer
	
	COMMUNITY HEALTH SYSTEMS, INC.,
		 	by	 	
		 		 	 /s/ James W. Doucette

		 		 	Name: James W. Doucette
		 		 	Title: Vice President and Treasurer

 
			
	 Abilene Hospital LLC

Abilene Merger LLC
 Anna Hospital
Corporation
 Berwick Hospital Company, LLC
 Big Bend Hospital Corporation
 Big Spring Hospital Corporation

Birmingham Holdings II, LLC
 Birmingham Holdings,
LLC
 Bluefield Holdings, LLC
 Bluefield
Hospital Company, LLC
 Bluffton Health System, LLC
 Brownsville Hospital Corporation
 Brownwood Medical Center, LLC

Bullhead City Hospital Corporation
 Bullhead City
Hospital Investment Corporation
 Carlsbad Medical Center, LLC
 Centre Hospital Corporation
 CHHS Holdings, LLC

CHS Kentucky Holdings, LLC
 CHS Pennsylvania
Holdings, LLC
 CHS Virginia Holdings, LLC
 CHS Washington Holdings, LLC
 Clarksville Holdings, LLC

Cleveland Hospital Corporation
 Cleveland
Tennessee Hospital Company, LLC
 Clinton Hospital Corporation
 Coatesville Hospital Corporation
 College Station Medical Center, LLC

College Station Merger, LLC
 Community GP
Corp.
 Community Health Investment Company, LLC
 Community LP Corp.
 CP Hospital GP, LLC
 CPLP, LLC
 Crestwood Hospital LP, LLC

		
	by  	 	
		 	/s/ James W. Doucette
		 	 Name: James W. Doucette

Title: Vice President and Treasurer

  

 
			
	 Crestwood Hospital, LLC
 CSMC, LLC
 CSRA Holdings, LLC
 Deaconess Holdings, LLC
 Deaconess Hospital Holdings, LLC

Deming Hospital Corporation
 Desert Hospital
Holdings, LLC
 Detar Hospital, LLC

DHFW Holdings, LLC
 DHSC, LLC

Dukes Health System, LLC
 Dyersburg Hospital
Corporation
 Emporia Hospital Corporation
 Evanston Hospital Corporation
 Fallbrook Hospital Corporation

Foley Hospital Corporation
 Forrest City Arkansas
Hospital Company, LLC
 Forrest City Hospital Corporation
 Fort Payne Hospital Corporation
 Frankfort Health Partner, Inc.

Franklin Hospital Corporation
 Gadsden Regional
Medical Center, LLC
 Galesburg Hospital Corporation
 Granbury Hospital Corporation
 Granite City Hospital Corporation

Granite City Illinois Hospital Company, LLC

Greenville Hospital Corporation
 GRMC Holdings,
LLC
 Hallmark Healthcare Company, LLC

Hobbs Medco, LLC
 Hospital of Barstow,
Inc.
 Hospital of Fulton, Inc.

Hospital of Louisa, Inc.
 Hospital of Morristown,
Inc.
 Jackson Hospital Corporation

Jackson Hospital Corporation
 Jourdanton Hospital
Corporation
 Kay County Hospital Corporation
 Kay County Oklahoma Hospital Company, LLC

		
	by  	 	
		 	/s/ James W. Doucette
		 	 Name: James W. Doucette

Title: Vice President and Treasurer

 
			
	 Kirksville Hospital Company, LLC
 Lakeway Hospital Corporation
 Lancaster Hospital Corporation

Las Cruces Medical Center, LLC
 Lea Regional
Hospital, LLC
 Lexington Hospital Corporation
 Longview Merger, LLC
 LRH, LLC
 Lutheran Health Network of Indiana, LLC
 Marion Hospital Corporation

Martin Hospital Corporation
 Massillon Health
Community System, LLC
 Massillon Health System, LLC
 Massillon Holdings, LLC
 McKenzie Tennessee Hospital Company, LLC

McNairy Hospital Corporation MCSA, L.L.C.

Medical Center of Brownwood, LLC
 Merger Legacy
Holdings, LLC
 MMC of Nevada, LLC

Moberly Hospital Company, LLC
 MWMC Holdings,
LLC
 Naticoke Hospital Company, LLC

National Healthcare of Leesville, Inc.
 National
Healthcare of Mt. Vernon, Inc.
 National Healthcare of Newport, Inc.
 Navarro Regional, LLC
 NC-DSH, LLC
 Northampton Hospital Company, LLC
 Northwest Hospital, LLC

NOV Holdings, LLC
 NRH, LLC

Oak Hill Hospital Corporation
 Oro Valley
Hospital, LLC

		
	by  	 	
		 	/s/ James W. Doucette
		 	 Name: James W. Doucette

Title: Vice President and Treasurer

 
			
	 Palmer-Wasilla Health System, LLC
 Payson Hospital Corporation
 Peckville Hospital Company, LLC

Pennsylvania Hospital Company, LLC
 Phillips
Hospital Corporation
 Phoenixville Hospital Company, LLC
 Pottstown Hospital Company, LLC
 QHG Georgia Holdings II, LLC

QHG Georgia Holdings, Inc.
 QHG of Bluffton
Company, LLC
 QHG of Clinton County, Inc.
 QHG of Enterprise, Inc.
 QHG of Forrest County, Inc.

QHG of Fort Wayne Company, LLC
 QHG of
Hattiesburg, Inc.
 QHG of Massillon, Inc.
 QHG of South Carolina, Inc.
 QHG of Spartanburg, Inc.

QHG of Springdale, Inc.
 QHG of Warsaw Company,
LLC
 Quorum Health Resources, LLC
 Red
Bud Hospital Corporation
 Red Bud Illinois Hospital Company, LLC
 Regional Hospital of Longview, LLC
 River Region Medical Corporation

Roswell Hospital Corporation
 Ruston Hospital
Corporation
 Ruston Louisiana Hospital Company, LLC
 SACMC, LLC
 Salem Hospital Corporation
 San Angelo Community Medical Center, LLC
 San Angelo Medical, LLC

San Miguel Hospital Corporation

		
	by  	 	
		 	/s/ James W. Doucette
		 	 Name: James W. Doucette

Title: Vice President and Treasurer

 
			
	 Scranton Holdings, LLC
 Scranton Hospital Company, LLC
 Scranton Quincy Holdings, LLC

Scranton Quincy Hospital Company, LLC

Shelbyville Hospital Corporation
 Siloam Springs
Arkansas Hospital Company, LLC
 Siloam Springs Holdings, LLC
 Southern Texas Medical Center, LLC
 Spokane Valley Washington Hospital Company, LLC

Spokane Washington Hospital Company, LLC

Tennyson Holdings, LLC
 Tomball Texas Holdings,
LLC
 Tomball Texas Hospital Company, LLC

Tooele Hospital Corporation
 Triad Health Care
Corporation
 Triad Holdings III, LLC

Triad Holdings IV, LLC
 Triad Holdings V,
LLC
 Triad Nevada Holdings, LLC
 Triad
of Alabama, LLC
 Triad of Oregon, LLC

Triad-ARMC, LLC
 Triad-El Dorado, Inc.

Triad-Navarro Regional Hospital Subsidiary, LLC

Tunhannock Hospital Company, LLC
 VHC Medical,
LLC
 Vicksburg Healthcare, LLC

Victoria Hospital, LLC
 Virginia Hospital
Company, LLC
 Warren Ohio Hospital Company, LLC
 Warren Ohio Rehab Hospital Company, LLC
 Watsonville Hospital Corporation

		
	by  	 	
		 	/s/ James W. Doucette
		 	 Name: James W. Doucette

Title: Vice President and Treasurer

 
			
	 Waukegan Hospital Corporation
 Waukegan Illinois Hospital Company, LLC
 Weatherford Hospital Corporation

Weatherford Texas Hospital Company, LLC
 Webb
Hospital Corporation
 Webb Hospital Holdings, LLC
 Wesley Health System, LLC
 West Grove Hospital Company, LLC

WHMC, LLC
 Wilkes-Barre Behavioral Hospital
Company, LLC
 Wilkes-Barre Holdings, LLC

Wilkes-Barre Hospital Company, LLC
 Williamston
Hospital Corporation
 Women & Children’s Hospital, LLC
 Woodland Heights Medical Center, LLC
 Woodward Health System, LLC

Youngstown Ohio Hospital Company, LLC

		
	by  	 	
		 	/s/ James W. Doucette
		 	 Name: James W. Doucette

Title: Vice President and Treasurer

  

			
	Brownwood Hospital, L.P.
	By: Brownwood Medical Center, LLC
	Its: General Partner
		
	by  	 	
		 	/s/ James W. Doucette
		 	 Name: James W. Doucette

Title: Vice President and Treasurer

  

			
	College Station Hospital, L.P.
	By: College Station Medical Center, LLC
	Its: General Partner
		
	by  	 	
		 	/s/ James W. Doucette
		 	 Name: James W. Doucette

Title: Vice President and Treasurer

 
			
	Navarro Hospital, L.P.
	By: Navarro Regional, LLC
	Its: General Partner
		
	by  	 	
		 	/s/ James W. Doucette
		 	 Name: James W. Doucette

Title: Vice President and Treasurer

  

			
	QHG Georgia, LP
	By: QHG Georgia Holdings II, LLC
	Its: General Partner
		
	by  	 	
		 	/s/ James W. Doucette
		 	 Name: James W. Doucette

Title: Vice President and Treasurer

  

			
	Victoria of Texas, L.P.
	By: Detar Hospital, LLC
	Its: General Partner
		
	by  	 	
		 	/s/ James W. Doucette
		 	 Name: James W. Doucette

Title: Vice President and Treasurer

 
					
	
	CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, individually and as Administrative Agent, Collateral Agent, Swingline Lender and Issuing Bank,
		 	by	 	
		 		 	 /s/ Robert Hetu

		 		 	Name: Robert Hetu
		 		 	Title: Managing Director
			
		 	by	 	
		 		 	 /s/ Rahul Parmar

		 		 	Name: Rahul Parmar
		 		 	Title: Associate

 EXHIBIT A 
 Incremental Term Loans 
 Summary of Terms 

 

					
	Final Maturity and Amortization:	  	 The Incremental Term Loans will mature on October 25, 2016 (the “Incremental Term Loan Maturity
Date”); provided that such Incremental Term Loan Maturity Date shall instead be (x) the Springing Maturity Date, unless, on or prior to April 25, 2014, (A) all but $50,000,000 of the Non-Extended Term Loans shall have been
repaid, redeemed, defeased or otherwise satisfied in full (a “Repayment”) (and, if such Repayment shall have been financed, in whole or in part, with the proceeds of indebtedness (“Non-Extended Term Loan
Refinancing Indebtedness”), such Non-Extended Term Loan Refinancing Indebtedness shall have a final maturity date that is at least 91 days after October 25, 2016) and/or (B) the final maturity date with respect to all but
$50,000,000 of the Non-Extended Term Loans shall have been extended to a date that is at least 91 days after October 25, 2016, or (y) if the Incremental Term Loan Maturity Date has not otherwise been modified in accordance with clause (x) to a
date earlier than April 15, 2015, April 15, 2015, unless, on or prior to April 15, 2015, all but $50,000,000 aggregate principal amount of the Senior Notes (as defined in the Credit Agreement) shall have been Repaid (and, if such
Repayment shall have been financed, in whole or in part, with the proceeds of indebtedness, such indebtedness shall have a maturity date that is at least 91 days after October 25, 2016).

 
 “Springing Maturity Date” shall mean (i) if more than $50,000,000 of
Non-Extended Term Loans having a final maturity date of July 25, 2014, are outstanding on April 25, 2014, April 25, 2014, or (ii) if clause (i) does not apply but more than $50,000,000 aggregate principal amount of any
Non-Extended Term Loan Refinancing Indebtedness and Non-Extended Term Loans that in each case have a final maturity date that is earlier than 91 days after October 25, 2016 shall be outstanding after July 25, 2014, the date that is 91 days
prior to the earliest final maturity date after July 25, 2014 of any such Non-Extended Term Loan Refinancing Indebtedness or Non-Extended Term Loans.

		
		  	For purposes of Section 2.11(a)(iv) of the Credit Agreement, the Borrower shall pay to the Administrative Agent, for the account of the Incremental Term Lenders, on
each date set forth below, or if any such date is not a Business Day, on the next succeeding Business Day, a principal amount of the Incremental Term Loans (as adjusted from time to time pursuant to Sections 2.12, 2.13(g) and 2.24(d) of the Credit
Agreement) equal to (a) the aggregate principal amount of the Incremental Term Loans outstanding on the Effective Date multiplied by (b) the percentage set forth below opposite such date, with the balance payable in full on the Incremental Term Loan
Maturity Date:

  

					
	 Date
	  	Amount	 
	 June 30, 2012
	  	 	1 2/3	% 
	 September 30, 2012
	  	 	1 2/3	% 
	 December 31, 2012
	  	 	1 2/3	% 
	 March 31, 2013
	  	 	2.50	% 
	 June 30, 2013
	  	 	2.50	% 
	 September 30, 2013
	  	 	2.50	% 
	 December 31, 2013
	  	 	2.50	% 
	 March 31, 2014
	  	 	2.50	% 
	 June 30, 2014
	  	 	2.50	% 
	 September 30, 2014
	  	 	2.50	% 
	 December 31, 2014
	  	 	2.50	% 
	 March 31, 2015
	  	 	3.75	% 
	 June 30, 2015
	  	 	3.75	% 
	 September 30, 2015
	  	 	3.75	% 
	 December 31, 2015
	  	 	3.75	% 
	 March 31, 2016
	  	 	15.0	% 
	 June 30, 2016
	  	 	15.0	% 
	 September 30, 2016
	  	 	15.0	% 

					
		  	All payments of principal made pursuant to this paragraph shall be accompanied by accrued and unpaid interest on the principal amount to be paid to but excluding the
date of such payment.
		
	Mandatory Prepayments:	  	Notwithstanding the provisions of Section 2.13(g) of the Credit Agreement, the proceeds of any Permitted Additional Debt or Pari Passu Debt shall not be required to be
applied to prepay Incremental Term Loans until the Non-Extended Term Loans have been repaid in full and until such time any such proceeds shall be allocated to the payment of Term Loans in accordance with Section 2.13(g) of the Credit Agreement as
if no Incremental Term Loans were outstanding. From and after the time that the Non-Extended Term Loans are no longer outstanding, the proceeds of any Permitted Additional Debt or Pari Passu Debt shall be applied in accordance with Section 2.13(g)
of the Credit Agreement without giving effect to the prior sentence of this paragraph.
		
	Applicable Percentage:	  	The Applicable Percentage will initially be, with respect to any Eurodollar Incremental Term Loan, 2.50% per annum, and with respect to any ABR Incremental Term Loan,
1.50% per annum. After the end of the first full fiscal quarter following the Effective Date, the Applicable Percentage in respect of the Incremental Term Loans will be determined by reference to the pricing grid set forth below and in accordance
with the provisions of the Credit Agreement.

									
	 Leverage Ratio (as defined in the Credit Agreement)
	  	Eurodollar Spread—
Incremental 
Term
Loans	 	 	ABR Spread—
Incremental 
Term
Loans	 
	 Category 1 3 5.50 to 1.00
	  	 	3.00	% 	 	 	2.00	% 
	 Category 2 3 5.00 to 1.00 and < 5.50 to 1.00
	  	 	2.75	% 	 	 	1.75	% 
	 Category 3 3 4.50 to 1.00 and < 5.00 to 1.00
	  	 	2.50	% 	 	 	1.50	% 
	 Category 4 3 4.00 to 1.00 and < 4.50 to 1.00
	  	 	2.25	% 	 	 	1.25	% 
	 Category 5 < 4.00 to 1.00
	  	 	2.00	% 	 	 	1.00	% 

 EXHIBIT B 
 Replacement Revolving Credit Facility 
 Summary of Terms 

 

							
	Final Maturity:	  	The Replacement Revolving Credit Facility will mature and the commitments thereunder will terminate on October 25, 2016; provided that such maturity date
shall instead be (x) the Springing Maturity Date, unless, on or prior to April 25, 2014, (A) all but $50,000,000 of the Non-Extended Term Loans shall have been Repaid (and, if such Repayment shall have been financed, in whole or in part, with
the proceeds of Non-Extended Term Loan Refinancing Indebtedness, such Non-Extended Term Loan Refinancing Indebtedness shall have a final maturity date that is at least 91 days after October 25, 2016) and/or (B) the final maturity date with
respect to all but $50,000,000 of the Non-Extended Term Loans shall have been extended to a date that is at least 91 days after October 25, 2016, or (y) if the Replacement Revolving Credit Facility maturity date has not otherwise been modified
in accordance with clause (x) to a date earlier than April 15, 2015, April 15, 2015, unless, on or prior to April 15, 2015, all but $50,000,000 aggregate principal amount of the Senior Notes shall have been Repaid (and, if such
Repayment shall have been financed, in whole or in part, with the proceeds of indebtedness, such indebtedness shall have a maturity date that is at least 91 days after October 25, 2016).
		
	Applicable Percentage:	  	The Applicable Percentage will initially be, with respect to any Eurodollar Revolving Loan, 2.50% per annum, and with respect to any ABR Revolving Loan, 1.50% per annum.
After the end of the first full fiscal quarter following the Effective Date, the Applicable Percentage with respect to any Revolving Loans will be determined by reference to the pricing grid set forth below and in accordance with the provisions of
the Credit Agreement.

  

									
	 Leverage Ratio (as defined in the Credit Agreement)
	  	Eurodollar Spread—
Revolving
Loans	 	 	ABR Spread—
Revolving 
Loans	 
	 Category 1 3 5.50 to 1.00
	  	 	3.00	% 	 	 	2.00	% 
	 Category 2 3 5.00 to 1.00 and < 5.50 to 1.00
	  	 	2.75	% 	 	 	1.75	% 
	 Category 3 3 4.50 to 1.00 and < 5.00 to 1.00
	  	 	2.50	% 	 	 	1.50	% 
	 Category 4 3 4.00 to 1.00 and < 4.50 to 1.00
	  	 	2.25	% 	 	 	1.25	% 
	 Category 5 < 4.00 to 1.00
	  	 	2.00	% 	 	 	1.00	% 

					
	Commitment Fees:	  	Initially, from the Effective Date until the end of the first full fiscal quarter following the Effective Date, the Applicable Percentage with respect to the Revolving
Credit Commitment Fee shall be 0.50% per annum. Thereafter, the Applicable Percentage with respect to the Revolving Credit Commitment Fee will be determined by reference to the pricing grid set forth below and in accordance with the provisions of
the Credit Agreement.

  

					
	 Leverage Ratio (as defined in the Credit Agreement)
	  	Revolving
Credit
Commitment
Fee Rate
(per annum)	 
	 Category 1 3 5.50 to 1.00
	  	 	0.50	% 
	 Category 2 3 5.00 to 1.00 and < 5.50 to 1.00
	  	 	0.50	% 
	 Category 3 3 4.50 to 1.00 and < 5.00 to 1.00
	  	 	0.50	% 
	 Category 4 3 4.00 to 1.00 and < 4.50 to 1.00
	  	 	0.375	% 
	 Category 5 < 4.00 to 1.00
	  	 	0.375	% 

 EXHIBIT C-1 
 Form of Kirkland & Ellis LLP Opinion 

 March 6, 2012 
 Credit Suisse AG, 
 as Administrative Agent, Collateral 

Agent, and Issuing Bank 
 Credit
Suisse Securities (USA) LLC, 
 as Sole Book Runner 
 and Sole Lead Arranger, 
 Each of the Lenders party to 

the Credit Agreement described below 
 Ladies and Gentlemen: 
 We are issuing this opinion letter in our capacity as
special legal counsel to: (i) CHS/Community Health Systems, Inc., a Delaware corporation (“Borrower”), (ii) Community Health Systems, Inc., a Delaware corporation (“Parent”), and (iii) each of the
Subsidiaries listed on the Schedule of Guarantors attached hereto as Schedule E (collectively, the “Guarantors” and each a “Guarantor”) in response to the requirement in Section 5(b)(i) of
the Replacement Revolving Credit Facility and Incremental Term Loan Assumption Agreement, dated as of even date herewith (the “Replacement and Assumption Agreement”), among Parent, Borrower, the Guarantors, the Lenders listed on the
signature pages thereto and Credit Suisse, as Administrative Agent and Collateral Agent (the “Agent”). Reference is made to that certain Credit Agreement, dated as of July 25, 2007, as amended and restated as of
November 5, 2010, and February 2, 2012 (as so amended and restated, the “Credit Agreement”), among Parent, Borrower, the Agent, and the Lenders party thereto. Parent, Borrower and the Guarantors are collectively referred
to herein as the “Credit Parties” and each a “Credit Party”. References herein to the “Delaware Credit Parties” means each of Parent and Borrower. 

Capitalized terms used and not otherwise defined herein have the meanings ascribed to such terms in the Credit Agreement. The Agent, the
Sole Bookrunner and Sole Lead Arranger, and the Lenders are sometimes referred to herein as “you”. The term “Credit Documents” whenever it is used in this letter means the Replacement and Assumption Agreement and
the Credit Agreement, in each case in the form executed by the parties thereto on the date hereof. 
 The term
“Organization Documents” whenever it is used in this letter means the certificate of incorporation and the bylaws of the relevant entity, in each case, as amended through the date hereof. 

 March 6, 2012 
  Page
 2
 
  

 Subject to the assumptions, qualifications, exclusions and other limitations that are
identified in this letter and in the schedules attached to this letter, we advise you, and, with respect to each legal issue addressed in this letter, it is our opinion, that: 

 

	1.	Each of the Delaware Credit Parties is a corporation existing and in good standing under the Delaware General Corporation Law, as in effect on the date hereof (the
“DGCL”). 

  

	2.	Each of the Delaware Credit Parties has the corporate power to execute and deliver the Replacement and Assumption Agreement and perform its respective obligations under
the Credit Documents to which it is a party. 

  

	3.	Each of the boards of directors of each of the Delaware Credit Parties has adopted by requisite vote or action, in accordance with the applicable provisions of its
Organization Documents granting such authority to the board of directors, the resolutions necessary to authorize such Delaware Credit Party’s execution and delivery of the Replacement and Assumption Agreement, and the performance of such
Delaware Credit Party’s obligations under, the Credit Documents to which it is a party. 

  

	4.	Each Delaware Credit Party has duly executed and delivered the Replacement and Assumption Agreement. 

 

	5.	Each of the Credit Documents executed by each Credit Party is a valid and binding obligation of each such Credit Party that is a party thereto, and is enforceable
against such Credit Party in accordance with its terms. 

  

	6.	The execution and delivery by each of the Delaware Credit Parties and, except in the case of the following clause (a), each of the other Credit Parties, of the
Replacement and Assumption Agreement, and the performance of its obligations under each Credit Document, will not (a) violate any existing provisions of the Organization Documents of such Delaware Credit Party, (b) constitute a violation
by such Credit Party of any applicable provision of existing statutory law or governmental regulation applicable to such Credit Party and covered by this letter or (c) result in the creation or imposition of (or obligation to create or impose)
any Lien on any property of any Credit Party (other than Liens created pursuant to the Loan Documents) under, or result in a breach or other violation of, or constitute a default under, any agreement listed on the Schedule I attached hereto
(the “Specified Agreements”) (except we express no opinion with respect to conflicts, breaches or defaults under any agreement which is not a Specified Agreement or with respect to financial covenants or tests).

  

	7.	 No Credit Party is presently required to obtain any consent, approval, authorization or order of any State of New York or United States federal court
or governmental agency in order to obtain the right to execute and deliver the Replacement and Assumption 

 March 6, 2012 
  Page
 3
 
  

	 	
Agreement and perform any of the Credit Documents to which it is a party, except for: (a) those obtained or made on or prior to the date hereof, (b) any actions or filings necessary to
perfect the liens and security interests granted under the Security Documents or to release existing liens, (c) consents, approvals, authorizations, orders, actions or filings required in connection with ordinary course conduct by such Credit
Party of its respective businesses and ownership or operation by such Credit Parties of its assets, (d) consents, approvals, authorizations, orders, actions or filings required under any laws, regulations or governmental requirements as set
forth on Schedule C hereto, and (e) any actions or filings that may be required by any banking, insurance or other regulatory statute to which you may be subject (as to which matters we express no opinion). 

 

	8.	The execution and delivery of the Replacement and Assumption Agreement will not, in and of itself, result in the loss of perfection (if any) of any security interest
arising under Article 9 of the UCC to the extent that such security interest was and remained perfected under the Guarantee and Collateral Agreement under Article 9 of the UCC immediately prior to such execution and delivery. For the avoidance of
doubt, we express no opinion regarding (i) the creation, priority or enforcement of any such security interest, (ii) the effect on such priority of the execution and delivery of the Replacement and Assumption Agreement, or (iii) the
perfection of any such security interest. 

 In preparing this letter, we have relied without any independent
verification upon the assumptions recited in Schedule B to this letter and upon: (i) information contained in certificates obtained from governmental authorities; (ii) factual information represented to be true in the Credit
Agreement and the other Credit Documents; (iii) factual information provided to us in a support certificate executed by one or more of the Credit Parties; and (iv) factual information we have obtained from such other sources as we have
deemed reasonable. We have examined the originals or copies certified to our satisfaction, of such other corporate records of the Delaware Credit Parties as we deem necessary for or relevant to our opinions, certificates of public officials and the
officers of the Delaware Credit Parties and we have assumed without investigation that there has been no relevant change or development between the dates as of which the information cited in the preceding sentence was given and the date of this
letter and that the information upon which we have relied is accurate and does not omit disclosures necessary to prevent such information from being misleading. 
 While we have not conducted any independent investigation to determine facts upon which our opinions are based or to obtain factual information about which this letter advises you, we confirm that we do
not have any actual knowledge that has caused us to conclude that our reliance and assumptions cited in the preceding paragraph are unwarranted or that any information supplied to us in connection with the preparation of this letter is wrong. The
terms “actual knowledge”, “knowledge”, “aware” or similar terms wherever they are used in this letter with respect to our firm mean conscious awareness at the time this letter is delivered on the
date it bears by the following Kirkland & Ellis LLP lawyers who have had significant involvement with negotiation or preparation of the Credit Agreement (herein called “our Designated Transaction Lawyers”): Ashley Gregory.

 March 6, 2012 
  Page
 4
 
  

 Except as set forth in the following sentences of this paragraph, our opinion on every
legal issue addressed in this letter (collectively, “our opinions”) is based exclusively on such internal law of the State of New York or such federal law of the United States, which, in each case, is in our experience normally
applicable to general business entities not engaged in regulated business activities and to transactions of the type contemplated between the Credit Parties, on the one hand, and you, on the other hand, in the Credit Documents, but without our
having made any special investigation as to any other laws. We express no opinion or advice as to any law (a) to which the Credit Parties may be subject as a result of your legal or regulatory status, your sale or transfer of any Loans or other
obligations or interests therein or your (as opposed to any other lender’s) involvement in the transactions contemplated by the Credit Documents, (b) identified on Schedule C, or (c) which might be violated by any
misrepresentation or omission or a fraudulent act. For purposes of the opinion in paragraph 1, as to existence and good standing, we have relied exclusively upon certificates issued by a governmental authority in each relevant jurisdiction
and such opinion is not intended to provide any conclusion or assurance beyond that conveyed by such certificates. For purposes of paragraphs 2 through 4 and 6(a), such opinions are based on the DGCL and we have rendered such opinions based
exclusively on our review of the statutory provisions of such statutes as published by Aspen Law & Business, as supplemented through January 3, 2012, without regard to any regulations promulgated thereunder or any judicial or
administrative interpretations thereof. We advise you that issues addressed by this letter may be governed in whole or in part by other laws, but we express no opinion as to whether any relevant difference exists between the laws upon which
our opinions are based and any other laws which may actually govern. Our opinions are subject to all qualifications in Schedule A and do not cover or otherwise address any law or legal issue that is identified in the attached Schedule
C or any provision in the Credit Agreement or any of the other Credit Documents of any type identified in Schedule D. Provisions in the Credit Documents that are not excluded by Schedule D or any other part of this letter or its
attachments are called the “Relevant Agreement Terms.” 
 Except to the extent set forth in the preceding
paragraph, each of our opinions on each legal issue addressed in this letter represents our opinion as to how the issue addressed in such opinion would be resolved were it to be considered by the highest court of the jurisdiction upon whose law our
opinion on that issue is based. The manner in which any particular issue would be treated in any actual court case would depend in part on facts and circumstances particular to the case, and this letter is not intended to guarantee the outcome of
any legal dispute that may arise in the future. It is possible that some Relevant Agreement Terms may not prove enforceable for reasons other than those cited in this letter should an actual enforcement action be brought, but (subject to all the
exceptions, qualifications, exclusions and other limitations contained in this letter) such unenforceability would not in our opinion prevent you from realizing the principal benefits purported to be provided by the Relevant Agreement Terms of a
remedial nature contained in the Credit Documents. 

 March 6, 2012 
  Page
 5
 
  

 This letter speaks as of the time of its delivery on the date it bears. We do not assume
any obligation to provide you with any subsequent opinion or advice by reason of any fact about which our Designated Transaction Lawyers did not have actual knowledge at such time, by reason of any change subsequent to such time in any law covered
by any of our opinions, or for any other reason. The attached schedules are an integral part of this letter, and any term defined in this letter or any schedule has that defined meaning wherever it is used in this letter or in any schedule to this
letter. 
 You may rely upon this letter only for the purposes served by the provisions in the Replacement and Assumption
Agreement cited in the initial paragraph of this letter in response to which it has been delivered. Without our written consent: (i) no person other than you may rely on this letter for any purpose; (ii) this letter may not be cited or
quoted in any financial statement, prospectus, private placement memorandum or other similar document; (iii) this letter may not be cited or quoted in any other document or communication that might encourage reliance upon this letter by any
person or for any purpose excluded by the restrictions in this paragraph; and (iv) copies of this letter or any portion hereof may not be furnished to anyone for purposes of encouraging or in a manner that might encourage such reliance;
provided, however, that financial institutions that subsequently become Lenders under the Credit Agreement in accordance with the assignment provisions thereof may rely on this letter as of the date hereof as if this letter were addressed to
them. 
  

	
	Sincerely,
	
	

 Schedule A 
 General Qualifications 
 The opinions in the letter to which this Schedule
is attached (“our letter”) are subject to the qualifications as set forth in this Schedule A. 
  

	1.	Bankruptcy and Insolvency Exception. Each of our opinions of our letter is subject to the effect of bankruptcy, insolvency, reorganization, receivership,
moratorium and other similar laws. This exception includes: 

  

	 	(a)	the Federal Bankruptcy Code and thus comprehends, among others, matters of turn-over, automatic stay, avoiding powers, fraudulent transfer, preference, discharge,
conversion of a non-recourse obligation into a recourse claim, limitations on ipso facto and anti-assignment clauses and the coverage of pre-petition security agreements applicable to property acquired after a petition is filed;

  

	 	(b)	all other Federal and state bankruptcy, insolvency, reorganization, receivership, moratorium, arrangement and assignment for the benefit of creditors laws that affect
the rights of creditors generally or that have reference to or affect only creditors of specific types of debtors; 

  

	 	(c)	state fraudulent transfer and conveyance laws; and 

  

	 	(d)	judicially developed doctrines in this area, such as substantive consolidation of entities and equitable subordination and the recharacterization of debt.

  

	2.	Equitable Principles Limitation. Each of our opinions is subject to the effect of general principles of equity, whether applied by a court of law or equity. This
limitation includes principles: 

  

	 	(a)	governing the availability of specific performance, injunctive relief or other equitable remedies, which generally place the award of such remedies, subject to certain
guidelines, in the discretion of the court to which application for such relief is made; 

  

	 	(b)	affording equitable defenses (e.g., waiver, laches, and estoppel) against a party seeking enforcement; 

 

	 	(c)	requiring good faith and fair dealing in the performance and enforcement of a contract by the party seeking its enforcement; 

 

	 	(d)	requiring reasonableness in the performance and enforcement of an agreement by the party seeking enforcement of the contract; 

 

	 	(e)	requiring consideration of the materiality of (i) a breach and (ii) the consequences of the breach to the party seeking enforcement; 

  
 A-1

	 	(f)	requiring consideration of the impracticability or impossibility of performance at the time of attempted enforcement; and 

 

	 	(g)	affording defenses based upon the unconscionability of the enforcing party’s conduct after the parties have entered into the contract. 

 

	3.	Other Common Qualifications. Each of our opinions of our letter is subject to the effect of rules of law that: 

 

	 	(a)	limit or affect the enforcement of provisions of a contract that purport to waive, or to require waiver of, the obligations of good faith, fair dealing, diligence and
reasonableness; 

  

	 	(b)	provide that forum selection (and not choice of law) clauses in contracts are not necessarily binding on the court(s) in the forum selected (except to the extent
provided in Section 5-1402 of the New York General Obligations Law); 

  

	 	(c)	limit the availability of a remedy under certain circumstances where another remedy has been elected; 

 

	 	(d)	provide a time limitation after which a remedy may not be enforced; 

  

	 	(e)	limit the right of a creditor to use force or cause a breach of the peace in enforcing rights; 

 

	 	(f)	relate to the sale or disposition of collateral by a secured creditor or the requirements of a commercially reasonable sale; 

 

	 	(g)	limit the enforceability of provisions releasing, exculpating or exempting a party from, or requiring indemnification of a party for, liability for its own action or
inaction, to the extent the action or inaction involves negligence, recklessness, willful misconduct, unlawful conduct, violation of public policy, or for strict product liability or litigation against another party determined adversely to such
party or for liabilities arising under the securities laws, or which limit the enforceability of provisions requiring indemnification of a party with respect to litigation between such party and another party from whom indemnification is
sought which is determined adversely to the party seeking indemnification; 

  

	 	(h)	may, where less than all of a contract may be unenforceable, limit the enforceability of the balance of the contract to circumstances in which the unenforceable portion
is not an essential part of the agreed exchange; 

  

	 	(i)	govern and afford judicial discretion regarding the determination of damages and entitlement to attorneys’ fees and other costs; 

 

	 	(j)	may permit a party that has materially failed to render or offer performance required by the contract to cure that failure unless (i) permitting a cure would
unreasonably hinder the aggrieved party from making substitute arrangements for performance or (ii) it was important in the circumstances to the aggrieved party that performance occur by the date stated in the contract;

  
 A-2

	 	(k)	may render guarantees or similar instruments or agreements unenforceable under circumstances where your actions, failures to act or waivers, amendments or replacement
of the Credit Documents (i) so radically change the essential nature of the terms and conditions of the guaranteed obligations and the related transactions that, in effect, a new relationship has arisen between the beneficiary and the Credit
Parties that is substantially and materially different from that presently contemplated by the Credit Documents, (ii) release a primary obligor, or (iii) impair a guarantor’s recourse against the primary obligor; and

  

	 	(l)	render unenforceable requirements in the Credit Documents that provisions therein may only be waived or amended in writing, to the extent that an oral agreement or an
implied agreement by trade practice or course of conduct has been created modifying any such provision. 

  

	4.	Referenced Provision Qualification. Each opinion regarding the validity, binding effect, or enforceability of a provision (the “First
Provision”) in any of the Credit Documents requiring any party to perform its obligations under, or to cause any other person to perform its obligations under, any other provision (the “Second Provision”) of any Credit
Document, or stating that any action will be taken as provided in or in accordance with any such Second Provision, are subject to the same qualifications as the corresponding opinion in this letter relating to the validity, binding effect, and
enforceability of such Second Provision. 

  

	5.	Collateral Qualifications. The opinions and advice contained in our letter are subject to the following advice (terms used herein that are defined in the New
York UCC or any other applicable Uniform Commercial Code having the meanings for purposes hereof are used herein in accordance with the meanings given to them therein): 

 

	 	(a)	rights of debtors and obligors and duties of secured parties referred to in Sections 1-102(3) and 9-602 of the New York UCC (and the corresponding sections of any other
applicable Uniform Commercial Code) may not be waived, released, varied, or disclaimed by agreement, and our opinions regarding any such waivers, releases, variations, and disclaimers are limited accordingly; 

 

	 	(b)	we express no opinion with respect to any self-help remedies with respect to the Collateral to the extent they vary from those available under the New York UCC or other
applicable Uniform Commercial Code or with respect to any remedies otherwise inconsistent with the New York UCC (to the extent that the New York UCC is applicable thereto) or other applicable law (including, without limitation, any other applicable
Uniform Commercial Code); 

  

	 	(c)	a substantial body of case law treats guarantors as “debtors” under the New York UCC, thereby according guarantors rights and remedies of debtors established
by the New York UCC: 

  
 A-3

	 	(d)	we note that your remedies under the Guarantee and Collateral Agreement with regard to the sale or after the sale of (i) any securities subject to any security
interest are subject to compliance with state and federal securities law or (ii) any interest in a limited liability company or partnership interest is subject to compliance with applicable law; 

 

	 	(e)	we express no opinion with respect to the enforceability of any provision of any Credit Document that purports to authorize you to purchase at a private sale the
Collateral, which is not subject to widely distributed standard price quotations or sold on a recognized market; 

  

	 	(f)	we express no opinion regarding the characterization of a transaction as one involving the creation of a lien on real property, the characterization of a contract as
one in a form sufficient to create a lien or a security interest in real property, the creation, perfection, priority or enforcement of a lien on real property or matters involving ownership or title to any real property; 

 

	 	(g)	we express no opinion regarding the enforceability of any pre-default waiver of notification of disposition of the Collateral, mandatory disposition of the Collateral
or redemption rights; 

  

	 	(h)	we express no opinion regarding the enforceability of any provisions asserting that the Collateral is owned by or is property of a secured party prior to such secured
party’s foreclosure of such Collateral in accordance with the applicable Uniform Commercial Code or, in the case of cash Collateral, the application of such cash Collateral in payment of the secured obligations; 

 

	 	(i)	we note that our opinions as to the validity, binding effect or enforceability of any Credit Document do not constitute opinions as to the creation, perfection, effect
of perfection or priority of any lien or security interest purported to be granted thereunder; as to which matters we express no opinion, except to the extent specifically set forth in opinion paragraph 8; 

 

	 	(j)	we express no opinion as to the enforceability of cumulative remedies to the extent such cumulative remedies purport to or would have the effect of compensating the
party entitled to the benefits thereof in amounts in excess of the actual loss suffered by such party or would violate applicable laws concerning real estate or mixed collateral foreclosures or elections of remedies; 

 

	 	(k)	we express no opinion with respect to the adequacy of the waivers set forth in any guaranty insofar as they might not be broad enough for all situations which might
arise for which you would find a waiver desirable; and 

  

	 	(l)	we express no opinion with respect to the enforceability of any provision of any Credit Document which purports to authorize you to sign or file financing statements or
other documents under circumstances not authorized under the applicable Uniform Commercial Code. 

  
 A-4

	6.	Lender’s Regulatory Qualification. We express no opinion with respect to, and all our opinions are subject to, the effect of the compliance or noncompliance
of each of you with any state or federal laws or regulations applicable to you because of your legal or regulatory status or the nature of your business or requiring you to qualify to conduct business in any jurisdiction. 

 

	7.	Usury Qualification. We express no opinion with regard to usury or other laws limiting or regulating the maximum amount of interest that may be charged,
collected, received or contracted for other than the internal laws of the State of New York, and, without limiting the foregoing, we expressly disclaim any opinion as to the usury or other such laws of any other jurisdiction (including laws of other
states made applicable through principles of federal preemption or otherwise) that may be applicable to the transactions contemplated by the Credit Documents. 

 

	8.	Savings Clause Qualification. We express no opinion regarding the enforceability of any “fraudulent conveyance or fraudulent transfer savings clause”
in the Guarantee and Collateral Agreement and any similar provision in any other document or agreement to the extent such provisions purport to limit the amount of the obligations of any party or the right to contribution of any other party with
respect to such obligations. 

  
 A-5

 Schedule B 
 Assumptions 
 For purposes of our letter, we have relied, without
investigation, upon each of the following assumptions: 
  

	1.	Each of the Credit Parties (i) has the requisite title and rights to any property involved in the transactions effected under the Credit Documents (herein called
the “Transactions”) including without limiting the generality of the foregoing, each item of Collateral existing on the date hereof and (ii) will have the requisite title and rights to each item of Collateral arising after the
date hereof. 

  

	2.	You are existing and in good standing in your jurisdiction of organization. 

 

	3.	You have the corporate power or, if you are not a corporation, other requisite power (including, without limitation, under the laws of your jurisdiction of
organization) to execute, deliver and to perform your obligations under each of the Credit Documents, and each of the Credit Documents to which you are a party has been duly authorized by all necessary action on your part and, to the extent you are
a party, has been duly executed and duly delivered by you. 

  

	4.	The Credit Documents to which you are a party constitute valid and binding obligations of yours and are enforceable against you in accordance with their terms (subject
to qualifications, exclusions, and other limitations similar to those applicable to our letter). 

  

	5.	You have satisfied those legal requirements that are applicable to you to the extent necessary to make the Credit Documents enforceable against you.

  

	6.	You have complied with all legal requirements pertaining to your status as such status relates to your rights to enforce the Credit Documents against the Credit
Parties. 

  

	7.	Each of the Credit Parties (other than the Delaware Credit Parties) is a corporation or other entity existing and in good standing under the law of their respective
state of organization. 

  

	8.	Each of the Credit Parties’ (other than the Delaware Credit Parties’) stockholders, board of directors or equivalent governing body has adopted by requisite
vote the resolutions or approvals necessary to authorize such Credit Party’s execution, delivery and performance by it of each such Credit Document to which it is a party. 

 

	9.	Each of the Credit Documents, including the powers of attorney related to the execution thereof, have been duly executed and delivered by each of the Credit Parties
(other than the Delaware Credit Parties) that is a party thereto on the date hereof. 

  

	10.	 The execution and delivery by each Credit Party (other than the Delaware Credit Parties) of the Credit Documents to which it is a party, and the
consummation by it of the lending transactions contemplated by each Credit Document to which it is a party to occur on the date hereof in accordance with the terms thereof will not (a) violate any existing

  
 B-1

	 	
provisions of the Organization Documents of such Credit Party, (b) constitute a violation by such Credit Party of any applicable provision of existing laws or governmental regulation or
(c) violate any existing order, writ, injunction, judgment, determination, award or decree of any court or governmental instrumentality applicable to such Credit Party. 

 

	11.	No Credit Party (other than the Delaware Credit Parties) is presently required by any law to obtain any consent, approval, authorization or order of any court or
governmental agency in order to obtain the right to enter into any of the Credit Documents to which it is a party or to take any of the actions taken by it in connection with the consummation of the lending transactions contemplated by such Credit
Documents to occur on the date hereof in accordance with the terms thereof. 

  

	12.	Each document submitted to us for review is accurate and complete, each such document that is an original is authentic, each such document that is a copy conforms to an
authentic original, and all signatures on each such document are genuine. 

  

	13.	Each Public Authority Document is accurate, complete and authentic and all official public records (including their proper indexing and filing) are accurate and
complete. The term (“Public Authority Documents”) means a certificate issued by any secretary of state of any other government official, office or agency concerning a person’s property or status, such as a certificate of
corporate or partnership existence or good standing, a certificate concerning tax status, a certificate concerning Uniform Commercial Code filings or a certificate concerning title registration or ownership. 

 

	14.	There has not been any mutual mistake of fact or misunderstanding, fraud, duress or undue influence. 

 

	15.	The conduct of the parties to the Credit Documents has complied with any requirement of good faith, fair dealing, and conscionability. 

 

	16.	You have acted in good faith and without notice of any defense against the enforcement of any rights created by, or adverse claim to any property or security interest
transferred or created as part of, the Transactions. 

  

	17.	There are no agreements or understandings among the parties, written or oral (other than the Credit Documents), and there is no usage of trade or course or prior
dealing among the parties that would, in either case, define, supplement or qualify the terms of the Credit Agreement or any of the other Credit Documents. 

 

	18.	The constitutionality or validity of a relevant statute, rule, regulation or agency action is not in issue. 

 

	19.	All parties to the Transactions will act in accordance with, and will refrain from taking any actions that are forbidden by, the terms and conditions of the Credit
Documents. 

  
 B-2

	20.	All agreements other than the Credit Documents (if any) with respect to which we have provided advice in our letter or reviewed in connection with our letter would be
enforced as written. 

  

	21.	None of the Credit Parties will in the future take any discretionary action (including a decision not to act) permitted under the Credit Documents that would result in
a violation of law or constitute a breach or default under any other agreements or court orders to which such entity may be subject. 

  

	22.	The Credit Parties will in the future obtain all permits and governmental approvals required, and will in the future take all actions required, relevant to the
consummation of the Transactions or performance of the Credit Documents. 

  

	23.	The representations made by each Credit Party in the Credit Documents to which it is a party with respect to its jurisdiction or organization, chief executive office
and location of equipment and inventory are and will remain true and correct. 

  

	24.	Each natural person who is executing any Credit Document on behalf of any Credit Party has sufficient legal capacity to enter into such Credit Document, and we have no
actual knowledge of any such incapacity. 

  

	25.	No Lender is subject to Regulation T of the Board of Governors of the Federal Reserve System; and no proceeds of the Loans will be used for any purpose which would
violate or be inconsistent with terms of the Credit Agreement. 

  

	26.	All information required to be disclosed in connection with any consent or approval by the Credit Parties’ respective board of directors, board of managers, or
manager, as applicable, or their stockholders (or equivalent governing or ownership group) and all other information required to be disclosed in connection with any issue relevant to our opinions or any matter relevant to any legal issue covered by
our opinions has been fully and fairly disclosed to all persons to whom it is required to be disclosed and no such disclosure contained any relevant error or omission. 

 

	27.	Each person who has taken any action relevant to any of our opinions in the capacity of director, management committee member, or officer was duly elected to that
director, management committee member, or officer position and held that position when such action was taken. 

  

	28.	Each of the Credit Parties’ Organization Documents, all amendments to each such Organization Document, and all resolutions adopted establishing classes or series
of stock or other equity interests under such Organization Documents have been adopted in accordance with all applicable legal requirements. 

  

	29.	The transactions contemplated by the Credit Documents are directly or indirectly related to the business interests of each Credit Party party thereto and the
transactions were fair and reasonable to each such entity at the time each such transaction was authorized by such Credit Party, and the transactions were necessary or convenient to the conduct, promotion, or attainment of the business of the Credit
Parties. 

  
 B-3

	30.	Immediately prior to the effectiveness of the Replacement and Assumption Agreement, each of the Credit Agreement and the other “Loan Documents” remains in
full force and effect and has not been amended, modified, supplemented (other than to join any Guarantor as a party thereto) or replaced since February 2, 2012. 

  
 B-4

 Schedule C 
 Excluded Law and Legal Issues 
 None of the opinions or advice contained in
our letter covers or otherwise addresses any of the following laws, regulations or other governmental requirements or legal issues: 
  

	1.	Federal securities laws and regulations (including all other laws and regulations administered by the United States Securities and Exchange Commission), state
“Blue Sky” laws and regulations, and laws and regulations relating to commodity (and other) futures and indices and other similar instruments. 

  

	2.	Pension and employee benefit laws and regulations (e.g., ERISA). 

  

	3.	Federal and state antitrust and unfair competition laws and regulations. 

  

	4.	Federal and state laws and regulations concerning filing and notice requirements (such as the Hart-Scott-Rodino Antitrust Improvements Act of 1986, as amended, and the
Exon-Florio Act, as amended) other than requirements applicable to charter-related documents such as a certificate of merger. 

  

	5.	Compliance with fiduciary duty requirements. 

  

	6.	The statutes and ordinances, the administrative decisions and the rules and regulations of counties, towns, municipalities and special political subdivisions and
judicial decisions to the extent that they deal with any of the foregoing. 

  

	7.	Fraudulent transfer and fraudulent conveyance laws. 

  

	8.	Federal and state environmental, land use and subdivision, tax, racketeering (e.g., RICO), health and safety and labor laws and regulations. 

 

	9.	To the extent not otherwise specified in this Schedule C, applicable zoning and building laws, ordinances, code, rules or regulations (e.g., OSHA).

  

	10.	Federal patent, trademark and copyright, state trademark, and other federal and state intellectual property laws and regulations. 

 

	11.	Federal and state laws, regulations and policies concerning (i) national and local emergency, (ii) possible judicial deference to acts of sovereign states,
and (iii) criminal and civil forfeiture laws. 

  

	12.	Other federal and state statutes of general application to the extent they provide for criminal prosecution (e.g., mail fraud and wire fraud statutes).

  

	13.	Any laws, regulations, directives and executive orders that prohibit or limit the enforceability of obligations based on attributes of the party seeking enforcement
(e.g., the Trading with the Enemy Act and the International Emergency Economic Powers Act). 

  
 C-1

	14.	The Anti-Terrorism Order, including Executive Order No. 13224 on Terrorism Financing, effective September 24, 2001 and the United and Strengthening America by
Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (together, the “Anti-Terrorism Order”) as amended, all rules and regulations promulgated thereunder and all federal, state and local laws,
statutes, ordinances, orders, governmental rules, regulations, licensing requirements and policies relating to the Anti-Terrorism Order, the foreign assets control regulations of the United States Treasury Department, and to the extent the following
relate to any Anti-Terrorism Law such anti-terrorism law or regulation (including without limitation the Executive order of September 23, 2001 Blocking Property and Prohibiting Transactions and Persons Who Commit and Threaten to Commit or
Support Terrorism) or the Anti-Terrorism Order: the ownership and operation of, or otherwise regulation of, companies which conduct, operate or otherwise pursue the business or businesses now and in the future conducted, operated or otherwise
pursued by any of the Credit Parties including, without limitation, the importation, transportation, manufacturing, dealing, purchase, use or storage of explosive materials. 

 

	15.	The Communications Act and the rules, regulations and policies of the Federal Communications Commission promulgated thereunder. 

 

	16.	The Federal Power Act, as amended, and the regulations implementing the Federal Power Act, all rules and regulations promulgated under any of the foregoing statutes,
the rules, regulations and policies of the Federal Energy Regulatory Commission and any other federal or any state or local regulatory authority, and all other federal state and local laws, orders, regulations, licensing requirements and policies
regulating, public utilities, electric utilities or energy facilities or services (and including without limitation any requirement under any such federal, state or local law or regulation that any Credit Party obtain any consent, approval,
authorization or order in order to enter into the Credit Documents and perform the transactions contemplated thereby or the effect of any failure to obtain any such consent, approval, authorization or order). 

 

	17.	The Fair Packaging and Labeling Act, as amended, the Food, Drug and Cosmetic Act, as amended, the Food Security Act of 1985, as amended, the Perishable Agricultural
Commodities Act, as amended, the Food, Agriculture, Conservation and Trade Act of 1990, as amended, the Nutritional Labeling and Education Act, as amended, all rules, policies and regulations promulgated under any of the foregoing statutes, and all
other federal, state and local laws, orders, regulations, licensing requirements and policies relating to the ownership, operation, processing, production, distribution, purchase or provisions of, or otherwise regulating, food or farm products or
animals. 

  

	18.	Federal, state and local liquor licensing laws and regulations. 

  

	19.	Title to any property. 

  

	20.	The Federal Reserve Board margin regulations. 

  

	21.	Any insurance, HMO, health insurance laws, hospital, regulations, directives or executive orders. 

  
 C-2

	22.	Federal, state and local laws, regulations, licensing requirements and policies relating to health care, hospitals, Medicare, Medicaid or CHAMPUS (including those of
any state regulatory agency or Centers for Medicare and Medicaid Services). 

  

	23.	Federal, state, or local regulation or order, of any authority, which relates to or otherwise imposes liability or standards of conduct concerning the licensure,
certification, qualification, or operation of a clinical or pathology laboratory, medical practice or other aspect of a Person’s business subject to such laws, including but not limited to laws governing Medicare and Medicaid laboratories, laws
regarding the professional standards of health care professionals; laws governing patient confidentiality and privacy; laws governing the corporate practice of medicine; laws governing laboratories; laws relating to kickbacks, self-referrals and
access to health care, as well as the Employee Health Care Access Act; 21 U.S.C. ‘301-392, the Federal Food Drug and Cosmetic Act; 21 U.S.C. 821 et seq., the Federal Drug Abuse Act; Sections 1128, 1128A and 1128B of the Social Security Act; The
Clinical Laboratory Improvement Amendments of 1988; 42 U.S.C. 1320a-7b, 42 C.F.R. Part 1001, 42 CFR Chapter IV, Subchapter C; Sections 1876 or 1903 of the Social Security Act; 45 CFR, Part 74; 45 CFR, Part 92; 42 CFR 455.109 Section 306 of the
Clean Air Act; 42 U.S.C. ‘1857(h) et seq., Section 508 of the Clean Water Act; 33 U.S.C. ‘1368 et seq., Executive Order 11738 and Environmental Protection Agency regulations; 40 CFR Part 15, Title VI of the Civil Rights Act of 1964;
42 U.S.C. ‘2000 d et seq., Section 504 of the Rehabilitation Act of 1933; 29 U.S.C. ‘7940; Title IX of the Education Amendments of 1972, 20 U.S.C. ‘1681 et seq., the Age Discrimination Act of 1975; 42 U.S.C. ‘6101 et seq.,
Section 654 of OBRA ‘81; 42 U.S.C. ‘9849 and the Americans with Disabilities Act of 1990; P.L. 101-336, OBRAs 1986 through 1993, as amended, the Health Insurance Portability and Accountability Act, as amended, the Patient Protection
and Affordable Care Act, as amended, the Health Care and Education Affordability Reconciliation Act of 2010, and any other similar federal, state or local regulations. 

 

	24.	The effect of any law, regulation or order which becomes effective after the date hereof. 

We have not undertaken any research for purposes of determining whether any of the Credit Parties or any of the Transactions that may
occur in connection with the Replacement and Assumption Agreement, the Credit Agreement or any of the other Credit Documents is subject to any law or other governmental requirement other than to those laws and requirements that in our experience
would generally be recognized as applicable to the general business corporations which are engaged in transactions of the type contemplated by the Credit Documents and which are not engaged in regulated business activities in the absence of research
by lawyers in the State of New York, and none of our opinions covers any such law or other requirement unless (i) one of our Designated Transaction Lawyers had actual knowledge of its applicability at the time our letter is or was delivered on
the date it bears and (ii) it is not excluded from coverage by other provisions in our letter or in any Schedule to our letter. 

  
 C-3

 Schedule D 
 Excluded Provisions 
 None of the opinions in the letter to which this
Schedule is attached covers or otherwise addresses any of the following types of provisions which may be contained in the Credit Documents: 
  

	1.	Covenants not to compete, including without limitation covenants not to interfere with business or employee relations, covenants not to solicit customers, and covenants
not to solicit or hire employees. 

  

	2.	Indemnification for negligence, bad faith, willful misconduct or wrongdoing or strict product liability or any indemnification for liabilities arising under securities
laws. 

  

	3.	Provisions mandating contribution towards judgments or settlements among various parties. 

 

	4.	Waivers of (i) legal or equitable defenses, (ii) rights to damages, (iii) rights to counter claim or set off, (iv) statutes of limitations,
(v) rights to notice, (vi) the benefits of statutory, regulatory, or constitutional rights, unless and to the extent the statute, regulation, or constitution explicitly allows waiver, (vii) broadly or vaguely stated rights, and
(viii) other benefits to the extent they cannot be waived under applicable law. 

  

	5.	Provisions providing for forfeitures or the recovery of amounts deemed to constitute penalties, or for liquidated damages, acceleration of future amounts due (other
than principal) without appropriate discount to present value, late charges, prepayment charges, interest upon interest, and increased interest rates upon default. 

 

	6.	Time-is-of-the-essence clauses. 

  

	7.	Provisions that provide a time limitation after which a remedy may not be enforced. 

 

	8.	Confession of judgment clauses. 

  

	9.	Agreements to submit to the jurisdiction of any particular court or other governmental authority (either as to personal jurisdiction or subject matter jurisdiction);
provisions restricting access to courts; waiver of the right to jury trial; waiver of service of process requirements which would otherwise be applicable; and provisions otherwise purporting to affect the jurisdiction and venue of courts.

  

	10.	Provisions that attempt to change or waive rules of evidence or fix the method or quantum of proof to be applied in litigation or similar proceedings.

  

	11.	Provisions appointing one party as an attorney-in-fact for an adverse party or providing that the decision of any particular person will be conclusive or binding on
others. 

  

	12.	Provisions purporting to limit rights of third parties who have not consented thereto or purporting to grant rights to third parties. 

  
 D-1

	13.	Provisions that purport to award attorneys’ fees solely to one party. 

 

	14.	Arbitration agreements. 

  

	15.	Provisions purporting to create a trust or constructive trust without compliance with applicable trust law. 

 

	16.	Provisions relating to the application of insurance proceeds and condemnation awards. 

 

	17.	Provisions that provide for the appointment of a receiver or the taking of possession by the Agent. 

 

	18.	Provisions or agreements regarding proxies, shareholders agreements, shareholder voting rights, voting trusts, and the like. 

 

	19.	Confidentiality agreements. 

  

	20.	Provisions, if any, which are contrary to the public policy of jurisdictions covered by our opinions. 

 

	21.	Choice of law provisions, other than, under New York statutory choice-of-law rules, those provisions in the Credit Documents that provide that the laws of the State of
New York shall govern. 

  

	22.	Provisions in any of the Credit Documents requiring any Credit Party to perform its obligations under, or cause any other person to perform its obligations under, or
stating that any action will be taken as provided in or in accordance with, any agreement or other document that is not a Credit Document. 

  

	23.	Provisions of the Credit Documents insofar as they authorize you or your affiliates to setoff and apply deposits at any time held, and any other indebtedness at anytime
owing by you to or for the account of any Credit Party. 

  

	24.	With your permission, Section 9.20(e) of the Credit Agreement. 

  
 D-2

 Schedule E 
 Schedule of Guarantors 
  

	
	 1.        Abilene Hospital, LLC

	
	 2.        Abilene Merger, LLC

	
	 3.        Anna Hospital Corporation

	
	 4.        Berwick Hospital Company, LLC

	
	 5.        Big Bend Hospital Corporation

	
	 6.        Big Spring Hospital Corporation

	
	 7.        Birmingham Holdings, LLC

	
	 8.        Birmingham Holdings II, LLC

	
	 9.        Bluefield Holdings, LLC

	
	 10.      Bluefield Hospital Company, LLC

	
	 11.      Bluffton Health System, LLC

	
	 12.      Brownsville Hospital Corporation

	
	 13.      Brownwood Hospital, L.P.

	
	 14.      Brownwood Medical Center, LLC

	
	 15.      Bullhead City Hospital Corporation

	
	 16.      Bullhead City Hospital Investment Corporation

	
	 17.      Carlsbad Medical Center, LLC

	
	 18.      Centre Hospital Corporation

	
	 19.      CHHS Holdings, LLC

	
	 20.      CHS Kentucky Holdings, LLC 

	
	 21.      CHS Pennsylvania Holdings, LLC

	
	 22.      CHS Virginia Holdings, LLC 

	
	 23.      CHS Washington Holdings, LLC 

	
	 24.      Clarksville Holdings, LLC

	
	 25.      Cleveland Hospital Corporation

	
	 26.      Cleveland Tennessee Hospital Company, LLC

	
	 27.      Clinton Hospital Corporation

	
	 28.      Coatesville Hospital Corporation

	
	 29.      College Station Hospital, L.P.

	
	 30.      College Station Medical Center, LLC

	
	 31.      College Station Merger, LLC

	
	 32.      Community GP Corp.

	
	 33.      Community Health Investment Company, LLC

	
	 34.      Community LP Corp.

	
	 35.      CP Hospital GP, LLC

	
	 36.      CPLP, LLC

	
	 37.      Crestwood Hospital, LP, LLC

	
	 38.      Crestwood Hospital, LLC

	
	 39.      CSMC, LLC

	
	 40.      CSRA Holdings, LLC

	
	 41.      Deaconess Holdings, LLC

	
	 42.      Deaconess Hospital Holdings, LLC

	
	 43.      Deming Hospital Corporation

	
	 44.      Desert Hospital Holdings, LLC

  
 E-1

	
	 45.      Detar Hospital, LLC

	
	 46.      DHSC, LLC 

	
	 47.      DHFW Holdings, LLC 

	
	 48.      Dukes Health System, LLC

	
	 49.      Dyersburg Hospital Corporation

	
	 50.      Emporia Hospital Corporation

	
	 51.      Evanston Hospital Corporation

	
	 52.      Fallbrook Hospital Corporation

	
	 53.      Foley Hospital Corporation

	
	 54.      Forrest City Arkansas Hospital Company, LLC

	
	 55.      Forrest City Hospital Corporation

	
	 56.      Fort Payne Hospital Corporation

	
	 57.      Frankfort Health Partner, Inc.

	
	 58.      Franklin Hospital Corporation

	
	 59.      Gadsden Regional Medical Center, LLC

	
	 60.      Galesburg Hospital Corporation

	
	 61.      Granbury Hospital Corporation

	
	 62.      Granite City Hospital Corporation

	
	 63.      Granite City Illinois Hospital Company, LLC

	
	 64.      Greenville Hospital Corporation

	
	 65.      GRMC Holdings, LLC

	
	 66.      Hallmark Healthcare Company, LLC 

	
	 67.      Hobbs Medco, LLC

	
	 68.      Hospital of Barstow, Inc.

	
	 69.      Hospital of Fulton, Inc.

	
	 70.      Hospital of Louisa, Inc.

	
	 71.      Hospital of Morristown, Inc.

	
	 72.      Jackson Hospital Corporation (KY)

	
	 73.      Jackson Hospital Corporation (TN)

	
	 74.      Jourdanton Hospital Corporation

	
	 75.      Kay County Hospital Corporation

	
	 76.      Kay County Oklahoma Hospital Company, LLC

	
	 77.      Kirksville Hospital Company, LLC

	
	 78.      Lakeway Hospital Corporation

	
	 79.      Lancaster Hospital Corporation

	
	 80.      Las Cruces Medical Center, LLC

	
	 81.      Lea Regional Hospital, LLC

	
	 82.      Lexington Hospital Corporation

	
	 83.      Longview Merger, LLC

	
	 84.      LRH, LLC

	
	 85.      Lutheran Health Network of Indiana, LLC

	
	 86.      Marion Hospital Corporation

	
	 87.      Martin Hospital Corporation

	
	 88.      Massillon Community Health System LLC

	
	 89.      Massillon Health System LLC

	
	 90.      Massillon Holdings, LLC

  
 E-2

	
	 91.      McKenzie Tennessee Hospital Company, LLC

	
	 92.      McNairy Hospital Corporation

	
	 93.      MCSA, L.L.C.

	
	 94.      Medical Center of Brownwood, LLC

	
	 95.      Merger Legacy Holdings, LLC

	
	 96.      MMC of Nevada, LLC

	
	 97.      Moberly Hospital Company, LLC

	
	 98.      MWMC Holdings, LLC

	
	 99.      Nanticoke Hospital Company, LLC

	
	 100.    National Healthcare of Leesville, Inc.

	
	 101.    National Healthcare of Mt. Vernon, Inc.

	
	 102.    National Healthcare of Newport, Inc.

	
	 103.    Navarro Hospital, L.P.

	
	 104.    Navarro Regional, LLC

	
	 105.    NC-DSH, LLC

	
	 106.    Northampton Hospital Company, LLC

	
	 107.    Northwest Hospital, LLC

	
	 108.    NOV Holdings, LLC

	
	 109.    NRH, LLC

	
	 110.    Oak Hill Hospital Corporation

	
	 111.    Oro Valley Hospital, LLC

	
	 112.    Palmer-Wasilla Health System, LLC

	
	 113.    Payson Hospital Corporation

	
	 114.    Peckville Hospital Company, LLC

	
	 115.    Pennsylvania Hospital Company, LLC

	
	 116.    Phillips Hospital Corporation

	
	 117.    Phoenixville Hospital Company, LLC

	
	 118.    Pottstown Hospital Company, LLC

	
	 119.    QHG Georgia Holdings, Inc.

	
	 120.    QHG Georgia Holdings II, LLC

	
	 121.    QHG Georgia, LP

	
	 122.    QHG of Bluffton Company, LLC

	
	 123.    QHG of Clinton County, Inc.

	
	 124.    QHG of Enterprise, Inc.

	
	 125.    QHG of Forrest County, Inc.

	
	 126.    QHG of Fort Wayne Company, LLC

	
	 127.    QHG of Hattiesburg, Inc.

	
	 128.    QHG of Massillon, Inc.

	
	 129.    QHG of South Carolina, Inc.

	
	 130.    QHG of Spartanburg, Inc.

	
	 131.    QHG of Springdale, Inc.

	
	 132.    QHG of Warsaw Company, LLC

	
	 133.    Quorum Health Resources, LLC

	
	 134.    Red Bud Hospital Corporation

	
	 135.    Red Bud Illinois Hospital Company, LLC

	
	 136.    Regional Hospital of Longview, LLC

  
 E-3

	
	 137.    River Region Medical Corporation

	
	 138.    Roswell Hospital Corporation

	
	 139.    Ruston Hospital Corporation

	
	 140.    Ruston Louisiana Hospital Company, LLC

	
	 141.    SACMC, LLC

	
	 142.    Salem Hospital Corporation

	
	 143.    San Angelo Community Medical Center, LLC

	
	 144.    San Angelo Medical, LLC

	
	 145.    San Miguel Hospital Corporation

	
	 146.    Scranton Holdings, LLC

	
	 147.    Scranton Hospital Company, LLC

	
	 148.    Scranton Quincy Holdings, LLC

	
	 149.    Scranton Quincy Hospital Company, LLC

	
	 150.    Shelbyville Hospital Corporation

	
	 151.    Siloam Springs Arkansas Hospital Company, LLC

	
	 152.    Siloam Springs Holdings, LLC

	
	 153.    Southern Texas Medical Center, LLC

	
	 154.    Spokane Valley Washington Hospital Company, LLC

	
	 155.    Spokane Washington Hospital Company, LLC

	
	 156.    Tennyson Holdings, LLC

	
	 157.    Tooele Hospital Corporation

	
	 158.    Tomball Texas Holdings, LLC

	
	 159.    Tomball Texas Hospital Company, LLC

	
	 160.    Triad Healthcare Corporation

	
	 161.    Triad Holdings III, LLC

	
	 162.    Triad Holdings IV, LLC

	
	 163.    Triad Holdings V, LLC

	
	 164.    Triad Nevada Holdings, LLC

	
	 165.    Triad of Alabama, LLC

	
	 166.    Triad of Oregon, LLC

	
	 167.    Triad-ARMC, LLC

	
	 168.    Triad-El Dorado, Inc.

	
	 169.    Triad-Navarro Regional Hospital Subsidiary, LLC

	
	 170.    Tunkhannock Hospital Company, LLC

	
	 171.    VHC Medical, LLC

	
	 172.    Vicksburg Healthcare, LLC

	
	 173.    Victoria Hospital, LLC

	
	 174.    Victoria of Texas, L.P.

	
	 175.    Virginia Hospital Company, LLC

	
	 176.    Warren Ohio Hospital Company, LLC

	
	 177.    Warren Ohio Rehab Hospital Company, LLC

	
	 178.    Watsonville Hospital Corporation

	
	 179.    Waukegan Hospital Corporation

	
	 180.    Waukegan Illinois Hospital Company, LLC

	
	 181.    Weatherford Hospital Corporation

	
	 182.    Weatherford Texas Hospital Company, LLC

  
 E-4

	
	 183.    Webb Hospital Corporation

	
	 184.    Webb Hospital Holdings, LLC

	
	 185.    Wesley Health System, LLC

	
	 186.    West Grove Hospital Company, LLC

	
	 187.    WHMC, LLC

	
	 188.    Wilkes-Barre Behavioral Hospital Company, LLC

	
	 189.    Wilkes-Barre Holdings, LLC

	
	 190.    Wilkes-Barre Hospital Company, LLC

	
	 191.    Williamston Hospital Corporation

	
	 192.    Women & Children’s Hospital, LLC

	
	 193.    Woodland Heights Medical Center, LLC

	
	 194.    Woodward Health System, LLC

	
	 195.    Youngstown Ohio Hospital Company, LLC

  
 E-5

 Schedule I 
 Specified Agreements 
  

	 	1.	Indenture dated as of July 25, 2007, among Borrower, the Guarantors and U.S. Bank National Association, as Trustee, relating to the sale by Borrower of
$3,021,331,000 8 7/8% Senior Notes due 2015, as supplemented. 

  

	 	2.	Indenture dated as of November 22, 2011, among Borrower, Parent, Guarantors and U.S. Bank National Association, relating to the sale by Borrower of $1,000,000,000
8% Senior Notes due 2019. 

  
 I-1

 EXHIBIT C-2 
 Form of Opinion of General Counsel of Parent 

 March 6, 2012 
 The Lenders and the Agent Referred to Below 
 c/o Credit Suisse AG 

as Administrative Agent, Collateral Agent and 

Issuing Bank 
 Eleven Madison Avenue 

New York, New York 10010 
  

			
	RE:	 	Replacement Revolving Credit Facility and Incremental Term Loan Assumption Agreement, dated as of March 6, 2012

 Ladies and Gentlemen: 
 I am Executive Vice President, Secretary and General Counsel of CHS/Community Health Systems, Inc., a Delaware corporation (the “Borrower”), and have acted as Counsel for the Borrower,
Community Health Systems, Inc. (“Parent”) and each of the Subsidiaries listed on the Schedule of Guarantors attached hereto as Schedule A (each a “Guarantor” and, collectively, the
“Guarantors”, and together with the Borrower and Parent, the “Credit Parties”) in connection with the Replacement Revolving Credit Facility and Incremental Term Loan Assumption Agreement, dated as of even date
herewith (the “Replacement and Assumption Agreement”), among Parent, the Borrower, the Guarantors, and Credit Suisse AG, as Administrative Agent and Collateral Agent (the “Agent”), and the Lenders listed on the
signature pages thereto. Reference is made to that certain Credit Agreement, dated as of July 25, 2007, as amended and restated as of November 5, 2010, and February 2, 2012 (as so amended and restated, the “Credit
Agreement”), among Parent, the Borrower, Agent, and the Lenders party thereto. 
 This opinion is delivered to you
pursuant to subsection Section 5(b)(ii) of the Replacement and Assumption Agreement. All capitalized terms used herein that are defined in, or by reference in, the Credit Agreement have the meanings assigned to such terms therein, or by
reference therein, unless otherwise defined herein. With your permission, all assumptions and statements of reliance herein have been made without any independent investigation or verification on my part except to the extent otherwise expressly
stated, and I express no opinion with respect to the subject matter or accuracy of such assumptions or items relied upon. 
 In
connection with this opinion, I have (i) investigated such questions of law, (ii) examined originals or certified, conformed or reproduction copies of such agreements, instruments, documents, and records of the Credit Parties, such
certificates of public officials and such other documents, and (iii) received such information from officers and representatives of the Credit Parties, as I have deemed necessary or appropriate for the purposes of this opinion. I have examined,
among other documents, the following (in each case dated as of the date of the Replacement and Assumption Agreement): 
  

	 	(a)	an executed copy of the Replacement and Assumption Agreement; and 

  

	 	(b)	a copy of the Credit Agreement. 

The documents referred to in items (a) and (b) above, inclusive, are referred to herein as the “Transaction
Documents”. 
 In all such examinations, I have assumed the legal capacity of all natural persons executing documents,
the genuineness of all signatures on original or certified, conformed or reproduction copies of 

 The Lenders and the Agent Referred to Below 
 c/o Credit Suisse 
 as Agent 
  Page
 2
 of 9 
  

 
documents of all parties (other than with respect to the Credit Parties to the extent signed in my presence), the authenticity of original and certified documents and the conformity to original
or certified documents of all copies submitted to me as conformed or reproduction copies. As to various questions of fact relevant to the opinions expressed herein, I have relied upon, and assume the accuracy of, certificates and oral or written
statements and other information of or from public officials and others, and assume compliance on the part of all parties to the Transaction Documents with their covenants and agreements contained therein. 

With respect to the opinions expressed in clauses (ii) and (iv) of paragraph (b) below, my opinions are limited
(x) to my actual knowledge of the respective business activities and properties of the Credit Parties in respect of such matters and without any independent investigation or verification on my part and (y) to my review of only those laws
and regulations that, in my experience, are normally applicable to transactions of the type contemplated by the Transaction Documents. 
 To the extent it may be relevant to the opinions expressed herein, I have assumed that the parties to the Transaction Documents, other than Parent, the Borrower and the Guarantors, have the corporate
power to enter into and perform such documents and that (except as set forth in paragraph (b) below) such documents have been duly authorized, executed and delivered by, and constitute legal, valid and binding obligations of, such parties.

 Based upon the foregoing, and subject to the limitations, qualifications and assumptions set forth therein, I am of the
opinion that: 
 (a) Each Guarantor is a corporation, limited liability company, or limited partnership validly existing and in
good standing under the laws of the jurisdiction of its incorporation or organization and has all power and authority necessary to execute, deliver and perform its obligations under the Transaction Documents. 

(b) The execution and delivery by each Credit Party of the Replacement and Assumption Agreement and the performance by each Credit Party
of its respective obligations under each of the Transaction Documents and the borrowings by the Borrower and the grant by each Credit Party of the security interests pursuant to the Transaction Documents to which it is a party (i) have been
authorized, in the case of each Guarantor, by all necessary action by such Guarantor, (ii) do not require under present law any filing or registration by any Credit Party with, or approval or consent to any Credit Party of, any governmental
agency or authority of the State of Tennessee that has not been made or obtained, except those required in the ordinary course of business in connection with the future performance, if any, by each Credit Party of its respective obligations under
certain covenants contained in the Transaction Documents to which it is a party or pursuant to securities or other laws that may be applicable to the disposition of any collateral subject thereto, (iii) do not contravene any provision of the
certificate of incorporation or bylaws or similar organizational document of any Guarantor, (iv) do not violate any present law, or present regulation of any governmental agency or authority, of the State of Tennessee known by me to be
applicable to any Credit Party or their respective properties, (v) breach or cause a default under any agreement or violate any court decree or order binding upon such Credit Party or its property (this opinion being limited (x) to those
agreements, decrees or orders that have been filed as exhibits (or are incorporated by reference as exhibits) to the Form 10-K of Parent for the year ended December 31, 2010 and (y) in that I express, no opinion with respect to any breach,
default or violation not readily ascertainable from the face of any such agreement, decree or order, or arising under or based upon any cross default provision insofar as it relates to a default under an agreement not so identified to

 The Lenders and the Agent Referred to Below 
 c/o Credit Suisse 
 as Agent 
  Page
 3
 of 9 
  

 
me, or arising under or based upon any covenant of a financial or numerical nature or requiring computation), and (vi) will not result in or require the creation or imposition of any Lien
upon any properties of a Credit Party pursuant to the provisions of any agreement (this opinion being limited to those agreements that have been filed as exhibits (or are incorporated by reference as exhibits) to the Form 10-K of Parent for the year
ended December 31, 2010). 
 (c) The Replacement and Assumption Agreement has been duly executed and delivered on behalf of
each Guarantor that is a party thereto. 
 To my actual knowledge, I am not aware of any pending legal proceeding before, or
pending investigation by, any court or administrative agency or authority, or any arbitration tribunal, against or directly affecting the Credit Parties, or any of their respective properties, which seeks to enjoin or otherwise prevent the
consummation of, or to recover any damages or obtain relief in connection with or which would adversely affect the legality, validity or enforceability of, any of the Transaction Documents or the transactions contemplated thereby. 

I have issued certain limited opinions above as to the corporate, limited liability company, or limited partnership organization,
existence, good standing and authority of the Guarantors under the law of their respective states of organization. I do not purport to be an expert in matters of law of jurisdictions other than the State of Tennessee and the federal law of the
United States of America, and have issued my opinions based solely upon my review of the corporate record of each Guarantor. 

The opinions set forth above are subject to the following qualifications and limitations: 

 

	 	(a)	I express no opinion regarding the application of federal or state securities laws to the transactions contemplated in the Transaction Documents;

  

	 	(b)	I express no opinion regarding (i) the effect of fraudulent conveyance, fraudulent transfer and other similar laws relating to or affecting the rights of creditors
and (ii) restrictions relating to capital adequacy that may be applicable to any Guarantor to the extent any Transaction Document may be deemed a dividend or distribution; and 

 

	 	(c)	to the extent that section 8.31 of the Revised Model Business Corporation Act (as adopted in any state in which a Credit Party is incorporated) or other corporation law
analogous thereto may apply, I have assumed the transactions described in the Transaction Documents are fair to the Credit Parties. 

 I am qualified to practice law in the State of Tennessee, and I am no expert in and express no opinions as to the laws of other jurisdictions other than to the federal laws of the United States of America
and the laws of the State of Tennessee, as currently in effect. I assume no obligation to supplement this opinion if any applicable laws change after the date hereof or if I become aware of any facts that might change the opinions expressed herein
after the date hereof. 
 [Remainder of page intentionally left blank.] 

 The Lenders and the Agent Referred to Below 
 c/o Credit Suisse 
 as Agent 
  Page
 4
 of 9 
  

 The opinions expressed herein are solely for the benefit of the Lenders and the Agent
and may not be relied on in any manner or for any purpose by any other person or entity. 
  

	
	Very truly yours,

 The Lenders and the Agent Referred to Below 
 c/o Credit Suisse 
 as Agent 
  Page
 5
 of 9 
  

 Schedule A 
 Schedule of Guarantors 
 Abilene Hospital, LLC 

Abilene Merger, LLC 
 Anna Hospital Corporation 
 Berwick Hospital Company, LLC 

Big Bend Hospital Corporation 
 Big Spring Hospital Corporation 
 Birmingham Holdings, LLC 

Birmingham Holdings II, LLC 
 Bluefield Holdings, LLC 
 Bluefield Hospital Company, LLC 

Bluffton Health System, LLC 
 Brownsville Hospital Corporation 
 Brownwood Hospital, L.P. 

Brownwood Medical Center, LLC 
 Bullhead City Hospital Corporation 
 Bullhead City Hospital Investment Corporation

 Carlsbad Medical Center, LLC 
 Centre Hospital Corporation 
 CHHS Holdings, LLC 

CHS Kentucky Holdings, LLC 
 CHS Pennsylvania Holdings, LLC 
 CHS Virginia Holdings, LLC

 CHS Washington Holdings, LLC 
 Clarksville Holdings, LLC 
 Cleveland Hospital Corporation 

Cleveland Tennessee Hospital Company, LLC 
 Clinton Hospital Corporation 
 Coatesville Hospital Corporation 

College Station Hospital, L.P. 
 College Station Medical Center, LLC 
 College Station Merger, LLC 

Community GP Corp. 
 Community Health Investment Company, LLC 
 Community LP Corp. 

CP Hospital GP, LLC 
 CPLP, LLC 
 Crestwood Hospital, LP, LLC 

Crestwood Hospital, LLC 
 CSMC, LLC 
 CSRA Holdings, LLC 

 The Lenders and the Agent Referred to Below 
 c/o Credit Suisse 
 as Agent 
  Page
 6
 of 9 
  

 Deaconess Holdings, LLC 

Deaconess Hospital Holdings, LLC 
 Deming Hospital Corporation 
 Desert Hospital Holdings, LLC 

Detar Hospital, LLC 
 DHSC, LLC 

 DHFW Holdings, LLC 
 Dukes Health System, LLC 
 Dyersburg Hospital Corporation 

Emporia Hospital Corporation 
 Evanston Hospital Corporation 
 Fallbrook Hospital Corporation 

Foley Hospital Corporation 
 Forrest City Arkansas Hospital Company, LLC 
 Forrest City Hospital Corporation

 Fort Payne Hospital Corporation 
 Frankfort Health Partner, Inc. 
 Franklin Hospital Corporation 

Gadsden Regional Medical Center, LLC 
 Galesburg Hospital Corporation 
 Granbury Hospital Corporation 

Granite City Hospital Corporation 
 Granite City Illinois Hospital Company, LLC 
 Greenville Hospital Corporation

 GRMC Holdings, LLC 
 Hallmark Healthcare Company, LLC 
 Hobbs Medco, LLC 

Hospital of Barstow, Inc. 
 Hospital of Fulton, Inc. 
 Hospital of Louisa, Inc. 

Hospital of Morristown, Inc. 
 Jackson Hospital Corporation (KY) 
 Jackson Hospital Corporation (TN) 

Jourdanton Hospital Corporation 
 Kay County Hospital Corporation 
 Kay County Oklahoma Hospital Company, LLC

 Kirksville Hospital Company, LLC 
 Lakeway Hospital Corporation 
 Lancaster Hospital Corporation 

Las Cruces Medical Center, LLC 
 Lea Regional Hospital, LLC 
 Lexington Hospital Corporation 

Longview Merger, LLC 
 LRH, LLC 

 The Lenders and the Agent Referred to Below 
 c/o Credit Suisse 
 as Agent 
  Page
 7
 of 9 
  

 Lutheran Health Network of Indiana, LLC 

Marion Hospital Corporation 
 Martin Hospital Corporation 
 Massillon Community Health System LLC 

Massillon Health System LLC 
 Massillon Holdings, LLC 
 McKenzie Tennessee Hospital Company, LLC 

McNairy Hospital Corporation 
 MCSA, L.L.C. 
 Medical Center of Brownwood, LLC 

Merger Legacy Holdings, LLC 
 MMC of Nevada, LLC 
 Moberly Hospital Company, LLC 

MWMC Holdings, LLC 
 Nanticoke Hospital Company, LLC 
 National Healthcare of Leesville, Inc.

 National Healthcare of Mt. Vernon, Inc. 
 National Healthcare of Newport, Inc. 
 Navarro Hospital, L.P. 

Navarro Regional, LLC 
 NC-DSH, LLC 
 Northampton Hospital Company, LLC 

Northwest Hospital, LLC 
 NOV Holdings, LLC 
 NRH, LLC 

Oak Hill Hospital Corporation 
 Oro Valley Hospital, LLC 
 Palmer-Wasilla Health System, LLC 

Payson Hospital Corporation 
 Peckville Hospital Company, LLC 
 Pennsylvania Hospital Company, LLC 

Phillips Hospital Corporation 
 Phoenixville Hospital Company, LLC 
 Pottstown Hospital Company, LLC 

QHG Georgia Holdings, Inc. 
 QHG Georgia Holdings II, LLC 
 QHG Georgia, LP 

QHG of Bluffton Company, LLC 
 QHG of Clinton County, Inc. 
 QHG of Enterprise, Inc. 

QHG of Forrest County, Inc. 
 QHG of Fort Wayne Company, LLC 
 QHG of Hattiesburg, Inc. 

QHG of Massillon, Inc. 

 The Lenders and the Agent Referred to Below 
 c/o Credit Suisse 
 as Agent 
  Page
 8
 of 9 
  

 QHG of South Carolina, Inc. 

QHG of Spartanburg, Inc. 
 QHG of Springdale, Inc. 
 QHG of Warsaw Company, LLC 

Quorum Health Resources, LLC 
 Red Bud Hospital Corporation 
 Red Bud Illinois Hospital Company, LLC 

Regional Hospital of Longview, LLC 
 River Region Medical Corporation 
 Roswell Hospital Corporation 

Ruston Hospital Corporation 
 Ruston Louisiana Hospital Company, LLC 
 SACMC, LLC 

Salem Hospital Corporation 
 San Angelo Community Medical Center, LLC 
 San Angelo Medical, LLC 

San Miguel Hospital Corporation 
 Scranton Holdings, LLC 
 Scranton Hospital Company, LLC 

Scranton Quincy Holdings, LLC 
 Scranton Quincy Hospital Company, LLC 
 Shelbyville Hospital Corporation

 Siloam Springs Arkansas Hospital Company, LLC 
 Siloam Springs Holdings, LLC 
 Southern Texas Medical Center, LLC 

Spokane Valley Washington Hospital Company, LLC 
 Spokane Washington Hospital Company, LLC 
 Tennyson Holdings, LLC 

Tooele Hospital Corporation 
 Tomball Texas Holdings, LLC 
 Tomball Texas Hospital Company, LLC 

Triad Healthcare Corporation 
 Triad Holdings III, LLC 
 Triad Holdings IV, LLC 

Triad Holdings V, LLC 
 Triad Nevada Holdings, LLC 
 Triad of Alabama, LLC 

Triad of Oregon, LLC 
 Triad-ARMC, LLC 
 Triad-El Dorado, Inc. 

Triad-Navarro Regional Hospital Subsidiary, LLC 
 Tunkhannock Hospital Company, LLC 
 VHC Medical, LLC 

Vicksburg Healthcare, LLC 

 The Lenders and the Agent Referred to Below 
 c/o Credit Suisse 
 as Agent 
  Page
 9
 of 9 
  

 Victoria Hospital, LLC 

Victoria of Texas, L.P. 
 Virginia Hospital Company, LLC 
 Warren Ohio Hospital Company, LLC 

Warren Ohio Rehab Hospital Company, LLC 
 Watsonville Hospital Corporation 
 Waukegan Hospital Corporation 

Waukegan Illinois Hospital Company, LLC 
 Weatherford Hospital Corporation 
 Weatherford Texas Hospital Company, LLC

 Webb Hospital Corporation 
 Webb Hospital Holdings, LLC 
 Wesley Health System, LLC 

West Grove Hospital Company, LLC 
 WHMC, LLC 
 Wilkes-Barre Behavioral Hospital Company, LLC 

Wilkes-Barre Holdings, LLC 
 Wilkes-Barre Hospital Company, LLC 
 Williamston Hospital Corporation 

Women & Children’s Hospital, LLC 
 Woodland Heights Medical Center, LLC 
 Woodward Health System, LLC 

Youngstown Ohio Hospital Company, LLC 

 SCHEDULE I 
 Incremental Term Lender Commitments and 
 Replacement Revolving Credit
Facility Commitments 
  

									
	 Incremental Term Lender/Replacement Revolving Credit Facility Lender
	  	Incremental Term Loan
Commitment	 	  	Replacement Revolving
Credit Facility Lender
Commitment	 
			
	 Credit Suisse AG
	  	$	62,500,000.00	  	  	$	62,500,000.00	  
			
	 Bank of America, N.A.
	  	$	57,500,000.00	  	  	$	57,500,000.00	  
			
	 Citibank, N.A.
	  	$	57,500,000.00	  	  	$	57,500,000.00	  
			
	 JPMorgan Chase Bank, N.A.
	  	$	57,500,000.00	  	  	$	57,500,000.00	  
			
	 Wells Fargo Bank, N.A.
	  	$	57,500,000.00	  	  	$	57,500,000.00	  
			
	 Credit Agricole Corporate and Investment Bank
	  	$	57,500,000.00	  	  	$	57,500,000.00	  
			
	 Royal Bank of Canada
	  	$	57,500,000.00	  	  	$	57,500,000.00	  
			
	 SunTrust Bank
	  	$	57,500,000.00	  	  	$	57,500,000.00	  
			
	 Morgan Stanley Senior Funding, Inc.
	  	$	31,500,000.00	  	  	$	57,500,000.00	  
			
	 Morgan Stanley Bank, N.A.
	  	$	26,000,000.00	  	  	$	0.00	  
			
	 Deutsche Bank Trust Company Americas
	  	$	37,500,000.00	  	  	$	37,500,000.00	  
			
	 Goldman Sachs Bank USA
	  	$	37,500,000.00	  	  	$	37,500,000.00	  
			
	 Fifth Third Bank
	  	$	37,500,000.00	  	  	$	37,500,000.00	  
			
	 The Bank of Nova Scotia
	  	$	37,500,000.00	  	  	$	37,500,000.00	  
			
	 The Bank of Tokyo-Mitsubishi UFJ, Ltd.
	  	$	25,000,000.00	  	  	$	25,000,000.00	  
			
	 BBVA Compass Bank
	  	$	25,000,000.00	  	  	$	25,000,000.00	  
			
	 General Electric Capital Corporation
	  	$	12,500,000.00	  	  	$	12,500,000.00	  
			
	 Regions Bank
	  	$	10,000,000.00	  	  	$	10,000,000.00	  
			
	 Sovereign Bank, N.A.
	  	$	5,000,000.00	  	  	$	5,000,000.00	  
		  	  
	  
	 	  	  
	  
	 
			
	 TOTAL
	  	$	750,000,000	  	  	$	750,000,000

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00200-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00200-of-00352.parquet"}]]